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9General Introduction, Aims & Outline of the Thesis
General Introduction
Attention-deﬁcit/hyperactivity disorder (ADHD) affects about 5% of the children worldwide 
(Polanczyk, de Lima, Horta, Biederman & Rohde, 2007) and is associated with a high risk for 
adverse psychiatric outcomes in adult life (Biederman et al., 2006), poorer educational and 
vocational outcomes (Kuriyan et al., 2013), parental strain (Hinojosa, Hinojosa, Fernandez-
Baca, Knapp & Thompson, 2012), and elevated ﬁnancial costs by burden on health, social 
care, and justice systems in society (Pelham, Foster & Robb, 2007). 
The essential feature of children with ADHD, deﬁned by the Diagnostic and Statistical 
Manual of Mental Disorders (ﬁfth ed.; DSM-5; American Psychiatric Association, 2013) is a 
persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with 
adaptive functioning or development. Children presenting with these symptoms have been 
described since almost three centuries. Due to variable opinions and increased knowledge, 
the nomenclature of the clustered symptoms has been changed over time. Today, the 
literature on ADHD consists of around twenty-three thousands papers worldwide with 
more than half of these published the last decade. This amount demonstrates an 
extraordinary effort by researchers to investigate the clinical concept, the etiological 
factors, the underlying pathophysiology, and potential effective treatment modalities. 
Despite this effort, there are still gaps in our knowledge about ADHD.
This general introduction comprises a historical overview of the clinical concept of ADHD, 
the state of the art of resting-state oscillations in ADHD, and a preface of two non-pharma-
cological interventions in children with ADHD, i.e., neurofeedback (NF) and working memory 
training (WMT). Then, the aims and outline of this thesis will be presented. In the subsequent 
chapters (Chapter II-VI), ﬁve studies are presented, addressing the aims of the thesis. 
These chapters will be followed by the summary (Chapter VII), the general discussion, the 
main conclusions, clinical implications, and directions for future research (Chapter VIII).  
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“See the naughty, restless child
Growing still more rude and wild,
Till his chair falls over quite.
Philip screams with all his might,
Catches at the cloth, but then
That makes matters worse again.
Down upon the ground they fall,
Glasses, plates, knives, forks, and all.
How Mamma did fret and frown,
When she saw them tumbling down!
And Papa made such a face!
Philip is in sad disgrace.”
Figure 1   Fragment of the poem about Fidgety Philip by Hoffmann (1844).
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The clinical concept of attention-deficit/hyperactivity disorder 
from a historical perspective
Zappel-Philip (in English Fidgety Philip, Figure 1) was among the ﬁrst references to a 
hyperactive child, described in a German children’s book with poems about misbehaving 
children (Hoffmann, 1844). However, the ﬁrst scientiﬁc description of a condition in children 
that most closely resembles the currently concept of ADHD, has recently been awarded to 
Weikard (1742-1803) (Barkley & Peters, 2012). Weikard’s book in which lack of attention was 
discussed, dated from around 1770-1775. It mainly comprised a description of the illness, 
causes, and treatment. Especially the description of the inattentive symptoms has 
remarkable similarities with the current conceptualization of inattentive symptoms in ADHD 
(Barkley & Peters, 2012). 
In 1798, Crichton published a chapter on disorders of attention in his medical textbook 
dealing with an inquiry into the nature of mental disorders (Crichton, 1798; Lange, Reichl, 
Lange, Tucha & Tucha, 2010). 
A century later, three lectures to the Royal College of Physicians were published in which 
Still described children with problems in sustained attention, hyperactivity, deﬁant and 
aggressive behavior, and an excess of emotions; all in relation to a deﬁcit in “inhibitory volition” 
(Still, 1902). He assigned these problems to a major defect in “moral control” in their 
behavior, and suggested the role for biological determinants (Still, 1902; Barkley, 2006b). 
From 1917 to 1928, the focus was further shifted towards the underlying pathophysiology 
of the earlier described problems, when an outbreak of encephalitis in the United States and 
Europe caused major cognitive and behavioral problems among children, who survived this 
disease. This ‘post-encephalitic hyperkinetic syndrome’ included -among others- the 
cardinal features (i.e., inattention, hyperactivity, and impulsivity) of what is today called 
ADHD. Since these features were observed in children who had experienced actual dis-
ease-related neurological impairments, it provided evidence that behavioral problems could 
have biological causes (Ebaugh, 1923). 
In 1932, the German physicians Kramer and Pollnow reported “Uber eine hyperkinetische 
Erkrankung im Kindesalter” (Kramer & Pollnow, 1932). They made the point that symptoms 
of this ‘hyperkinetic disease’ had previously been observed, but not distinguished from 
other diseases with similar symptoms, such as the residual effects of the epidemic 
encephalitis. Kramer and Pollnow established a concept of the hyperkinetic disease that 
closely resembles the current concept of ADHD by recognizing the three core behavioral 
symptoms of ADHD, together with an early onset and the persistence of the disorder into 
adulthood (Rothenberger & Neumärker, 2005). 
A rising number of reports on brain damage in children with hyperactivity hypothesized 
that brain damage was the cause of this symptom. This idea was supported by the “Frontal 
Lobe Ablation Studies of Monkeys” (1930-1940) in which frontal lobe lesions often caused 
excessive restlessness, inability to sustain interest in activities, and behavioral disorganization 
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(Barkley, 2006a). This resulted in the development of the concept ‘minimal brain damage’ 
which stated that hyperactive behavior may be caused by minimal damage to the brain, 
even when this could not be objectiﬁed (Ross & Ross, 1976; Barkley, 2006a). 
In the 1960s, the idea that every child with hyperactivity had brain damage was challenged. 
It was argued that children did exist with hyperactivity but without any classically traumatic 
or infectious factor in their historical background and so a dysfunction of the diencephalon 
was suggested (Denhoff, Laufer & Solomons, 1957). Therefore, the Oxford International 
Study Group of Child Neurology advocated a shift in terminology by replacing the former 
term by ‘minimal brain dysfunction’. Although this concept persisted until the 1980s, its 
custom declined already in the 1960s when severe concerns arose (Rothenberger & 
Neumärker, 2005). It was found that many cases of known brain damage or dysfunction did 
not show hyperactivity or other symptoms postulated by the concept of minimal brain 
damage or dysfunction. Furthermore, the concept was criticized to be too general and 
heterogeneous.
In 1968, a deﬁnition of the concept of hyperactivity (at that time seen as the core feature 
of the clinical concept) was incorporated in the DSM-II. It was labeled as ‘Hyperkinetic 
Reaction of Childhood’, characterized by overactivity, restlessness, distractibility, and a 
short attention span, especially in young children with the notiﬁcation that the symptoms 
usually diminished in adolescence. This deﬁnition was of great importance because it 
replaced the etiological hypotheses of the past with a simple description of observable 
behavior.
In 1971, the Canadian psychologist Douglas presented in a Presidential Address to the 
Canadian Psychological Association her theory that deﬁcits in sustained attention and 
impulse control were more likely to account for the difﬁculties of these children than 
hyperactivity. Her landmark paper shifted the focus of research within the ﬁeld from 
hyperactivity to attention deﬁcit (Douglas, 1972).   
With the release of the DSM-III in 1980, the disorder was renamed by ‘attention deﬁcit disorder 
(with or without hyperactivity)’, based on the recognition that both inattention and impulsivity 
were signiﬁcant symptoms in establishing a diagnosis (Barkley, 2006a). However, the two 
subtypes were believed to correlate so highly that the disorder was regarded as a one-dimen-
sional construct. This led to the abolition of these subtypes, and so the name was changed 
into ‘attention- deﬁcit/hyperactivity disorder (ADHD)’ in the DSM-III–R.
Next, however, critics argued that this one-dimensional construct could increase rates of 
diagnostic errors (Atkins, Pelham & Licht, 1985, 1989). A multi-dimensional construct was 
hypothesized and studies showed that two dimensions of ADHD consistently emerged in 
exploratory factor analytic studies, i.e., an inattention factor and a combined impulsivi-
ty-hyperactivity factor (Pelham, Gnagy, Greenslade & Milich, 1992; Healey et al., 1993). This 
led to the implementation of three subtypes of ADHD - predominantly inattentive, 
predominantly hyperactive-impulsive, and a combined type - in the DSM-IV (Lahey et al., 
1994). The DSM-IV-TR did not modify the diagnostic classiﬁcation of ADHD. 
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The International Statistical Classiﬁcation of Diseases and Related Health Problems (10th 
rev. ICD-10; World Health Organization, 1992), until recently the most common used 
classiﬁcation system of psychiatric disorders, had almost identical criteria for inattention, 
hyperactivity, and impulsivity compared to the DSM-IV(-TR). However, there are differences; 
the ICD-10 uses the term ‘hyperkinetic disorder’, and only recognizes a combined type. 
Furthermore, the diagnosis demands the presence of criteria in each domain (inattention, 
hyperactivity, and impulsivity), requires all necessary criteria to be present in two settings 
and direct observation of the symptoms. Furthermore, the ICD-10 is stricter in the exclusion 
criteria. For the differences between the DSM-IV and the ICD-10 in detail, see for example, 
the paper by Tripp, Luk, Schaughency & Singh (1999).
In the DSM-5, special attention is given to guide clinicians in diagnosing adults with ADHD 
with the ultimate goal that all people with ADHD can get care throughout their lives if 
needed. In light of this purpose, the threshold criterion of at least ﬁve actual symptoms 
after the age of 17 for the diagnosis was added. Furthermore, the subtypes were held but 
renamed into presentation subtypes, rather than subtypes, the disorder was placed among 
the neurodevelopmental disorders, the criterion for the age of onset was expanded from 7 
to 12 years, and the possibility to specify the severity was included.
In sum, a behavioral pattern similar to what today is called ADHD, has been described for 
centuries. After the ﬁrst reference to a hyperactive child, more than 250 years ago, and 
after more than 50 years of research, ADHD is still based on a description of symptoms, 
established by classiﬁcation systems. 
Resting-state oscillations in ADHD
Resting-state oscillations 
Electroencephalography (EEG), a method to examine brain cortical activity was introduced 
by Berger (1929). An electroencephalogram (EEG) represents summed oscillations arising 
from synchronous ﬁring of large collections of neurons measured by electric ﬁeld differences 
on the scalp. The electrodes are often located far from the region from which the signals 
originate, thereby causing a relatively poor source localization and spatial resolution. 
Oscillations are characterized by their amplitude, phase, and frequency. 
Oscillatory frequencies are clustered by temporal and functional similarities in frequency- 
bands. Deﬁnitions of the boundaries of these bands vary, but are generally determined as; 
delta (<4 Hertz [Hz]), theta (4-7 Hz), alpha (8-12 Hz), beta (13-30 Hz; often split into beta-1/
sensorimotor rhythm [SMR], 13-16 Hz, and beta-2, 17-30 Hz), and gamma (30-up to 200 
Hz) (Onton & Makeig, 2009; Loo & Makeig, 2012; Saby & Marshall, 2012). In childhood, 
boundaries of the corresponding bands appear to be lower (Saby & Marshall, 2012). Slow 
oscillations (delta, theta, and alpha) have been supposed to be related to higher levels of the 
hierarchy regarding brain processes (meaning they are linked to more basic and general 
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processes) than the fast oscillations (beta and gamma) (Engel et al., 2010). Slow oscillations 
span relatively large cortical regions, hypothesized to serve the purpose of integration 
across diverse cortical sites by synchronizing coherent activity and phase coupling across 
widely spatially distributed neural assemblies (Nunez, 1995). Fast oscillations are distributed 
over a smaller area, seen as elementary signals of the brain, and functionally related to 
various brain processes (Schurmann, Demiralp, Basar-Eroglu & Basar, 1999). Although 
clear-cut knowledge about the implications of frequency-bands is still topic of research, 
they are supposed to represent certain neurocognitive processes and levels. In rest, delta 
power has been related to a state of deep sleep. Together with theta power, they are 
hypothesized to represent activity in brain systems that regulate behavior on the basis of 
motivational drives and emotional appraisal, and involved in salience detection and 
emotional learning (Knyazev, 2012). Alpha power has typically been associated with 
inhibition of brain areas and may be involved in cognitive processes associated with 
attention and memory (Jensen, Gelfand, Kounios & Lisman, 2002). According to the 
inhibition hypothesis, alpha has been shown to play a role in the cortex by a selective 
increase of power when that region is task irrelevant, while inhibition is released where 
reduced alpha power is measured (Klimesch, Sauseng & Hanslmayr, 2007). Furthermore, 
alpha power has been stated as a measure for resting-state arousal (Barry, Clarke, Johnstone, 
Magee & Rushby, 2007). The three slow bands together (delta, theta, and alpha) are thought 
to be reciprocally connected in a way that relative prevalence of alpha oscillations is 
associated with inhibition of behavioral patterns peculiar to the delta and theta power 
(Knyazev, 2007). Beta power has been hypothesized to play a role in motor networks 
(Mackay, 1997; Jenkinson & Brown, 2011) but also in cognitive processes, like executive 
functioning (Buschman, Denovellis, Diogo, Bullock & Miller, 2012; Groppe et al., 2013). 
Gamma power has been associated with a wide variety of higher cognitive processes 
including attention, perception, memory, and language (Benasich, Gou, Choudhury & Harris, 
2008).
Resting-state oscillations in ADHD
Oscillations in ADHD during rest (i.e., awake but without directed cognitive and motor 
activity) have been widely investigated. 
First reports in children with behavioral problems (among them problems corresponding 
with those seen in the currently concept of ADHD) indicated ‘EEG slowing’ (Jasper, Solomon 
& Bradley, 1938), later labeled as ‘theta’ (Walter & Dovey, 1944). Nowadays, elevated theta 
power is the most consistent ﬁnding in children and adults with ADHD (Mann, Lubar, 
Zimmerman, Miller & Muenchen, 1992; Matsuura et al., 1993; Janzen, Graap, Stephanson, 
Marshall & Fitzsimmons, 1995; Chabot & Serfontein, 1996; Clarke, Barry, McCarthy & 
Selikowitz, 1998; Lazzaro et al., 1998; Bresnahan, Anderson & Barry, 1999; Lazzaro et al., 
1999; Clarke, Barry, McCarthy & Selikowitz, 2001d, 2001c; Bresnahan & Barry, 2002; Clarke, 
Barry, McCarthy & Selikowitz, 2002, 2003a; Clarke et al., 2003b; Hermens et al., 2004; 
15General Introduction, Aims & Outline of the Thesis
Hermens, Kohn, Clarke, Gordon & Williams, 2005a; Hermens et al., 2005b; Bresnahan, Barry, 
Clarke & Johnstone, 2006; Clarke et al., 2006; Clarke, Barry, McCarthy, Selikowitz & 
Johnstone, 2007a; Hobbs, Clarke, Barry, McCarthy & Selikowitz, 2007; Clarke, Barry, 
McCarthy, Selikowitz & Johnstone, 2008; Koehler et al., 2009; Barry et al., 2010; Woltering, 
Jung, Liu & Tannock, 2012; Clarke et al., 2013). This is in line with the conclusion of a recent 
meta-analysis in children with ADHD (Arns, Conners & Kraemer, 2012). 
Diminished beta power has also been found in ADHD (Callaway, Halliday & Naylor, 1983; 
Mann et al., 1992; Matsuura et al., 1993; Clarke et al., 2001c; Bresnahan & Barry, 2002; 
Barry et al., 2010; Woltering et al., 2012), but far less consistently (i.e.,  not always a 
difference was found between ADHD and controls) (Lazzaro et al., 1998; Lazzaro et al., 
1999; Clarke, Barry, McCarthy & Selikowitz, 2001a; Bresnahan et al., 2006; Hobbs et al., 
2007; Barry, Clarke, Johnstone & Brown, 2009; Koehler et al., 2009; Liechti et al., 2013). 
Further, several studies have identiﬁed a subgroup (13-20%) of children with ADHD (Arns, 
2012) with excess beta power (Chabot & Serfontein, 1996; Kuperman, Johnson, Arndt, 
Lindgren & Wolraich, 1996; Clarke et al., 1998; Chabot, Orgill, Crawford, Harris & Serfontein, 
1999; Clarke et al., 2001d; Clarke et al., 2013). 
Research on the alpha power during rest also yielded inconsistent ﬁndings. This may 
partially be explained by the great individual differences in alpha power and the choice of 
analyzing and reporting data. The absolute power, the actual measured power in a 
frequency-band, can be elevated, while the relative power, the percentage of power in a 
frequency-band compared to for instance the overall power, can be diminished in the same 
individual. This may partially clarify that some studies reported elevation for the absolute 
alpha power (Bresnahan & Barry, 2002; Koehler et al., 2009) or for relative alpha power 
(Chabot & Serfontein, 1996), one study reported an elevation for both absolute and relative 
alpha (Lazzaro et al., 1999), another study reported elevation of absolute alpha and 
diminished relative alpha in the same sample (El-Sayed, Larsson, Persson & Rydelius, 2002). 
Further ﬁndings include absolute as well as diminished relative alpha power (Woltering et 
al., 2012), diminished relative alpha power, without difference in absolute power (Clarke et 
al., 2001a; Barry et al., 2010), or without a clear description whether relative or absolute 
alpha was obtained (Clarke et al., 2001d), and diminished alpha power without reporting if 
the results referred to absolute or relative power (Loo et al., 2009). Finally, some studies did 
not ﬁnd any difference regarding alpha power (absolute and relative) (Bresnahan et al., 
1999; Bresnahan et al., 2006). 
In addition, elevated delta power has been found in ADHD (Matousek, Rasmussen & Gillberg, 
1984; Clarke et al., 1998, 2001a, 2001c; Barry et al., 2010). 
Recently, gamma power was shown to be reduced in ADHD children (Barry et al., 2010). 
Two main underlying neurobiological hypotheses have been proposed about the ﬁndings 
regarding resting-state oscillations in ADHD: 
1) The hypo-arousal theory. This theory, ﬁrst proposed by Satterﬁeld & Dawson (1971), 
was initially based on the reduced skin conductance in hyperactive children. Lubar 
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(1991) further developed this theory, linking Satterﬁeld and Dawson’s (1971) report of 
hypo-arousal with Jasper and colleagues’ report (1938) that normal resting EEG power 
is dominant in the theta and alpha bands, but shifts to the beta band during activity. 
He hypothesized that the ability to produce beta power is diminished in subjects with 
ADHD, and instead theta power is produced. Based on this hypothesis, a decrease of 
beta power together with an increase of theta power (elevated theta/beta power ratio) 
was supposed to represent a hypo-aroused state. However, an elevated theta/beta 
power ratio was later found not to be directly related with arousal in ADHD (Barry, 
Clarke, Johnstone, McCarthy & Selikowitz, 2009). The former hypothesis was expanded 
with the suggestion that an excess of beta power reﬂects a hyper-arousal state (Clarke 
et al., 2001d). A recent study further investigated this hypothesis by dividing children 
with ADHD into an “excess beta group” and an “excess theta group” and measuring the 
skin conductance level (SCL) as a marker of central nervous system arousal. Both ADHD 
groups had a signiﬁcant reduced SCL compared to the control group, but the two 
groups did not differ from each other on SCL, indicating that ADHD children with 
excess beta power are not hyper-aroused and that the theta/beta power ratio is not 
associated with arousal (Clarke et al., 2013).
2) The maturational lag model (Gasser, Verleger, Bacher, & Sroka, 1988). This model refers 
to the hypothesis that ADHD shows a lag in the normal timetable for development 
(Burke & Edge, 2013). This model is based on ﬁndings that there is a decrease in the 
relative contribution of low-frequency rhythms and an increase in higher-frequency 
rhythms during the child’s development (Gibbs & Knott, 1949; Corbin & Bickford, 1955; 
Matousek & Petersen, 1973; John et al., 1980). This model expects elevated amount of 
slow waves (i.e., delta, theta, and alpha) and diminished fast waves (beta and gamma) 
often found in ADHD. 
The use of resting-state oscillations for diagnostic and prognostic purposes
The use of resting-state oscillations as diagnostic tool in ADHD has a long history. The idea 
of the theta/beta power ratio for diagnostic purpose was introduced to discriminate healthy 
children from children with ADHD and learning disorders (Lubar, 1991). Elevation of this 
ratio in ADHD has been replicated frequently with a large mean effect size (ES) of around 
0.7. Nevertheless, caution in its interpretation is recommended, because ES has shown a 
decrease across the years, due to an increase of the theta/beta power ratio in controls (Arns 
et al., 2012). In line, a recently published large study on the theta/beta power ratio, did not 
ﬁnd any difference at all between ADHD and controls (Loo et al., 2013).  An analysis, taking 
into account both the sensitivity and speciﬁcity, showed an accuracy of 58% in discrimination 
on the theta/beta power ratio between children with and without ADHD (Ogrim et al., 
2012). So, the theta/beta power ratio cannot be regarded as a reliable diagnostic tool in 
ADHD. Furthermore, the lack of deviation in the theta/beta power ratio when using 
individual frequency-bands rather than ﬁxed frequency-bands has been explained by 
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mediation of a low alpha peak frequency (APF) (Arns, Gunkelman, Breteler & Spronk, 2008; 
Lansbergen, Arns, van Dongen-Boomsma, Spronk & Buitelaar, 2011a). This suggests the 
existence of two subgroups in ADHD; one group with an actual excess of theta power 
without any mediation of the APF, and a second group with alpha peaking at a lower 
frequency, thereby ‘leaking’ into the theta band causing the ﬁxed theta band estimate to be 
falsely interpreted as inﬂated (Arns et al., 2012). 
In addition, effort has been made to differentiate subgroups of ADHD based on resting-state 
oscillations; greater abnormalities in the combined subtype compared to the inattentive 
subtype have been found (Chabot & Serfontein, 1996; Clarke et al., 1998, 2001a; Clarke, 
Barry, McCarthy & Selikowitz, 2001b; Barry & Clarke, 2009). Furthermore, several studies 
have shown additional deviated oscillations in ADHD patients with comorbidity (e.g., 
learning disorders, see for example Barry, Clarke, McCarthy & Selikowitz (2009). 
Resting-state oscillations have also been examined as potential predictive markers by 
attempting to identify subgroups to predict treatment-response. Excess of beta, frontal 
theta, and frontal alpha power have been supposed to predict a better stimulant treatment 
response. In contrast, a slow individual APF has been proposed as a marker of treatment 
resistance (Arns, 2012).
Resting-state oscillations and neurocognitive and behavioral correlates in ADHD
Research on the relationship between resting-state oscillations and neurocognitive and 
behavioral correlates in ADHD is sparse. Apart from the study described in this thesis 
(Chapter II), neurocognitive correlates of resting-state oscillations have only been studied 
in children. An elevated theta power has been found to correlate with less accuracy on an 
auditory oddball task (Hermens et al., 2005b), lower reaction time in an attention task (i.e., 
the Test of Variables of Attention [TOVA]) (Swartwood et al., 1998; Swartwood, Swartwood, 
Lubar & Timmermann, 2003), and increased response variability on a continuous 
performance task (CPT) (Loo & Smalley, 2008). Elevated alpha power was correlated with 
less inhibition on a CPT (Loo & Smalley, 2008), slower reaction time, more variability on the 
TOVA (Swartwood et al., 1998; Swartwood et al., 2003), and impaired attention in a Go/
No-Go task (Lansbergen et al., 2011a). 
Furthermore, research on the relationship between resting-state oscillations and the core 
behavioral symptoms of ADHD is also limited. Besides the study described in this thesis 
(Chapter II), only one other study was performed in adults (Koehler et al., 2009), reporting 
a positive relationship between theta power and inattention scores on the Adult ADHD 
Self-Report Scale (Kessler et al., 2005). Furthermore, diminished gamma power was 
correlated with higher inattention scores on the Conners’ Parent Rating Scale-Revised 
(CPRS-R) (Conners, Sitarenios, Parker & Epstein, 1998; Barry et al., 2010). In another study, 
beta power correlated positively with inattention and the total symptom-score on the 
CPRS-R (Ogrim, Kropotov & Hestad, 2012). In yet two other studies, beta power was 
positively correlated with impulsivity (Swartwood et al., 1998; Swartwood et al., 2003) and 
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negatively with inattention (Swartwood et al., 1998). Theta power correlated positively with 
inattention and negatively with hyperactivity and impulsivity on the Conners’ Rating Scale 
Revised (Ogrim et al., 2012). For the theta/beta power ratio, a weak correlation was found 
with inattentive symptoms (Loo et al., 2013).
Inconsistency of these ﬁndings and the small amount of studies reporting correlations 
between resting-state oscillations and neurocognitive and/or behavioral measures in ADHD 
make ﬁrm conclusions not yet possible. The small amount of studies may be even smaller 
than it seems at ﬁrst sight; the studies by Swartwood and colleagues (1998; 2003) have 
possibly used the same data set, suggested by exactly the same results. 
So, despite the robust evidence for elevated theta power and - to a lesser degree - diminished 
beta power, the ﬁndings on resting-state oscillations, and their correlations with neuro- 
cognitive and behavioral measures in ADHD are inconsistent. This may have different causes 
and those will be further addressed in the discussion (Chapter VIII). This inconsistency has 
led to - among other reasons - innovating technical aspects of the EEG, such as independent 
component analysis (Loo & Makeig, 2012). Furthermore, research has been expanded to 
other electrophysiological approaches. Slow cortical potentials (SCPs), for example, also 
used as target for NF (see later in this introduction), are slow event-related direct-current 
shifts of the EEG, originating from the upper cortical layer (Birbaumer, Elbert, Canavan & 
Rockstroh, 1990). They are not oscillatory in nature but occur as a consequence of external 
or internal events (Strehl et al., 2006). It has been suggested that SCP shifts in the negative 
direction reﬂect increased excitability, while shifts in the positive direction reﬂect reduced 
excitability (Birbaumer et al., 1990; Hinterberger et al., 2003). The contingent negative 
variation, a SCP associated with cognitive preparation, has found to be reduced in children 
with ADHD in several ERP studies suggesting dysfunctional regulation of energetically 
resources in ADHD (Sergeant, 2005; Banaschewski & Brandeis, 2007). Other examples of 
electrophysiological approaches are coherence analyses (Clarke et al., 2007b) and 
event-related potentials (see for a review Johnstone, Barry & Clarke, 2013). 
These approaches may have different purposes, like 1) to understand more about the neural 
mechanism underlying ADHD and its relationship with the clinical concept of ADHD, 
2) to detect a diagnostic or prognostic tool that sufﬁciently discriminates on individual 
level, or 3) to detect an electrophysiological target suitable for treatment modalities.
 
Non-pharmacological interventions in children with ADHD; 
neurofeedback and working memory training
National and international guidelines describe a multimodal, stepped-care treatment plan 
with an individual approach for children with ADHD (Taylor et al., 2004; Landelijke Stuurgroep 
Multidisciplinaire Richtlijnontwikkeling in de GGZ, 2005; National Institute of Mental Health 
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[NIMH], 2009). Psycho-education (for parents, older children, and their teachers) is seen as 
the ﬁrst step in treatment. It includes information about the etiology, clinical course, and 
prognosis of ADHD, together with information about the various treatment options, possible 
community supports, and school resources. Further treatment depends on the level of 
disability, the context in which the problems exist and the age of the child. In sum, when the 
child is below the age of 6, or has a mild expression of ADHD symptoms, ﬁrst-line treatment 
consists of behavioral interventions, parent training, and/or school liaison. If these 
interventions have shown insufﬁcient improvement, the use of medication has to be 
considered. For children older than 6 years with severe and pervasive disabilities, ﬁrst-choice 
treatment is medication. Combined therapy (i.e., stimulants and behavioral therapy) has 
shown additional beneﬁts (e.g., improvement of symptoms other than the core behavioral 
symptoms of ADHD, parent-child interaction, parental satisfaction, and social skills) 
compared to stimulants alone (MTA Cooperative Group, 1999b, 1999a). However, the 
general recommendation is to indicate combined therapy only if stimulant treatment alone 
has shown insufﬁcient improvement of the ADHD symptoms or in case of comorbidity with 
other psychiatric disorders, such as oppositional deﬁant disorder (ODD) and conduct disorder.
Currently, the most effective treatment for severe ADHD is medication, with placebo- 
controlled large ESs on the core ADHD symptoms for amphetamine, methylphenidate 
(Faraone & Buitelaar, 2010) and atomoxetine (Michelson et al., 2002; Banaschewski et al., 
2008). Although large ESs, interpretation of the implication for the individual patient, asks 
for cautiousness; reanalysis of the NIMH-funded Multimodal Treatment of Attention Deﬁcit 
Hyperactivity Disorder (MTA) data showed that only 56% of the patients in the medication 
group met the deﬁnition of success at the end of treatment (Swanson et al., 2001). 
Furthermore, some concerns accompany the use of medication in children. First, side effects 
have been reported and for some serious and life-threatening side effects, the risk is still 
not fully known and will likely to stay uncertain due to their rarity (Graham et al., 2011). 
The leading cause of negative attitudes in children with ADHD and their parents is based on 
concerns regarding (negative) long-term effects (Berger, Dor, Nevo & Goldzweig, 2008). 
Second, there is insufﬁcient evidence of long-term efﬁcacy of medication for ADHD (van de 
Loo-Neus, Rommelse & Buitelaar, 2011). Third, the symptoms of ADHD reappear after 
discontinuing drug treatment (Jensen et al., 2007; Murray et al., 2008). Based on these 
concerns children with ADHD and their parents may be reserved about pharmacotherapy. 
Therefore, non-pharmacological treatment modalities are needed. Currently, NF and WMT 
are two of the most studied non-pharmacological treatment options in ADHD. In the 
following part of this introduction these two interventions will be discussed regarding the 
efﬁcacy in children with ADHD.
Neurofeedback
After the ﬁrst introduction of recording brain oscillations in humans by Berger in the 1920s, 
it took decades until the ﬁrst published experiments took place in modulating these 
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oscillations. These experiments started in the 1950s, leading to the ﬁrst publication on 
frequency NF (F-NF) in humans, showing control over their brain activity by entering the 
‘alpha-state’, associated with a state of relaxation (Kamiya, 1968). In the same period, in 
1965, Sterman accidentally discovered that cats could be trained to produce SMR and that 
these trained cats had built resistance against a toxic substance known to provoke seizures 
(Sterman, Wyrwicka & Howe, 1969). Sterman replicated this discovery successively in 
monkeys, in humans, and ﬁnally in patients with epileptic symptoms (Sterman, Macdonald 
& Stone, 1974). Eventually Lubar and Shouse were the ﬁrst to report F-NF in a child with a 
hyperkinetic disorder (Lubar & Shouse, 1976).
NF is a form of biofeedback targeting brain oscillations, including the conventional F-NF 
and SCP-NF, and is deﬁned as a process, in which sensors are placed on the scalp and 
devices are used to monitor and provide moment-to-moment information about the 
physiological brain activity, that is fed back to the individual to improve brain functioning 
(Hammond et al., 2011). F-NF has been hypothesized to aim at tonic aspects of cortical 
arousal, while SCP-NF has been hypothesized to aim at phasic excitability (Gevensleben et 
al., 2009). The idea is that NF works via operant learning, in which simultaneous and 
contingent feedback is given by positive reinforcement through visual and/or acoustic 
signals when changes in the brain oscillations are made in the desired direction, leading to 
voluntary modulation of these oscillations and controlling their underlying processes and 
thereby enhancing the self-regulation (Gevensleben, Rothenberger, Moll & Heinrich, 2012). 
In children with ADHD, F-NF protocols usually target the deviations of the resting-state 
oscillations found in children with ADHD. For example, the child trains to increase the 
production of beta activity while suppressing the production of theta activity, whereby the 
feedback consists of rewarding the production of the desired frequency activity (Monastra 
et al., 2005; Gevensleben et al., 2012). The SCP-NF protocol targets the hypothesized 
impaired regulation of cortical excitation in ADHD (Sergeant, 2005; Banaschewski & 
Brandeis, 2007) by practicing to produce positive and negative shifts (Moriyama et al., 
2012). Feedback consists of rewarding the changes in the polarity (i.e.,  positivity vs. 
negativity) of the EEG over the sensorimotor cortex  (Arns, de Ridder, Strehl, Breteler & 
Coenen, 2009). 
The ﬁrst review addressing the efﬁcacy of F-NF in children with ADHD concluded that F-NF 
was ‘probably efﬁcacious’ in children with ADHD (Monastra et al., 2005). This conclusion 
was based on The Guidelines for Evaluation of Clinical Efﬁcacy of Psychophysiological 
Interventions (LaVaque et al., 2002), accepted by the Association for Applied Psychophysi-
ology & Biofeedback as well as the International Society for Neurofeedback and Research, 
and similar to those from the American Psychological Association. These guidelines contain 
ﬁve levels of classiﬁcation, ranging from ‘Not empirically supported’ to ‘Efﬁcacious and 
Speciﬁc’. The authors of this review further stated that although they reported beneﬁcial 
effects, studies with a more robust methodological design are needed (Monastra et al., 
2005), further underscored in the review by Loo & Barkley (2005). Since then, studies with 
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a better methodological design were performed and today’s literature on this topic counts 
more than 20 randomized controlled trials. Using the same guidelines (LaVaque et al., 2002), 
the meta-analysis by Arns and colleagues (2009) concluded that NF in children is ‘efﬁcacious 
and speciﬁc’. However, this conclusion was based on both randomized and non-randomized 
studies, but not on placebo-controlled trials (not available at that moment). Most of the 
more recently published reviews are more reserved about the efﬁcacy of NF in children with 
ADHD due to methodological shortcomings of the studies (e.g., lack of large samples and a 
double-blind, placebo-controlled design) (Lofthouse, Arnold, Hersch, Hurt & DeBeus, 2012; 
Lofthouse, Arnold & Hurt, 2012; Moriyama et al., 2012). Furthermore, conclusions about the 
state of F-NF as monotherapy are regarded as presumptive, since the great majority of 
studies investigated F-NF as an adjunctive treatment, and for ethical reasons other 
treatments were usually not discontinued (Moriyama et al., 2012). The review by Gevensleben 
and colleagues (2012) is characterized by a more positive line with the suggestion that 
negative results may be ascribed to certain study shortcomings (such as the lack of transfer 
strategies into daily life) and some directions for future research to optimize NF studies, 
based on the use of common variables of earlier performed trials with positive results (e.g., 
age 7-14, standard protocols instead of personalized protocols, block wise treatment, two or 
three times a week, including transfer trials, simple and clearly represented feedback, and 
25-40 sessions) (Gevensleben et al., 2012). 
Despite a rise of the number of randomized controlled trials (RCTs) by time of conducting 
our F-NF study (in 2007), not any placebo-controlled trial was performed in children with 
ADHD. By now, four published papers (Perreau-Linck, Lessard, Levesque & Beauregard, 
2010; Lansbergen, van Dongen-Boomsma, Buitelaar & Slaats-Willemse, 2011b; Arnold et al., 
2012; van Dongen-Boomsma, Vollebregt, Slaats-Willemse & Buitelaar, 2013) describe a RCT 
including a placebo-condition investigating the efﬁcacy of F-NF on the core behavioral 
symptoms of ADHD, among them two papers of our research group (Lansbergen et al., 
2011b; van Dongen-Boomsma et al., 2013); the latter is part of this thesis (Chapter IV) and 
will be discussed later (Chapter VIII). The three other studies did not ﬁnd a superior effect 
of F-NF on the core behavioral symptoms of ADHD. This conclusion was in line with the 
most recent systematic review/meta-analysis of randomized controlled trials of non-phar-
macological interventions in children with ADHD; analyses of probably unblinded ratings 
for NF in children with ADHD showed an ES of 0.29 (p = .07) (Sonuga-Barke et al., 2013). 
Thus, so far, convincing evidence is lacking for beneﬁcial effects of NF on the core behavioral 
symptoms of ADHD in children. Even more, neurophysiological evidence that NF leads to 
improvement of neural regulation is poor, and subsequently leads to signiﬁcantly positive 
effects on behavioral outcome measures, has sparsely been investigated. Although ﬁndings 
suggest normalization of neurophysiological markers in ADHD after NF (Monastra, Monastra 
& George, 2002; Heinrich, Gevensleben, Freisleder, Moll & Rothenberger, 2004) and even so 
that improved behavioral outcome measures follow improved neural regulation (Kropotov 
et al., 2005; Strehl et al., 2006; Doehnert, Brandeis, Straub, Steinhausen & Drechsler, 2008), 
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these ﬁndings should be interpreted with caution, especially due to inconsistent and weak 
ﬁndings, methodological limitations and the small numbers of studies. 
In spite of these concerns, F-NF is widely used in Europe and the United States of America 
as a treatment modality for ADHD. In The Netherlands, F-NF is partly reimbursed by some 
health insurance companies, despite the state of evidence. So, a methodological well- 
designed study is needed to answer the question if daily practice F-NF merits its current 
position as a widely used and evidence-based treatment by investigating its efﬁcacy in 
children with ADHD.
Working memory training
Decades of research on neurocognitive functioning in ADHD has yielded invaluable 
knowledge about the neurocognitive deﬁcits often found in ADHD. Deﬁcits are found in 
attention regulation (Losier, McGrath & Klein, 1996; Epstein et al., 2003), executive functions 
(EFs) (Martinussen, Hayden, Hogg-Johnson & Tannock, 2005; Willcutt, Doyle, Nigg, Faraone 
& Pennington, 2005), reward-related processes (Sonuga-Barke, Sergeant, Nigg & Willcutt, 
2008), and timing (Noreika, Falter & Rubia, 2013). Problems in EFs are found in domains of 
response inhibition, vigilance, planning, and working memory (WM), with the latter found 
to be affected most strongly in children with ADHD (Willcutt et al., 2005). Neurocognitive 
deﬁcits in ADHD may have contributed to shift the focus of identifying treatment modalities 
in ADHD from direct amelioration behavioral symptoms towards improvement of underlying 
neurocognitive functioning in ADHD. Furthermore, this shift is even more understandable 
by the ﬁnding that persistence of neurocognitive deﬁcits in ADHD is strongly associated 
with future occupational problems and morbidity (Barkley & Murphy, 2010; Biederman et 
al., 2012).
An example of such a treatment modality is Cogmed WMT (CWMT). This training is based 
on the idea that intensive training of WM may improve WM, other neurocognitive functions, 
and ultimately diminish the core behavioral symptoms of ADHD. WM is deﬁned as the ability 
to temporarily hold information while simultaneously manipulating the information 
(Baddeley, 1986), and is often regarded as a fundamental neurocognitive function underlying 
other EFs (Klingberg et al., 2005). 
Neurophysiological studies showed that maintenance of information in WM is associated 
with elevated and sustained neural ﬁring over a delay when information is kept in mind 
(Funahashi, Bruce & Goldman-Rakic, 1989). Neuroimaging studies have mapped WM-related 
activity to both sensory association cortices and the prefrontal cortex (Curtis & D’Esposito, 
2003; Linden, 2007; Klingberg, 2010). Neurobiological studies indicated an important role 
for dopamine in WM (Luciana, Depue, Arbisi & Leon, 1992; Muller, von Cramon & Pollmann, 
1998; Diamond, Briand, Fossella & Gehlbach, 2004). The past decade, research has focused 
on neural correlates of WMT. Increased activity of prefrontal and parietal regions (i.e., the 
middle frontal gyrus and the superior and inferior parietal cortices) as well as thalamic and 
caudate regions was found following WM training. Decreased brain activation in the right 
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cingulate sulcus was also found and hypothesized to reﬂect the decreased need for motor 
planning (Olesen, Westerberg & Klingberg, 2004). Furthermore, changes in the density of 
cortical dopamine D1 receptors, namely larger decreases in dopamine D1 binding potential, 
were associated with larger improvements in WM in both prefrontal and parietal cortices 
after WMT (McNab et al., 2009). Volumetric brain changes were also found following WM 
training, represented by a reduced regional gray matter volume in the bilateral frontoparietal 
regions and the left superior temporal regions (Takeuchi et al., 2011). These ﬁndings indicate 
plasticity of the WM capacity (Klingberg, 2010), however, a speciﬁc neural mechanism 
underlying WMT and transfer effects has not yet been indicated (Buschkuehl, Jaeggi & 
Jonides, 2012) and research on this aspect in ADHD is lacking. See for a comprehensive 
review on this topic, Buschkuehl and colleagues (2012). 
So far, eight studies, among one study in this thesis (Chapter VI) examined the efﬁcacy of 
CWMT in children with ADHD (Klingberg, Forssberg & Westerberg, 2002; Klingberg et al., 
2005; Holmes, Gathercole & Dunning, 2009; Beck, Hanson, Puffenberger, Benninger & 
Benninger, 2010; Gibson et al., 2011; Gray et al., 2012; Green et al., 2012); all but one used 
an RCT design (Holmes et al., 2009). The study by Gibson and colleagues (2011) showed that 
CWMT focuses on a component of WM that is less supposed to be affected in ADHD 
(primary memory rather than secondary memory). Because, this study used a modiﬁed 
training program, and was not designed to investigate the efﬁcacy of CWMT in ADHD, this 
study will not further be included in the discussion about the efﬁcacy of CWMT in ADHD. 
Our study will be presented in this thesis (Chapter VI), and reviewed in the discussion 
(Chapter VIII).
Four out of the six studies investigated the efﬁcacy of CWMT on the core behavioral 
symptoms in ADHD. Three of them showed signiﬁcant treatment effects (Klingberg et al., 
2005; Beck et al., 2010; Green et al., 2012). Five studies reported improvement on at least 
one trained WM task (Klingberg et al., 2002; Klingberg et al., 2005; Holmes et al., 2009; Gray 
et al., 2012; Green et al., 2012), four studies reporting non-trained neurocognitive 
parameters, in which only two found signiﬁcant improvement on some neurocognitive 
parameters (i.e.,  in the domains of EFs [WM, response inhibition]), and attention (Klingberg 
et al., 2002; Klingberg et al., 2005).
Findings of recently published reviews and meta-analyses on this topic are in line with the 
mixed results of the individual studies. A review/meta-analysis on non-pharmacological 
interventions in children with ADHD, reported no signiﬁcant treatment effect (ES 0.24, 
p = .34) when probably blinded assessments were analyzed for cognitive training, including 
CWMT (Sonuga-Barke et al., 2013). This ﬁnding is not optimistic, but must be interpreted 
with caution because it represents the total mean efﬁcacy of all included cognitive training 
modalities and only included one study on CWMT in children, namely the study by Klingberg 
and colleagues (2005). Another meta-analytic review on non-pharmacological interventions 
concerning children with ADHD concluded that WMT on the basis of average weighted 
ES across the outcome measures (i.e., core behavioral symptoms and neurocognitive 
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performance), did not result in greater improvement in the treatment group in contrast to 
the control group (Hodgson, Hutchinson & Denson, 2012). This conclusion was based solely 
on the study by Klingberg and colleagues (2005). Furthermore, a meta-analytic review was 
performed on different WMT programs, including 23 studies with clinical samples as well as 
samples of typically developing children and adults (Melby-Lervag & Hulme, 2013). Results 
indicated that WMT improved WM; however for verbal WM, these effects were not sustained 
at follow-up, whereas for visuospatial WM, limited evidence suggested that such effects 
might be maintained. In addition, there was no evidence of generalization of WMT to other 
neurocognitive functions. However, because of mixed included samples (i.e., clinical and 
non-clinical, children and adults), the inclusion of all types of WMT, and because the 
ﬁndings are based on neurocognitive parameters, conclusions about the clinical implication 
of CWMT for children with ADHD cannot be drawn. Shipstead and colleagues (2012) also 
reviewed different WMT programs in clinical and non-clinical samples, including all ages, 
and also expressed concerns about the claims for the efﬁcacy of WMT. In sum, the authors 
reported the problematic tendency among researchers to deﬁne change by the use of a 
single measure, the use of invalid WM tasks that do not differ from the trained tasks, the 
use of no-contact control groups, and inclusion of subjective non-blinded measurement of 
change. In addition, they concluded that there is a need to demonstrate directly that WM 
capacity increases in response to training, and that transfer effects take place to other 
neurocognitive functions. Further, the authors recommended the use of a wider variety of 
tasks might eliminate the possibility that results can be explained by task speciﬁc learning. 
A recent meta-analysis on training-modalities targeting neurocognitive functioning in 
children with ADHD, focusing explicitly on near vs. far transfer effects, concluded that 
CWMT was associated with moderate near transfer effects only (d = 0.63); far transfer 
effects were lacking (Rapport, Orban, Koﬂer & Friedman, 2013). Due to these ﬁndings, 
further concerns about the potential transfer effects of these training-modalities were 
expressed. A review including only CWMT studies in children with ADHD has been published 
by Chacko and colleagues (2013). They included all studies, reported earlier in this 
introduction, except for the study by Gibson and colleagues (2011), due to not meeting the 
predetermined inclusion criteria and included one extra study, the study by Mezzacappa 
and colleagues (2010). This latter study included children without a ﬁrm ADHD diagnosis, 
but with elevated scores on an ADHD Rating Scale, rated by their teacher. The four trials 
(Klingberg et al., 2005; Beck et al., 2010; Gray et al., 2012; Green et al., 2012) that were 
determined as having an Evidence Based Treatment status, espoused by the Society for 
Clinical Child and Adolescent Psychology (Silverman & Hinshaw, 2008), led to the conclusion 
that CWMT can be regarded as a ‘Possibly Efﬁcacious’ treatment for youth with ADHD. 
Concerns like the inconsistent ﬁndings within and between studies, the weak evidence for 
the hypothesized underlying working mechanism, the questionable quality of the placebo 
condition and the differences between the sample characteristics were discussed. Future 
directions were mainly based on these concerns, and consisted of the recommendations to 
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investigate CWMT in a more heterogeneous and so more clinical sample, with a smaller and 
lower age range with broadening outcome measures referring functional impairment. 
So far, current ﬁndings raise doubt about the efﬁcacy of CWMT. Altogether, CWMT is (still) 
not a well-established treatment modality in children with ADHD. Even more, a gap in the 
literature exists for the young children with ADHD. Especially for the younger ADHD 
population, in which even more barriers may rise in the decision to start medication (e.g., 
due to poor efﬁcacy [Riddle et al, 2013] and far less knowledge about side effects compared 
to older children), a non-pharmacological treatment option would be of great value. In 
addition, since WM shows a fast development throughout preschool and early school-age 
(Carlson, 2005), early training of WM may possibly prevent development of ADHD-related 
neurocognitive deﬁcits and behavioral problems. For these reasons, stepping up the effort 
to investigate the efﬁcacy of WMT in young children in ADHD is necessary.
Aims & Outline of the Thesis
For decades, resting-state oscillations in ADHD have been investigated with the most 
consistent ﬁnding of elevated theta in adults as well as in children. However, also signiﬁcant 
inconsistent ﬁndings regarding resting-state oscillations in ADHD have been found. In 
addition, there are few studies on the relationship between resting-state oscillations on one 
hand and neurocognitive functioning and core behavioral symptoms on the other hand and 
the ﬁndings are inconsistent. Thus, the role of resting-state oscillations in ADHD and their 
relationship with neurocognitive and behavioral functioning is still unclear. 
Furthermore, F-NF is a widely used treatment modality in children with ADHD. However, 
whether F-NF is efﬁcacious for this target population is still an open question. Besides, 
neurophysiological evidence that NF improves neural regulation and that such an 
improvement signiﬁcantly affects behavioral outcome measures, is scarce.
The same is true for CWMT; widely used but with an unclear state of evidence regarding 
efﬁcacy in the treatment for children with ADHD. In addition, the efﬁcacy of CWMT in 
younger children with ADHD has not been studied.
Therefore, the aims of this thesis are:
a. To examine resting-state oscillations in ADHD and the relationship between 
resting-state oscillations on one hand, and neurocognitive functioning and core 
behavioral symptoms of ADHD on the other hand, in adults as well as in children with 
ADHD. (Chapter II and III)
b. To investigate the efﬁcacy of daily practice F-NF on core behavioral symptoms, 
neurocognitive, and global clinical functioning as well as the safety of F-NF in children 
with ADHD by using a stratiﬁed, semi-randomized, double-blind, placebo-controlled 
treatment design. In addition, the neurophysiological background is addressed. 
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(Chapter IV and V)
c. To investigate the efﬁcacy of CWMT on core behavioral symptoms, neurocognitive, 
daily executive, and global clinical functioning in young children with ADHD by using a 
stratiﬁed, semi-randomized, triple-blind, placebo-controlled treatment design. 
(Chapter VI)
To this end, data from three different samples were analyzed. 
The ﬁrst sample consisted of 24 adults with ADHD (combined subtype), based on the 
DSM-IV, and 24 healthy controls (matched on age, gender, and IQ). Psychiatric 
comorbidity was allowed, as well as regular use of psychotropic medication, provided 
the use during the assessments. All adults performed a stop-signal task after recording 
of a resting-state EEG. Resting-state oscillations were analyzed and further related to 
the performance on the stop-signal task and the core behavioral symptoms of ADHD 
(Chapter II).
The second sample consisted of 41 children (age between 8-15 years) with a primary 
diagnosis of ADHD (all subtypes), based on the DSM-IV-TR, without any other 
psychiatric disorder (except for ODD and anxiety disorders) or any other serious medical 
condition. The use of a stable dosage of stimulants and/or atomoxetine was allowed, 
provided the presence of room for improvement on behavioral level. The children in this 
sample were semi-randomly assigned to F-NF or placebo-feedback for 30 sessions, twice 
a week. Assignment was based on stratiﬁcation on age, electrophysiological state of 
arousal, and medication use. At baseline, resting-state oscillations were measured. Before 
treatment and at study end, behavioral measurements were performed and a wide 
selection of neurocognitive tasks was administered. Baseline resting-state oscillations 
were explored and analyzed in relation to the performance on the neurocognitive tasks 
and the core behavioral symptoms of ADHD (Chapter III). Efﬁcacy of F-NF was 
measured by analyzing the difference between groups on core behavioral symptoms 
and global clinical functioning (Chapter IV) and neurocognitive functioning (Chapter V) at 
study end compared to baseline measurements. Furthermore, electrophysiological 
background was explored by analyzing the oscillations during the sessions (Chapter V).
The third sample consisted of 51, medication-free children (age between 5-7 years) with a 
primary diagnosis of ADHD (all subtypes), based on the DSM-IV-TR, without any other 
psychiatric disorder (except for ODD and Pervasive Developmental Disorder Not Otherwise 
Speciﬁed) or any other serious medical condition. Children in this sample were semi-randomly 
assigned to the active or the placebo condition of the Cogmed JM training program for 25 
sessions, ﬁve times a week. Assignment was based on stratiﬁcation on age and gender. At 
baseline and at study end, behavioral measurements were performed and a comprehensive set 
of neurocognitive tasks was administered. Efﬁcacy was measured by analyzing the difference 
between groups on core behavioral symptoms, neurocognitive, daily executive and global 
clinical functioning at study end, compared to baseline measurements (Chapter VI).
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Abstract
Attention-deﬁcit/hyperactivity disorder (ADHD) in children is characterized by elevated 
levels of slow wave activity and reduced fast wave activity in resting-state electro-
encephalogram (EEG). In adults with ADHD, resting state EEG ﬁndings are scarce and 
inconsistent. 
The present study examined whether the disparate ﬁndings are due to EEG recording 
conditions (i.e., eyes-open vs. eyes-closed). A second goal of the current study was to 
assess relations between EEG spectral indices to performance measures obtained using a 
stop-signal task, and to behavioral ADHD symptoms. The present study included 24 adults 
with ADHD and 24 control adults. 
The EEG results showed a greater reduction in alpha power from eyes-closed to eyes-open 
(i.e., alpha attenuation) in ADHD compared to controls. In addition, the theta/beta power 
ratio was negatively correlated to the speed of responding to choice stimuli. 
These ﬁndings were interpreted vis-à-vis a biophysical model assuming that the hypo- 
arousal in ADHD is due to an overdrive of the locus coeruleus resulting in inhibitory activity 
of the thalamic reticular nucleus.
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Introduction
Attention-deﬁcit/hyperactivity disorder (ADHD) affects 5 to 10% of all school-aged children 
in European countries, and persists into adulthood in one third of the cases or more (Spencer, 
Biederman & Mick, 2007). According to current views, multiple cognitive deﬁcits contribute 
to ADHD, such as deﬁcient inhibitory control, impaired attention regulation, deﬁcits in 
working memory, and problems related to motivation and decision-making (Castellanos, 
Sonuga-Barke, Milham & Tannock, 2006). 
A considerable body of research focused on deﬁcient inhibitory control in ADHD (e.g., 
Bekker et al., 2005; Lijfﬁjt, Kenemans, Verbaten & van Engeland, 2005). The stop-signal 
paradigm is a widely used task to assess response inhibition (Logan, 1994). Meta-analyses 
reported signiﬁcant deﬁcits in the ability to inhibit responses in children and adults 
diagnosed with ADHD (mean effect sizes [ESs] range from 0.58 to 0.79) (e.g., Lijfﬁjt et al., 
2005). Moreover, it has been demonstrated that in adults with ADHD, the ability to inhibit 
is speciﬁcally impaired over and beyond general deﬁcits in response activation and execution 
(Lijfﬁjt et al., 2005). 
Neurophysiological measures have been a major focus of research in ADHD. Brain electrical 
activity can be recorded during rest or while individuals perform a cognitive task. In children 
with ADHD, resting-state electroencephalographic (EEG) studies report elevated levels of 
slow wave activity, especially theta activity, reduced amounts of alpha, and beta power, as 
well as higher theta/beta and theta/alpha power ratios compared to control children (Barry, 
Clarke & Johnstone, 2003). These ﬁndings attracted different interpretations. Some authors 
suggested that these ﬁndings pointed to hypo-arousal in children with ADHD compared to 
controls (Satterﬁeld & Cantwell, 1974; Rowe et al., 2005). Alternatively, elevated theta/beta 
power ratios in children with ADHD have been interpreted to suggest reduced cortical 
control over increased subcortical drives (Schutter, Leitner, Kenemans & van Honk, 2006).
Few studies examined resting-state EEG in older individuals with ADHD. The most consistent 
ﬁnding refers to elevated levels of theta activity in adolescents and adults with ADHD 
(Lazzaro et al., 1999; Bresnahan & Barry, 2002; Hermens et al., 2004; Hermens, Kohn, Clarke, 
Gordon & Williams, 2005a; Bresnahan, Barry, Clarke & Johnstone, 2006; Hobbs, Clarke, 
Barry, McCarthy & Selikowitz, 2007; Koehler et al., 2009). Elevated levels of alpha activity 
have also been reported in adolescents and adults with ADHD (Lazzaro et al., 1999; 
Bresnahan & Barry, 2002; Koehler et al., 2009). The ﬁndings for beta oscillations are far 
from consistent (Lazzaro et al., 1999; Bresnahan & Barry, 2002; Bresnahan et al., 2006; 
Hobbs et al., 2007; Koehler et al., 2009). Finally, all studies, except one recent study (Koehler 
et al., 2009), report an elevated theta/beta power ratio in adolescents and adults with 
ADHD as compared to controls (Bresnahan & Barry, 2002; Hermens et al., 2005a; Bresnahan 
et al., 2006; Hobbs et al., 2007). Summing up, the EEG literature relating to older individuals 
with ADHD yielded disparate ﬁndings in contrast to the relatively consistent results reported 
for children with ADHD.
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The apparent discrepancies between children versus adolescent and adult ADHD studies of 
resting state EEG might be due to various factors, including developmental change, study 
design, EEG recording, and quantiﬁcation procedures. In broad outline, it should be noted 
that the large majority of studies in children refer to EEG recorded when eyes were closed, 
whereas in three of seven adolescent and adults studies, recordings were done when eyes 
were open (Lazzaro et al., 1999; Bresnahan & Barry, 2002; Bresnahan et al., 2006). 
In order to evaluate this potentially critical factor, the current study will analyze EEG data 
recorded in adults with ADHD both under eyes-open and eyes-closed conditions. In 
addition, few studies - and only studies in children and adolescents - examined relations 
between resting state EEG indices and attention/cognitive performance measures, and 
those that did assess such relations yielded inconsistent results. One study examining the 
relation between EEG theta power and performance accuracy on an auditory oddball task 
in adolescents with ADHD reported a negative correlation for both ADHD individuals and 
controls (Hermens et al., 2005b). Another study observed a positive relation between theta 
power and the variability of responses when children with ADHD performed a Conners’ 
continuous performance task (CPT) and a negative relation between alpha and beta power 
and the incidence of response omissions (Loo & Smalley, 2008). Finally, other investigators 
failed to obtain signiﬁcant relations between resting state EEG indices and performance 
measures obtained when children with ADHD underwent a CPT (Swartwood, Swartwood, 
Lubar & Timmermann, 2003). In view of the lack of studies examining relations between 
resting- state EEG and neurocognitive task performance in older individuals with ADHD, 
the present study will assess relations between resting-state EEG indices obtained under 
conditions of eyes-open vs. eyes-closed and various performance measures that can be 
derived from the frequently used stop-signal task (i.e., speed of responding and the 
efﬁciency of response inhibition). 
A ﬁnal goal of the current study is to explore the relations between resting-state EEG and 
behavioral symptoms observed in adults with ADHD. Recently, diminished frontal theta and 
elevated frontal beta activity have been related to parent behavior ratings of improved 
attention and hyperactivity/impulsivity in children with ADHD on methylphenidate (Loo, 
Hopfer, Teale & Reite, 2004). However, another study failed to observe a signiﬁcant relation 
between theta activity and ratings of attention in children with ADHD (Swartwood et al., 
1998). In conclusion, the relation between resting-state EEG and ratings of behavioral 
ADHD symptoms is still unclear. 
In sum, based on previous studies examining stop-signal performance in individuals with 
ADHD, we predicted that adults with ADHD would show a slower speed of responding and 
less efﬁcient response inhibition. In addition, we assumed that the apparent inconsistencies 
between child versus adult studies of resting-state EEG in individuals with ADHD are related 
to EEG recording conditions; eyes-open versus eyes-closed. Furthermore, we predicted a 
negative relation between slow EEG frequencies and performance on the stop-signal task 
based on the hypothesis that elevated slow resting-state oscillations signals hypo-arousal 
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(Satterﬁeld & Cantwell, 1974; Rowe et al., 2005) and on ﬁndings suggesting reduced 
performance when attention is sub-optimal (Chee, Logan, Schachar, Lindsay & Wachsmuth, 
1989). Finally, we will explore relations between resting-state EEG and ratings of behavioral 
ADHD symptoms.
Methods
In the current study, we examined data available from a previous study (Bekker et al., 2005). 
The methods, procedures, and materials have been described in detail elsewhere (Bekker et 
al., 2005). Here, we will provide only the essentials for the present study.
Twenty-four outpatient adults diagnosed with ADHD combined subtype (34.3 ± 11.68 years; 
range, 18-57 years; 12 men; 3 left-handed) were matched on age, IQ, and gender with 24 
control participants (34.9 years; range, 18-57 years; 12 men; 1 left-handed). A semi-struc-
tured interview for adult ADHD (Kooij, 2002), four sections of the Diagnostic Interview 
Schedule (Robins, Cottler, Bucholz & Compton, 1995), and the computerized Composite 
International Diagnostic Interview (lifetime version 2.1) (Robins et al., 1988; ter Smitten, 
Smeets & van den Brink, 1997) were used to evaluate current and childhood ADHD symptoms 
and co-morbid disorders in all participants (see Bekker et al., 2005). Additionally, all 
participants ﬁlled out translated versions of the Brown ADD Scale (BADDS; Brown, 1996), 
the Conners’ Adult ADHD Rating Scales (CAARS; Conners Erhardt & Sparrow, 1999) and 
the ADHD Rating Scale-IV (ADHD-RS) for current and childhood ADHD symptoms (DuPaul, 
Power, Anastopoulos & Reid, 1998). An experienced physician and nurse made the Diagnostic 
and Statistical Manual of Mental Disorders (4th ed.; DSM-IV; American Psychiatric Association, 
1994) diagnosis of childhood-onset and current ADHD combined subtype. For the diagnosis 
of ADHD, patients must have 1) met the criteria for the diagnosis of ADHD combined 
subtype in childhood (i.e., 6 out of 9 DSM-IV criteria of inattention and 6 out of 9 DSM-IV 
criteria of hyperactivity/impulsivity in childhood), 2) met the criteria for the diagnosis of 
current ADHD combined subtype (i.e., at least 5 of 9 criteria DSM-IV criteria of inattention 
and 5 out of 9 DSM-IV criteria of hyperactivity/impulsivity in adulthood (Kooij, 2002), and 
3) experienced impairment in a moderate or severe level attributed to the ADHD symptoms. 
Controls were excluded if currently suspected of ADHD (scores on the BADDS, CAARS, and 
the DSM-IV Rating Scale had to be below the cut-off point for ADHD), diagnosed with a 
developmental disorder in childhood (i.e., ADHD, oppositional deﬁant disorder, conduct 
disorder, and/or autism), reporting an ADHD diagnosis among relatives, or treated by a 
health-care professional. Participants gave written informed consent in accordance with 
the guidelines of the Ethics Committee of the University Medical Center. All further 
procedures were in compliance with the guidelines of the review board for Scientiﬁc 
Research in Humans of the Faculty of Social Sciences. 
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Participants performed the stop-signal task after recording resting-state EEG during an 
eyes-open and eyes-closed condition in a sound-attenuating cabin. The stop-signal task 
consisted of the presentation of square-wave, black-on-white gratings with a high (4.8 
cycles per degree [cpd]) or low (0.6 cpd) fundamental spatial frequency (750 milliseconds 
[ms]). Participants were required to discriminate between the two gratings and press the 
correct (left or right) button. Unpredictably, on 40% of the trials, a tone (1000 Hertz [Hz], 
80 decibel, 400 ms) was presented binaurally through earplugs, which indicated that the 
planned response to the grating should be withheld. The delay between go stimuli and stop 
signals (stimulus onset asynchrony [SOA]) was adjusted using a tracking algorithm to yield 
about 50% successful inhibitions, corrected for the estimated number of omissions. The 
time-interval between successive trials varied from 1000 to 1250 ms. There were six trial 
blocks that contained 76 trials without a stop-signal and 50 trials with a stop-signal. Mean 
reaction time (MRT) was computed for correct responses to the choice stimulus, excluding 
extremely fast or slow responses (i.e., < 150 ms and > 1250 ms post-stimulus). The time it 
takes to inhibit the response to the choice stimulus was estimated using the formalizations 
associated with the stop-signal task (Logan, 1994). The latency of response inhibition is 
dubbed stop-signal reaction time (SSRT). 
The EEG data were recorded using an elastic cap with 62 tin electrodes referenced to the left 
mastoid. The ground electrode was placed within the cap between Fpz and Fz. Vertical elec-
trooculogram (VEOG) was recorded from electrodes attached above and below the left eye 
and the horizontal electrooculogram (HEOG) from the outer canthi of both eyes. Electrode 
impedance was kept below 5 kOhm. EEG and EOG were ampliﬁed with a bandwidth of 
0.05-50 Hz. The sampling rate was 1000 Hz. Participants were asked to sit quietly for four 
minutes (min), two min with eyes-open and two min with eyes-closed, during which 
resting-state EEG was recorded.
EEG and EOG data were analyzed using Brain Vision Analyzer software (Brainproducts, 
Gilching, Germany). EEG signals were re-referenced off-line to the average of all electrodes 
and the sampling-rate was changed to 256 Hz with a notch ﬁlter of 50 Hz. The 2-min 
continuous EEG data were segmented into 2-s epochs, separately for the eyes-open and 
eyes-closed condition. Trials with artifacts were rejected from further analysis (absolute 
amplitude criterion of 120 μV; low activity criterion of 0.3 μV within a 50 ms time window) 
and ocular artifact correction was conducted according to the Gratton et al. algorithm. The 
average number of EEG epochs used for the Fast Fourier Transform analyses was 51 (SD = 
10.6) for the eyes-open and 49 (SD = 12.6) for the eyes-closed condition in the ADHD group 
and 56.2 (SD = 9.1) for the eyes-open and 57.2 (SD = 4.8) for the eyes-closed condition in 
the control group. EEG data were Fourier transformed (Hanning window length of 20%) and 
subsequently ln-transformed. Power estimates were derived from the average for the theta 
(4-7.5 Hz), alpha (8-12 Hz), and beta (12.5-25 Hz) frequency-bands at frontal (Fz, F3, F4), 
central (Cz, C3, C4), and parietal (Pz, P3, P4) sites. Theta/beta and theta/alpha power ratios 
were calculated between the frequency-bands by dividing the power of the lower frequency- 
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band by the power of the higher frequency-band. Additionally, mean alpha peak frequency 
(APF) was deﬁned as the frequency at which alpha power was maximum within 7.5-15 Hz 
over the occipital electrodes (O1, Oz, O2) in the eyes-closed condition. Visual inspection was 
conducted for peak frequencies occurring at the boundaries of the search window. One 
adult with ADHD did not show a clear alpha peak and was excluded from the APF analysis. 
Separate one-way ANOVAs were conducted for MRT, SSRT, and APF to examine group 
differences. Separate repeated-measures analyses of variance (ANOVAs) were conducted 
for absolute theta, alpha, and beta power and theta/alpha and theta/beta power ratios with 
condition (eyes-open vs. eyes-closed), laterality (left, midline, right) and area (frontal, 
central, parietal), as within-subjects factors, and group (ADHD vs. control participants) as 
between-subjects factor. We were only interested in (interaction with) group effects. If the 
omnibus ANOVAs revealed signiﬁcant interaction effects with group, post-hoc analyses 
were conducted to examine the group effect. Furthermore, parametric correlation analyses 
were performed to investigate the relation between task performance (MRT and SSRT) and 
EEG power values. Additionally, the relation between behavioral symptoms of ADHD and 
EEG power was examined by computing non-parametric correlation coefﬁcients between 
EEG power values and the total score of the BADDS, the ADHD index of the CAARS, and the 
attention-deﬁcit and hyperactivity/impulsivity items in childhood as well as in the last 6 
months for the ADHD-RS. The alpha level of signiﬁcance was set at .01 two-tailed.
Results 
As reported in a previous study (Bekker et al., 2005), the ADHD group had longer SSRTs than 
the control group, F (1,46) = 7.12, p = .010 (mean ± SD, 185.2 ± 38.9 ms for the control and 
237.3 ± 87.2 ms for the ADHD group, respectively). The ADHD group committed more 
omission errors to the trials without stop-signals relative to the controls, F (1,46) = 4.24, p = 
.045 (mean ± SD: 1.22% ± 1.18 for the control and 2.63% ± 3.05 for the ADHD group, 
respectively)1, but the groups did not differ regarding MRTs, F (1,46) = 0.04, p = .842 (mean ± 
SD, 463.3 ± 68.8 ms for the control and 467.9 ± 87.6 ms for the ADHD group, respectively). 
Table 1 (see supplement) presents mean theta, alpha, and beta power, and theta/beta and 
theta/alpha power ratios at midline electrodes, for the eyes-closed and eyes-open condition, 
separately for the ADHD and control group. ANOVAs did not yield any signiﬁcant main 
group effect for theta, alpha, and beta power, for theta/alpha and theta/beta power ratios 
or APF (all F -values < 1). 
We found three signiﬁcant interaction effects including group. First, a signiﬁcant group 
(ADHD vs. control) x area (frontal, central, parietal) x condition (eyes-closed vs. eyes-open) 
interaction was found for alpha, F
(2,92) = 4.90, p = .010. Post-hoc analyses per area revealed 
a signiﬁcant group x condition effect over parietal sites, F (1,46) = 4.69, p = .036, but not over 
frontal or central sites. Although parietal alpha activity did not signiﬁcantly differ between 
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groups in both conditions, the alpha attenuation from the eyes-closed to the eyes-open 
condition was signiﬁcantly greater for the ADHD than the control group (Figure 1). Second, 
a trend for a group x laterality effect was found for theta/beta power ratio, F (2, 92) = 3.03, 
p = .053, indicating that the theta/beta power ratio was larger for ADHD than for controls 
at midline compared to lateral electrodes (Figure 2), but group differences did not reach 
signiﬁcance at either midline or lateral electrodes (F < 1). Finally, a signiﬁcant group x 
laterality x condition effect was found for the theta/alpha, F (2, 92) = 6.73, p = .002. Post-hoc 
analyses per laterality revealed no signiﬁcant group x condition effects. 
Correlation analyses were conducted to assess relations between EEG and task performance 
or behavioral symptoms (see supplement). Based on the signiﬁcant interaction effects 
including group for alpha activity, the theta/beta power ratio, and the theta/alpha ratio, 
differences in power values were used in the correlation analyses. The reason for using 
differences in power values in the analyses is to reduce the intra-individual variability in 
power values. Negative correlations were observed between MRT and the theta/beta power 
ratio (midline minus lateral; averaged across areas and eyes-closed/open conditions) for 
both the ADHD and control group (r = -0.55, p = .005; and r = -0.62, p = .001, respectively). 
The theta/alpha ratio (midline minus lateral sites; averaged across areas) also correlated 
negatively with MRT; for the ADHD group in the eyes-open condition (r = -0.52, p = .010) 
and for the control group in the eyes-closed condition (r = -0.52, p = .009). All other 
correlations between EEG measures and performance measures or behavioral symptoms 
failed to reach an acceptable signiﬁcance level.
Figure 1 Mean alpha power over parietal sites in the eyes-open and eyes-closed condition 
for ADHD adults and matched control participants. Error bars represent the standard error 
of the mean.
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Discussion 
The current study set out to assess resting-state EEG in adults with ADHD and to relate EEG 
indices to performance measures obtained using a stop-signal task, and to behavioral 
symptoms characterizing ADHD. The data were derived from a previous report showing that 
response inhibition was less efﬁcient in the ADHD group compared to controls while the 
speed of responding did not signiﬁcantly differentiate between groups. 
In contrast to previous studies examining EEG in adults with ADHD, the present study 
assessed potential EEG differences between individuals with ADHD and controls under both 
eyes-open and eyes-closed conditions. The current ﬁndings indicated that parietal alpha in 
either condition failed to distinguish between the ADHD group and controls, but the 
reduction in parietal alpha power between conditions (i.e., alpha attenuation) did 
discriminate between the groups. This ﬁnding seems to underscore the importance of this 
procedural detail (i.e., eyes-open vs. closed). Note the relatively large difference in parietal 
alpha power between groups in the eyes-closed, but not in the eyes-open condition. Based 
on the assumption that alpha activity reﬂects arousal state (Barry, Clarke, Johnstone, Magee 
& Rushby, 2007) and the current ﬁndings showing that ADHD adults had a greater difference 
in alpha power in the eyes-closed compared to the eyes-open condition than control adults, 
we may speculate that adults with ADHD are hypo-aroused during an eyes-closed resting 
condition (Satterﬁeld & Cantwell, 1974). This interpretation is consistent with the hypo- 
arousal model of ADHD assuming that individuals with ADHD are cortically hypo-aroused 
and are seeking external stimulation in an attempt to normalize their arousal level.
Figure 2 Mean theta/beta power ratio at left, midline and right electrode sites for adults 
with ADHD and matched control controls. Error bars represent the standard error of the 
mean.
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The current study did not replicate previous ﬁndings of elevated theta power in adolescents 
and adults ADHD relative to controls (Lazzaro et al., 1999; Bresnahan & Barry, 2002; 
Hermens et al., 2004; Hermens et al., 2005a; Bresnahan et al., 2006; Hobbs et al., 2007; 
Koehler et al., 2009). Although theta power was larger for the ADHD than the control group 
at midline electrodes, these group differences did not reach an acceptable signiﬁcance level. 
A possible explanation points to the large variability in theta power across participants, as 
indicated by high standard errors of the mean (Figure 2). The theta/beta power ratio 
correlated negatively with the ADHD index of the CAARS. The latter ﬁnding was unexpected 
given the recent observation reported by Koehler and colleagues (Koehler et al., 2009), 
indicating a positive relation between theta and inattention scores on the Adult ADHD 
Self-Report Scale. Before interpreting this apparent inconsistence, the robustness of the 
current ﬁnding should be established in future research.
The theta/beta and theta/alpha power ratios, although not discriminating between groups, 
were signiﬁcantly related to performance in the ADHD and control group; larger ratios were 
associated with faster responding to the choice stimuli in the stop-signal task. At ﬁrst 
glance, the observation of a positive relation between higher EEG ratios and faster 
responding to the choice stimuli on the stop-signal-task seems at odds with previous 
ﬁndings indicating that patients with ADHD are characterized by higher EEG ratios, most 
notably the theta/beta power ratio, and with worse performance on the stop-signal task as 
compared to control participants (Barry et al., 2003; Lijfﬁjt et al., 2005). The current ﬁnding, 
however, should be interpreted in relation to both speed and accuracy. Although groups did 
not differ in the speed of responding, the ADHD group committed signiﬁcantly more 
omission errors relative to the controls (2.63% and 1.22%, respectively). This pattern 
suggests a speed-accuracy trade-off in the ADHD group; that is, individuals with ADHD are 
inclined to respond to the choice stimulus before it is completely analyzed. Thus, the current 
pattern of higher EEG ratios associated with faster responding might index higher levels of 
impulsivity rather than improved cognitive efﬁciency. The relation between slow EEG 
frequencies and impulsivity is consistent with observations that elevated ratios of slow/fast 
wave EEG activity are associated with risky decision-taking (Schutter & van Honk, 2005). 
More speciﬁcally, it has been suggested that slow EEG frequencies are associated with 
‘deeper’ motivational systems and fast EEG frequencies with ‘higher’ cognitive systems, 
such that a balance towards slow frequencies biases the system to response activation 
whereas a balance to fast frequencies would promote inhibition (Schutter et al., 2006).
To conclude, the current study showed that the alpha attenuation from the eyes-closed to 
the eyes-open condition was larger in adults with ADHD compared to controls. This ﬁnding 
was interpreted in terms of the hypo-arousal model of ADHD (Rowe et al., 2005). In addition, 
the current study showed a positive correlation between theta/alpha and theta/beta power 
ratios and the speed of responding in the stop-signal task. In adults with ADHD this pattern 
was associated with a higher error rate relative to the control group. This ﬁnding was 
interpreted in relation to previous ﬁndings suggesting a relation between an elevated theta/
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beta power ratio and impulsive behavior (Schutter et al., 2006). A uniﬁed account of both 
ﬁndings is provided by a biophysical model presented by Rowe and colleagues (Rowe et al., 
2005). This model assumes that hypo-arousal of the cortex is due to a tonic overdrive of the 
locus coeruleus resulting in an increase in inhibitory activity of the thalamic reticular 
nucleus, which in turn results in elevated EEG slow waves. The cortical hypo-arousal affects 
several mechanisms including the fronto-striatal circuitry implicated in the ability to inhibit 
pre-potent and premature responses (Bradshaw, 2001). The biophysical model proposed by 
Rowe and colleagues ﬁtted data from an ADHD-medication study quite well and might 
open up interesting avenues for future investigations of hypo-arousal and its behavioral 
consequences in ADHD.
1 Note that the proportion of omission errors may violate the assumption of a normal distribution. To 
obtain more normally distributed values, proportions of omission errors were transformed using the 
arcsin function: arcsin(SQRT[p]).
50
Ch
ap
te
r 
II
Supplement
Correlation analyses
First, parametric correlation analyses were conducted to examine the relation between 
brain oscillations at rest and task performance (SSRT, MRT). Second, non-parametric 
correlation analyses were conducted to assess the relations between EEG and behavioral 
symptoms of ADHD (i.e., total score of the BADDS, ADHD index of the CAARS, and attention 
deﬁcit and hyperactivity/impulsivity items in childhood and in the last 6 months for the 
ADHD-RS). 
Based on the signiﬁcant interaction effects including group for alpha activity, the theta/
beta ratio, and the theta/alpha ratio, differences in power values were used in the correlation 
Table 1   Mean power (μV2) and mean power ratios (in parentheses standard error of 
the mean) at midline electrodes for the ADHD and control group.
ADHD adults control adults
eyes-open eyes-closed eyes-open eyes-closed
theta Fz 0.23 (0.10) 0.30 (0.13) 0.22 (0.13) 0.28 (0.16)
Cz 0.21 (0.07) 0.28 (0.13) 0.21 (0.13) 0.27 (0.17)
Pz 0.17 (0.07) 0.27 (0.17) 0.17 (0.08) 0.25 (0.14)
alpha Fz 0.22 (0.15) 0.57 (0.35) 0.22 (0.13) 0.46 (0.25)
Cz 0.19 (0.13) 0.49 (0.32) 0.19 (0.10) 0.40 (0.21)
Pz 0.27 (0.17) 0.72 (0.43) 0.31 (0.20) 0.59 (0.30)
beta Fz 0.08 (0.05) 0.10 (0.07) 0.08 (0.04) 0.09 (0.05)
Cz 0.08 (0.08) 0.11 (0.08) 0.08 (0.07) 0.10 (0.08)
Pz 0.08 (0.05) 0.13 (0.08) 0.08 (0.05) 0.11 (0.08)
theta/beta ratio Fz 3.65 (1.94) 3.35 (1.37) 3.14 (1.47) 3.16 (1.31)
Cz 3.76 (1.82) 3.32 (1.74) 3.26 (2.11) 3.02 (1.57)
Pz 2.45 (1.07) 2.41 (1.25) 2.32 (1.09) 2.32 (1.04)
theta/alpha ratio Fz 1.32 (0.58) 0.63 (0.26) 1.16 (0.60) 0.66 (0.30)
Cz 1.37 (0.60) 0.66 (0.25) 1.19 (0.58) 0.70 (0.35)
Pz 0.80 (0.43) 0.44 (0.24) 0.70 (0.41) 0.47 (0.25)
Note: Standard deviations of the mean are given in parentheses.
Abbreviations: ADHD, attention-deﬁcit/hyperactivity disorder.
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analyses for these variables to reduce the number of tests and to reduce the intra-individ-
ual variability in power values: 1) Parietal alpha power in the eyes-open condition was 
subtracted from parietal alpha power in the eyes-closed condition, 2) the average theta/
beta ratio across conditions and lateral sites was subtracted from the average theta/beta 
ratio across conditions at midline sites, and 3) the average theta/alpha ratio across lateral 
sites was subtracted from the theta/alpha ratio at midline sites, separately for the eyes-open 
and eyes-closed condition. For the correlation analyses with theta and beta power, mean 
EEG power was calculated per area by averaging over lateral and midline electrodes. To 
correct for the large number of statistical tests, the alpha level of signiﬁcance was set at .01 
two-tailed. Bonferroni corrections were not conducted, because the test statistics were 
assumed to be highly dependent. 
Tables 2 and 3 show Pearson’s correlation coefﬁcients for the relation between EEG and 
task performance on the stop-signal task. As presented in Table 2, a signiﬁcant positive 
correlation was obtained for the ADHD group between central beta power in the eyes-open 
condition and SSRT (r = 0.54, p = .007). However, as illustrated in Figure 1, one outlier was 
mainly responsible for these results. The correlation between SSRT and beta power was not 
signiﬁcant anymore in a post-hoc correlation analysis without this outlier (r = 0.32, p = .14). 
Table 3 and Figure 2 present the signiﬁcant negative relation between MRT and theta/beta 
ratio for both the ADHD and control group (r = -0.55, p = .005; and r = -0.62, p = .001, 
respectively). Furthermore, a signiﬁcant negative correlation was observed between theta/
alpha ratio and MRT in the eyes-open condition for the ADHD group (r = -0.52, p = .010) 
and in the eyes-closed condition for the control group (r = -0.52, p = .009) (see Table 3 and 
Figures 3 and 4).
No signiﬁcant correlations were observed between EEG measures and the behavioral 
symptoms of ADHD.
52
Ch
ap
te
r 
II
Table 2   Pearson’s correlation coefﬁcients between cognitive performance on the 
stop-signal task and mean power in the theta and beta band across 
electrodes, for each brain area (frontal, central and parietal) in the eyes-open 
and eyes-closed condition, separately for the ADHD and control group.
ADHD control
SSRT MRT SSRT MRT
theta eyes-closed frontal 0.22 0.04 -0.06 -0.16
central 0.25 0.03 -0.02 -0.25
parietal 0.18 -0.03 0.11 -0.02
eyes-open frontal 0.13 -0.09 -0.11 -0.28
central 0.22 0.00 -0.09 -0.40
parietal 0.27 -0.02 -0.00 -0.33
beta eyes-closed frontal 0.47* 0.39 0.26 0.13
central 0.47* 0.39 0.21 0.10
parietal 0.31 0.27 0.34 0.08
eyes-open frontal 0.41* 0.23 -0.12 0.13
central 0.54** 0.34 0.14 0.09
parietal 0.42* 0.33 0.36 0.03
* p < .05 (two-tailed), ** p < .01 (two-tailed). 
Abbreviations:  ADHD, attention-deﬁcit/hyperactivity disorder; SSRT, stop-signal reaction time; 
MRT, mean reaction time.
Table 3   Pearson’s correlation coefﬁcients between cognitive performance on the 
stop-signal task and differences in power values, separately for the ADHD  
and control group.
ADHD control
SSRT MRT SSRT MRT
parietal alpha (eyes-closed minus eyes-open) 0.15 0.17 0.11 0.21
TB (lateral sites minus midline sites) -0.29 -0.55** -0.22 -0.62**
TA eo (lateral sites minus midline sites) -0.28 -0.52** 0.03 -0.39
TA ec (lateral sites minus midline sites) -0.15 -0.45* -0.01 -0.52**
* p < .05 (two-tailed), ** p < .01 (two-tailed).
Abbreviations: ADHD, attention-deﬁcit/hyperactivity disorder; SSRT, stop-signal reaction time; 
MRT, mean reaction time, TB, theta/beta power ratio; TA, theta/alpha power ratio; eo, eyes-open; ec, eyes-closed.
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Figure 1 The relation between mean beta power at central sites in the eyes-open condition 
and stop-signal reaction time (SSRT) for both groups.
Figure 2 The relation between theta/beta ratio (averaged over conditions; midline minus 
lateral sites) and mean reaction time (MRT) for both groups.
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Figure 3 The relation between theta/alpha ratio (midline minus lateral sites) in the eyes- 
open (eo) condition and mean reaction time (MRT) for both groups.
Figure 4 The relation between theta/alpha ratio (midline minus lateral sites) in the eyes- 
closed (ec) condition and mean reaction time (MRT) for both groups.
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Abstract
Attention-deﬁcit/hyperactivity disorder (ADHD) has been associated with an elevated 
resting-state theta/beta power ratio and elevated theta power. However, the potential 
confounding effect of a low individual alpha peak frequency (IAPF) on the theta power 
estimate has often been disregarded, when studying the relationship between ADHD and 
the theta/beta power ratio or theta power alone. The current study assessed whether the 
theta/beta power ratio and relative theta power correlated with behavioral functioning in 
children with ADHD such as expected from previous work. Subsequently, the inﬂuence of 
IAPF and the amount of supposed overlap between the individually determined alpha-band 
and the ﬁxed theta-band were studied. 
For 38 children (age between 8-15 years) EEG data and investigator-scored ADHD IV Rating 
Scales were available. Additional neurocognitive data were available for 32 children. 
As expected, the theta/beta power ratio and theta were positively related to the ADHD 
core-symptoms. This relationship strengthened when controlling for IAPF, although 
correlations did not signiﬁcantly differ from each other. Eight out of 38 (21%) children 
showed a supposed overlap between their individually determined alpha-band and the 
theta-band. Neurocognitive performance did not show any relationship with the theta/beta 
power ratio or theta. 
The results of this study conﬁrmed that the theta/beta power ratio and theta indeed 
correlated with behavioral symptoms in children with ADHD and underscore the relevance 
of taking the IAPF into account. 
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Introduction
Children with attention-deﬁcit/hyperactivity disorder (ADHD) display impairments in 
sustained attention and set-shifting (Weissman, Chu, Reddy & Mohlman, 2012), response 
inhibition, vigilance, working memory, and planning (Martinussen, Hayden, Hogg-Johnson 
& Tannock, 2005; Willcutt, Doyle, Nigg, Faraone & Pennington, 2005), reward processing 
(Luman, Oosterlaan & Sergeant, 2005; Luman, Tripp & Scheres, 2010), and temporal 
processing (Noreika, Falter & Rubia, 2013). The persistence of these neurocognitive 
impairments is clinically relevant for ADHD by their strong association with impairment in 
global functioning (Biederman et al., 2012). 
The past decades, research has been conducted to understand the neurophysiological 
underpinnings of behavioral (i.e., symptomatic and neurocognitive) functioning in children 
with ADHD using quantitative electroencephalography (qEEG). A recent meta-analysis of 
studies on oscillatory activity at the vertex during an eyes-open resting-state condition in 
children with ADHD, showed that elevated absolute power in the theta-band is reported 
most consistently in ADHD (Arns, Conners & Kraemer, 2012). Resting-state theta power has 
been positively correlated with inattention on symptomatic (Loo, Hopfer, Teale & Reite, 
2004; Ogrim, Kropotov & Hestad, 2012) and neurocognitive level (Swartwood et al., 1998; 
Swartwood, Swartwood, Lubar & Timmermann, 2003; Hermens et al., 2005; Loo & Smalley, 
2008) and negatively with hyperactive/impulsive symptoms (Ogrim et al., 2012). In addition, 
a diminished resting-state beta power has been found, although 13-20% of patients 
 with ADHD showed excess beta power or beta spindles (Arns, 2012). Other inconsistent 
ﬁndings suggest that beta power correlated positively with inattention and the overall 
symptoms-score of ADHD (Ogrim et al., 2012), but correlated positively with impulsivity 
(Swartwood et al., 1998; Swartwood et al., 2003) and negatively with inattention 
(Swartwood et al., 1998). 
Elevation of the ratio between power in the theta- and beta-band has been regarded as a 
robust ﬁnding at the vertex in children with ADHD compared to controls (Arns et al., 2012). 
The eyes-closed resting-state theta/beta power ratio showed a weak correlation with 
inattention symptoms (Loo et al., 2013). Despite its robustness, caution in interpretation is 
warranted for several reasons (Arns et al., 2012). Firstly, the accuracy of discrimination 
between ADHD and controls based on this ratio is too low to serve as a diagnostic tool 
(Monastra et al., 1999; Ogrim et al., 2012). Secondly, although ﬁxed frequency-bands 
showed a difference in theta/beta power ratio between boys with ADHD and healthy 
controls, this difference was absent using individual alpha peak frequency (IAPF) to 
determine individualized frequency-bands (Lansbergen, Arns, van Dongen-Boomsma, 
Spronk & Buitelaar, 2011). These results suggested the existence of a group with an actual 
excess of theta power without any IAPF mediation, and another group with a lower IAPF 
which consequently ‘leaks’ into the theta-band, causing the theta-band power estimate to 
falsely inﬂate when using a ﬁxed frequency-band (Arns, 2012). 
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IAPF rises until the teenage years in healthy development (Chiang, Rennie, Robinson, van 
Albada & Kerr, 2011). Developmental change seems an important observation since ADHD 
is regarded as a neurodevelopmental disorder. Power in the alpha-band has been related to 
functional inhibition of neuronal activity and processing (Klimesch, Sauseng & Hanslmayr, 
2007). A failure to suppress incoming distracting information, hence to modulate alpha 
power, is per deﬁnition a present core-feature of ADHD. Alpha power modulation during 
task performance indeed has been shown aberrant in children and adults with ADHD 
(Mazaheri et al., 2010; ter Huurne et al., 2013). Following the inhibition hypothesis, a low 
IAPF has been hypothesized to slow the process of allowance and stopping of information 
transfer (Grandy et al., 2013). In the literature, IAPF has been considered low if < 9 Hertz 
(Hz) for 9-17 and < 8.5 Hz for 6-9 years old children (Arns, Gunkelman, Breteler & Spronk, 
2008). Importantly, a low IAPF has been shown to be important by its relation with 
non-response to stimulant medication in ADHD (Arns, 2012). Furthermore, the IAPF is 
thought to be trait-like and considerably heritable (Posthuma, Neale, Boomsma & de Geus, 
2001; van Beijsterveldt & van Baal, 2002; Smit et al., 2010; Grandy et al., 2013) suggesting 
that despite changes during development, genetic factors play a lasting role.
Most research regarding these conventional electrophysiological measures focused on a 
dichotomous difference between ADHD and controls rather than gradual changes. The few 
studies that focused on gradual changes within ADHD have rather inconsistent methods 
and results and were not always described in sufﬁcient detail (e.g., concerning the use of 
absolute or relative power and the use of correction for multiple statistical comparisons). 
Differences between study designs (e.g., regarding age-range, neurocognitive tasks, and 
medication use) further complicate comparisons.
The aim of this study was twofold. Rather than making a dichotomous distinction between 
ADHD and controls, the theta/beta power ratio and theta power were ﬁrst correlated with 
behavioral functioning using a broad range of behavioral measures. Although Ogrim and 
colleagues (2102)  found a negative correlation between absolute theta power and 
hyperactive/impulsive symptoms (rated by teacher), we expected a positive relationship, 
driven by the elevated theta power found in children with ADHD with an inherent clinical 
symptom-level of both inattention and hyperactivity/impulsivity. Likewise, a lower 
performance on neurocognitive tests, with a higher theta/beta power ratio and relative 
theta power was expected. Second, these relationships were studied while controlling for 
IAPF, comparing zero-correlations with IAPF controlled correlations. Also, the amount of 
children showing an IAPF for which overlap between individually determined alpha-band 
and ﬁxed theta-band can be expected was determined. Taken together, the current study 
was designed to unravel the confounded interpretation of conventional electrophysiological 
measurements due to low IAPFs. 
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Methods
Participants
Data acquired from a clinical trial on EEG-neurofeedback in children with ADHD were 
examined (http://www.clinicaltrials.gov; NCT00723684). The study was approved by the 
Dutch Central Medical Ethics Committee (www.ccmo.nl) and conducted in accordance with 
the declaration of Helsinki. All parents and all children * 12 years gave their written informed 
consent before participation; children < 12 year gave oral assent. Findings related to 
treatment efﬁcacy and methodological procedures have been described in detail elsewhere 
(van Dongen-Boomsma, Vollebregt, Slaats-Willemse & Buitelaar, 2013; Vollebregt, van 
Dongen-Boomsma, Buitelaar & Slaats-Willemse, 2013). Here, we will provide the information 
relevant for the present study only.
Children (8-15 years old) with a diagnosis of ADHD classiﬁed according to the Diagnostic 
and Statistical Manual of Mental Disorders (4th ed., text rev.; DSM-IV-TR, American 
Psychiatric Association, 2000) without any comorbid psychiatric diagnosis (except for 
oppositional deﬁant disorder) or any serious other medical condition. Use of ADHD- 
medication was allowed albeit with clinically signiﬁcant remaining ADHD symptoms, i.e., at 
least six inattentive or hyperactive/impulsive symptoms above the clinical threshold.
Behavior
ADHD symptom rating. Total severity of inattentive and hyperactive/impulsive symptoms of 
ADHD, according to the DSM-IV-TR based ADHD Rating Scale IV (ADHD-RS; Zhang, Faries, 
Vowles & Michelson, 2005), was scored by the investigator in an interview with the parents, 
using a 4-point Likert scale (0 = never occurs, 1 = occurs sometimes, 2 = occurs often, 3 = 
occurs very often). The sum per subscale and the sum of all symptoms were used for further 
analyses.
Neurocognitive performance. Participating children underwent a neurocognitive assessment 
of approximately 90 minutes (min). Complete task descriptions can be found elsewhere 
(Vollebregt et al., 2013). Sustained attention was measured with the Sustained Attention 
Dots task (SA-DOTS), visuospatial memory with Visuospatial Sequencing (VSS), verbal 
working memory with Digit Span from the Wechsler Intelligence Scale for Children-III, 
verbal working and long term memory with The Rey Auditory-Verbal Learning Test (RAVLT), 
instrumental/operant learning with the Instrumental Learning task, precision of time 
perception with the Time Production task, and precision of time reproduction with the Time 
Reproduction task.
Electrophysiology
Instruction. EEG was acquired during 10-min eyes-open and 10-min eyes-closed resting- 
state conditions. Children were instructed to sit quietly and ﬁx their eyes on one spot during 
the measurement. In between they had a small break.
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Data processing. Data were processed and analyzed using MATLAB 2012a (The MathWorks, 
Inc., Natrick, MA) and the FieldTrip EEG analysis toolbox (Oostenveld, Fries, Maris & 
Schoffelen, 2011). Data segments showing artifacts such as vertical and horizontal EOG 
exceeding 100 microvolt, muscle potentials, ampliﬁer or electrode noise, were identiﬁed 
using a semiautomatic routine and excluded from further analysis. When less than two 
minutes data remained within a dataset, the EEG signal quality was regarded inadequate 
and the subject was excluded from further analysis. 
EEG system. EEG was recorded from 21 scalp electrodes placed according to the 10-20 
system using the TruScan EEG system (DEYMED Diagnostic, Payette, ID). Electrode 
impedance was kept below 10 kOhm. Electrode Fpz was used as ground and the common 
reference was placed just anterior of electrode Fz. For all, but 8 children EEG data were 
recorded with a bandwidth of 0.1-102 Hz and the sampling rate was 256 Hz. For 8 children 
EEG data were recorded with a bandwidth of 0.1-64 Hz and a sampling rate of 128 Hz. Eye 
movements were not separately recorded but were detectable in the frontal EEG channels. 
Electrophysiological procedure. First, spectrally resolved power was calculated using a Fast 
Fourier Transform. To make an informed choice of analysis parameters and to limit the 
number of EEG variables, i.e., minimize multiple statistical comparisons for the subsequent 
analysis, we used literature and a pilot analysis on independent data (see supplement for 
details). These resulted in a selection of relative theta power at the vertex for further 
analyses. The theta/beta power ratio was included based on literature ﬁndings. The 
condition, electrode position, and bandwidth of theta and beta were chosen to be consistent 
with (most) studies from the recent meta-analysis on the theta/beta power ratio (Arns et 
al., 2012); power was estimated at electrode Cz at the vertex for theta (4-8 Hz) and beta 
(13-21 Hz) frequency-bands in the eyes-open condition, using a time windows of 1 second 
(sec) and a Hanning taper. The theta/beta power ratio was calculated by dividing the average 
power over frequency bins within the theta-band by the average power over frequency bins 
within the beta-band. Theta was derived by dividing the average power over frequencies 
within the theta-band by the overall power of all frequencies measured at that electrode. As 
from here, theta/beta power ratio (O/ )` and theta mentioned together will be abbreviated 
with O&O/ .`
To investigate the possibility of alpha-band power leaking into the theta-band estimate, the 
IAPF was determined. Figure 1 depicts how the IAPF may confound the estimate of theta 
using illustrative data from two children. Obviously, higher alpha power inﬂuences the 
theta-band estimate more. However, to limit the number of statistical comparisons, only 
IAPF was a-priori selected for this study. To yield an accurate estimate of the IAPFs, we 
constructed a power spectrum with higher resolution than used in the standard analysis. 
Time windows of 3 sec were Hanning windowed and Fourier transformed, resulting in 1/3 
Hz frequency resolution. The IAPF was determined by the maximum power attenuation 
between the eyes-open and eyes-closed condition within 6-15 Hz at the occipital electrodes 
(average O1 and O2). All outcomes were checked by visual inspection without prior 
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Figure 1 This ﬁgure shows two data set examples how activity from the alpha-band may 
lead to false interpretations of the theta-band power estimate. For illustrative purposes, the 
1/f component has been removed from the power spectra in this ﬁgure. The striped area 
under the alpha-curve indicates the area in which alpha power may falsely be estimated as 
theta power. Figure a. depicts a case in which a – somewhat low – alpha peak frequency 
results in ‘leaking into’ the theta power estimation. Since the amplitude, hence the power of 
alpha is at least three times higher than of theta, this small overlap with the theta-band will 
inﬂate the theta power estimate. Figure b. depicts a case in which the frequency of the alpha 
peak is clearly low, resulting in even more ‘leakage’ into the theta power estimation. Note 
that with a same peak frequency, a higher alpha amplitude (i.e., power) would have a bigger 
inﬂuence on the theta power estimation.
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knowledge on any of the other outcome variables. In case of multiple peaks, the peak 
closest to 10 Hz. was chosen. Next, recognition of the determined peak was veriﬁed at the 
vertex. 
Statistics
Statistical analyses were performed with IBM SPSS Statistics, version 20.0 (Armonk, New 
York; IBM Corp.). The signiﬁcance level was set at p = .05, two-tailed. Imputation was used 
to deal with random missing data to obtain the most accurate data set (Donders, van der 
Heijden, Stijnen & Moons, 2006). We largely avoided the multiple comparison problem by 
performing the partial correlations only on a few electrophysiological variables of interest, 
predetermined in the independent pilot study. 
First, the amount of children with an IAPF < 9 Hz, thereby supposedly displaying an overlap with 
the ﬁxed 4-8 Hz theta-band, and the correlation between IAPF and theta were determined. 
O&O/` were then correlated with the variables of interest (i.e., variables derived from the 
ADHD-RS ﬁlled out by investigator and the neurocognitive tasks) while controlling for IAPF. 
Zero-order correlations were compared to correlations after keeping IAPF constant by 
determining whether a signiﬁcant relation was revealed or abolished after controlling for 
IAPF, and by statistically comparing the correlation coefﬁcients using a z-test. Pooled data 
for imputed data sets do not yield p-values. Therefore, for imputed data sets, correlations were 
reported on pooled data, while signiﬁcance was determined based on the original data sets.
Results
Demographic and clinical characteristics
Forty-nine children were selected for EEG-measurement. For all children clinical information 
and scores on the ADHD-RS were available. Six children were excluded due to inadequate 
EEG-signal quality. Another ﬁve children were excluded from the main analyses because a 
non-comparable EEG-system was used; these data were used for pilot analyses. Hence, for 
38 children (10.5 ± 2.6 years, 84.2% boys) the relationship between ADHD-RS rated by 
investigator and EEG data were analyzed. Six children were excluded from the treatment 
study, consequently lacking administration of the neurocognitive test-battery in these 
children. For the remaining 32 children (mean age 10.6 ± 2.2, 81.3% boys) neurocognitive 
measurements were available. An overview of the selection procedure is depicted in ﬁgure 
1 of the supplement. Descriptive characteristics can be found in table 1 of the supplement. 
Imputation of missing data was used for the SA-DOTS and VSS (3.12%) and the Time 
Reproduction task (6.25%).
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Overlap between individual alpha-band and relative theta power 
In line with our hypothesis, eight children (21%) showed an IAPF < 9 Hz, supposedly creating 
an overlap between the individual determined alpha-band and the conventionally deﬁned 
theta-band (4-8 Hz). Consequently, a signiﬁcant negative correlation was found between 
the IAPF and theta (r =-.412, p = .010) which disappeared after excluding these eight 
children from analyses (r = -.280, p = .133). Eight additional children (another 21%) showed 
an IAPF of 9 Hz, potentially creating a slight overlap (see Figure 1a).
Partial correlations
Signiﬁcant relationships were found between theta and part of the ADHD symptoms 
(inattentive symptoms: r = .112, p = .505; hyperactive/impulsive symptoms: r = .344, p = .034; 
total symptoms: r = .315, p = .054). These became stronger after controlling for IAPF 
(inattentive symptoms: r = .272, p = .104; hyperactive/impulsive symptoms: r = .396, p = .015; 
total symptoms: r = .427, p = .008). Similarly, signiﬁcant relationships between the theta/
beta power ratio and part of the ADHD symptoms (inattentive symptoms: r = .212, p = .202; 
hyperactive/impulsive symptoms: r = .312, p = .057; total symptoms: r = .335, p = .040) 
became stronger after controlling for IAPF (inattentive symptoms: r = .307, p = .065; 
hyperactive/impulsive symptoms: r = .331, p = .045; total symptoms: r = .392, p = .017). The 
differences between the zero-order and IAPF-controlled correlations were non-signiﬁcant. 
Also, no signiﬁcant relationships were found between the O&O/` and any of the 
neurocognitive measures with or without controlling for IAPF. Results can be found in table 
2 of the supplement.
Discussion
In this study a gradual reference framework was used by correlating O&O/` with behavioral 
functioning in children with ADHD. Furthermore, it was investigated whether IAPF inﬂuenced 
this correlation by keeping IAPF variability constant. The hypotheses that led us to conduct 
this study were twofold; 1) positive relationships between O&O/` and clinical symptoms 
were expected based on the robust ﬁnding of elevated theta power in children with ADHD 
with an inherent clinical symptom-level of inattention and hyperactivity/impulsivity; a 
similar expectation was suggested regarding deviation of accompanying neurocognitive 
ADHD-characteristics, 2) the IAPF was hypothesized to inﬂuence these relationships by 
showing a supposed overlap between individually determined alpha-band and ﬁxed 
theta-band in part of the children, thereby potentially falsely overestimating theta. 
In line with a dichotomous difference between ADHD and controls found in previous studies 
(see the meta-analysis by Arns and colleagues, 2012) and as expected, a positive relationship 
was found between theta/beta power ratio and the total and hyperactive/impulsive 
symptom score on the ADHD-RS. In addition, also expected, a positive relationship was 
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found between theta and hyperactive/impulsive symptoms. Twenty-one percent of the 
children in our study showed a supposed overlap between the individually based alpha-band 
and ﬁxed theta-band. Consequently, IAPF and theta correlated moderately. As hypothesized, 
all relationships between the O&O/ ,` and core-symptoms of ADHD became stronger when 
controlling for IAPF. However, the differences between zero-correlations and IAPF- 
controlled correlations were non-signiﬁcant. Still, the relationship between theta and total 
symptom score after controlling for IAPF changed from non-signiﬁcant to a strong 
signiﬁcant correlation. In contrast to what was expected, neurocognitive performance did 
not show any relationship with O&O/ .` 
On symptomatic level, results conﬁrmed our hypotheses; the O&O/` were related to 
core-symptoms of ADHD and controlling for IAPF inﬂuenced these relationships. The 
direction of the results however, was different from what would be expected based on 
literature. Lansbergen and colleagues (2011) found that a dichotomous difference between 
ADHD and controls was lacking when taking into account the IAPF. To come to this 
conclusion, the theta frequency-band in that study was determined using IAPF as anchor 
point (0.4*IAPF-0.6*IAPF). A shift of IAPF however, does not necessarily imply a proportional 
shift of the other frequency-bands, among them the theta-band. Application of this method 
on the current example data sets showed that the theta-band in Figure 1a. would become 
3.5-5.2 Hz, resulting in an estimation of the theta-band based on the theta-band as well as 
an additional lower peak. The theta-band in Figure 1b. would become 3.1-4.7 Hz, resulting 
in an underestimation of theta since not the entire theta-band would be covered by this 
new determined band. Although the results of Lansbergen and colleagues illustrated that 
the IAPFs differ enough from 10 Hz to shift the bands away from the dichotomous 
difference, the results do not necessarily imply an actual lack of the dichotomous difference 
from the ‘normative’ theta- and beta-band. The current study aimed at unraveling the 
inﬂuence of the IAPF-based alpha-band on the ﬁxed theta-band of 4-8 Hz. By using a ﬁxed 
theta-band comparable to the majority of previous studies (Arns et al., 2012), and an 
individual alpha-band comparable to Lansbergen and colleagues, we were able to show that 
the relationship between the conventional O&O/ ,` and core-symptoms of ADHD became 
stronger when controlling for IAPF rather than eliminated. 
The hypothesis of a relationship between O&O/` and neurocognitive results could not be 
conﬁrmed by this study, which might be explained in different ways. Although neurocognitive 
deﬁcits have been recognized in ADHD, without partitioning the neurocognitive hetero- 
geneity within the group of children with ADHD (Nigg, 2005), the measures might not be 
sensitive enough to detect relationships such as with O&O/ .` Furthermore, both 
neurocognitive and neurophysiological measurements are more vulnerable for transient 
state effects due to the short duration of measurement than a behavioral measurement, 
which is based on a signiﬁcantly longer time period (Kendler & Neale, 2010). Consequently, 
transient state effects might be smallest in the conﬁrmed behavioral hypotheses. 
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The interpretation of our ﬁndings should take into account a number of limitations. First, 
medication use has shown to have a large impact on the EEG activity in children with ADHD 
(Swartwood et al., 1998; Loo et al., 2004). The majority of the children in our sample used 
medication; yet, all children nevertheless displayed symptoms in the clinical range, meaning 
that medication-use did not diminish ADHD-symptoms sufﬁciently. Also, our sample size 
and hence the statistical power were relatively small. This prohibited analyses of 
neurocognitive subtypes as suggested in the literature (Nigg, 2005). To control the false 
alarm rate for the statistical inference, we a-priori chose a limited number of electrophysi-
ological variables based on previous studies and our pilot-analysis. These choices restricted 
the analyses to one electrode, enlarging the potential inﬂuence of noise and disallowing 
topographical localization of the measures. The lack of a relationship between neurocognitive 
results and other measures questions whether causal claims can be made about different 
characteristics of ADHD; in particular the directionality and nature of relationship between 
core-symptoms, neurocognitive characteristics, and neurophysiology (Kendler & Neale, 
2010). Simultaneous measurement of neurocognition and neurophysiology might give 
more insight as to whether these are part of a similar causal pathway; an important question 
that needs to be addressed in the future (Kendler & Neale, 2010). As a last remark, this study 
was performed under the assumption that ﬁndings can be captured within frequency-bands 
with independent functions. A more integrated analysis will contribute to a more full 
understanding of the underlying neurophysiology. In conclusion, this study conﬁrmed the 
inﬂuence of IAPF on the conventional EEG measures in ADHD. Until now, resting-state EEG 
research in ADHD has been primarily focused on ﬁxed theta- and beta-band; future research 
should expand to studying individualized frequency band patterns. 
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Supplement
Independent pilot study
To make an informed choice of analysis parameters and to limit the number of EEG variables, 
i.e., minimize multiple comparisons for the subsequent analysis, we used literature and a 
pilot analysis on independent data. These data came from children participating in the 
selection procedure from the same clinical trial, that were a priori excluded from analysis 
due EEG-recording with a non-comparable EEG system (n = 5, all data available n = 4). In 
these subjects EEG was recorded from 32 scalp electrodes placed according to the 10-20 
system using the Acticap and BrainAmp system (Brain Products GmbH, Munich). The left 
mastoid (earlobe) was used as online reference, ofﬂine the data were referenced to linked 
mastoids (earlobes). Electrode Fpz was used as ground. Electrode impedance was kept 
below 10 kOhm. The sampling rate was set to 256 Hz.
Regarding theta power, the pilot results showed – in line with the literature (Boutros, 
Fraenkel & Feingold, 2005) – that relative rather than absolute theta power was more 
predictive. Relative power is less sensitive to individual variation (accounting for the 
variation in thickness and resistance of the skull). The analyses suggested no relationship 
between the behavioral measures and absolute or relative beta power, consistent with the 
ambiguous ﬁndings in the literature (Arns et al., 2012), although possibly also due to the 
small pilot sample size. Alpha activity is generally observed strongest in the visual/occipital 
regions when closing the eyes. To verify whether individualized alpha frequencies (IAPFs) 
could also be derived from the vertex, the method to derive the IAPFs was applied to 
occipital and vertex electrodes. The pilot data showed that it was possible to identify the 
IAPF at the vertex. 
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Figure 1 CONSORT ﬂow diagram of study participants.
Abbreviations: CONSORT, Consolidated Standards of Reporting Trials, n, number; EEG, electroencephalographic; 
SD, standard deviation.
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Table 1   Descriptive characteristics
descriptive characteristics EEG analyses
core symptoms analyses 
(n = 38)
neurocognitive analyses 
(n = 32)
age, m (SD), y 10.5 ± 2.6 10.6 ± 2.2
gender, n (%)
male 32 (84.2) 26 (81.3)
race, n (%)
Caucasian
Black
36 (94.7)
2 (5.3)
30 (93.8)
2 (6.3)
handedness, n (%)
right
left
34 (89.5)
4 (10.5)
29 (90.6)
3 (9.4)
full scale IQ, m (SD) 104.5 ± 17.1x 103.8 ± 15.9
medication for ADHD, n (%)
psychostimulants
atomoxetine
no medication
21 (55.3)
1 (2.6)
16 (42.1)
18 (56.3)
1 (3.1)
13 (40.6)
melatonin, n (%) 8 (21.1) 7 (21.9)
ADHD subtype, n (%)
combined
inattentive
hyperactive/impulsive
27 (71.1)
10 (26.3)
1 (2.6)
23 (71.9)
8 (25.0)
1 (3.1)
comorbidity, n (%)
oppositional deﬁant disorder 
anxiety disorders
dyslexia
5 (13.2)
4 (10.5)
5 (13.2)
5 (15.6)
3 (9.4)
2 (6.3)
ADHD-RS, m (SD)
total score
inattentive symptom score
hyperactive/impulsive symptom score
32.2 ± 9.2
18.3 ± 4.1
13.8 ± 7.0
32.2 ± 8.8
18.3 ± 4.2
13.9 ± 6.9
Note: x indicates that the n is two points lower than the rest.
Abbreviations: EEG, electroencephalographic; n, number; m, mean; SD, standard deviation; y, years, 
IQ, Intelligent Quotient; ADHD-RS, ADHD Rating Scale IV.
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Table 2   Partial correlations
test variables no control IAPF control IAPF
O` O O` O
ADHD-RS
total symptoms 
inattentive symptoms
hyperactive/impulsive symptoms
.335*
.212
.312
.315
.112
.344*
.392*
.307
.331*
.427**
.272
.396*
SA-DOTSx 
mean response time
standard deviation of response time
number of hits
number of correct rejections
.046
-.105
.121
.015
-.007
-.060
-.010
-.126
.034
-.126
.186
.052
-.057
-.133
.165
-.009
VSSx
number of correct trials
number of identiﬁed targets
number of identiﬁed targets in correct order
number of false alarms
-.169
-.227
-.121
.236
-.111
-.196
-.051
.210
-.147
-.210
-.095
.220
.003
-.111
.073
.125
Digit Span-WISC-III
forward repetition of digits
backward repetition of digits
-.085
-.027
-.075
.110
-.052
-.004
.071
.212
RAVLT
direct recalled words
delayed recalled words
.177
-.065
-.021
-.162
.171
-.057
-.052
-.141
Instrumental Learning task
high reward % targets chosen in reward condition
high reward % target chosen in neutral condition
reach learning criterion in reward condition
reach learning criterion in neutral condition
.098
.075
-.158
-.096
-.029
-.107
.105
-.110
.116
.088
-.154
-.110
.030
-.067
.131
-.163
Time Production task
mean deviation
standard deviation from mean deviation
.082
-.002
.019
-.075
.082
.019
.020
-.004
Time Reproduction taskx
mean deviation
standard deviation from mean deviation
.055
.025
.111
.110
.044
.014
.039
.049
* p ) .05, ** p ) .01.
Note: x indicates that the r is displayed for pooled results after imputation. 
Abbreviations; IAPF, individual alpha peak frequency; O, relative theta power; O` , theta/beta ratio; ADHD-RS, ADHD 
Rating Scale IV; SA-DOTS, Sustained Attention Dots task; VSS, Visuospatial Sequencing; Digit Span-WISC-III, 
Digit Span from the Wechsler Intelligence Scale for Children-III; RAVLT, Rey Auditory-Verbal Learning Test.
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Abstract 
A double-blind, randomized, placebo-controlled study was designed to assess the efﬁcacy 
and safety of electroencephalographic (EEG) neurofeedback in children with attention-deﬁ-
cit/hyperactivity disorder (ADHD). The study started in August 2008 and ended in July 2012 
and was conducted at Karakter Child and Adolescent Psychiatry University Centre in 
Nijmegen, The Netherlands. 
Forty-one children (8-15 years) with a DSM-IV-TR diagnosis of ADHD were randomly 
assigned to EEG-neurofeedback or placebo-neurofeedback treatment for 30 sessions, given 
as 2 sessions per week.  The children were stratiﬁed by age, electrophysiological state of 
arousal, and medication use. Everyone involved in the study, except the neurofeedback 
therapist and the principal investigator, was blinded to treatment assignment. The primary 
outcome was the severity of ADHD symptoms on the ADHD Rating Scale IV, scored at 
baseline, during treatment, and at study end. Clinical improvement as measured by the 
Clinical Global Impressions-Improvement (CGI-I) scale was a secondary outcome. 
While total ADHD symptoms improved over time in both groups (p < .001), there was no 
signiﬁcant treatment effect, i.e., group x time interaction (F
(1,39) = 0.36, p = .554); the same 
was true for clinical improvement as measured by the CGI-I scale (p = .092). No clinically 
relevant side effects were observed. Among the children and their parents, guessing 
treatment assignment was not better than chance level (p = .224 for children, p = .643 for 
parents). 
EEG-neurofeedback was not superior to placebo-neurofeedback in improving ADHD 
symptoms in children with ADHD.
Trial Registration: ClinicalTrials.gov identiﬁer: NCT00723684.
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Introduction
A substantial proportion of children with attention-deﬁcit/hyperactivity disorder (ADHD) fails 
to respond favorably to the ﬁrst-line treatment medication (Brown et al., 2005). Indications 
that long-term use of medication affects growth, neural functioning and the cardiovascular 
system (Graham et al., 2011) and the absence of evidence for long-term efﬁcacy of medication 
for ADHD (Spencer, Biederman, Wilens & Faraone, 2002; van de Loo-Neus, Rommelse & 
Buitelaar, 2011) points to the need for non-pharmacological treatment options. 
Electroencephalographic (EEG) neurofeedback is such an option. With EEG-neurofeedback, 
the hypothesis is that voluntary modulation of speciﬁc brain activity patterns can be learned 
by operant learning strategies via provision of continuous real-time feedback, i.e., positive 
reinforcement when changes are made in the desired direction, through visual and/or acoustic 
signals representing the brain activity (Gevensleben, Rothenberger, Moll & Heinrich, 2012). 
Most often, the aim of EEG-neurofeedback is to increase beta activity (or sensorimotor rhythm 
(SMR), 12-15 Hz over the motor cortex), while suppressing theta activity (Monastra et al., 
2005). This goal is based on the observation that slow-wave activity (primarily theta [4-7 Hz]) 
is increased and fast-wave activity (beta [12-30 Hz]) is decreased in most patients with ADHD 
(see the review by Barry et al, 2003). Different EEG-neurofeedback treatment protocols are in 
use. For example, a predetermined protocol (mostly a theta/beta protocol) can be used that 
does not necessary require pre-treatment EEG analysis to assess the individual resting-state 
EEG. Alternatively, a pre-treatment quantitative electroencephalogram (qEEG) analysis is 
performed, and, after comparison of ﬁndings with those from a normative database, a 
personalized treatment protocol focusing on the resting-state EEG features of that individual 
is drawn up. The ﬁrst method has the advantage that a standardized treatment protocol is 
used, and the second has the advantage that treatment is personalized and targeted to the 
speciﬁc EEG deviations of that individual.
Recent reviews are reserved about the efﬁcacy of EEG-neurofeedback in children with ADHD, 
despite the ﬁnding of medium to large effect sizes (ESs), mainly because of methodological 
shortcomings of the studies (Gevensleben et al., 2012; Lofthouse, Arnold, Hersch, Hurt & 
DeBeus, 2012; Lofthouse, Arnold & Hurt, 2012; Moriyama et al., 2012). Although the most 
recent published studies have more robust methodological designs, only 3 of more than 20 
published randomized controlled trials (RCTs) included a placebo condition (Perreau-Linck, 
Lessard, Levesque & Beauregard, 2010; Lansbergen, van Dongen-Boomsma, Buitelaar & 
Slaats-Willemse, 2011; Arnold et al., 2012).  A systematic review and meta-analysis of RCTs of 
non-pharmacological interventions in children with ADHD reported non-signiﬁcant results 
for the blinded rating of symptoms (p = .07) (Sonuga-Barke et al., 2013). Moreover, none of 
the three published placebo-controlled trials showed EEG-neurofeedback to be superior to 
placebo-neurofeedback. The question whether EEG-neurofeedback is a safe treatment has still 
to be addressed. As far as we know, our pilot study was the ﬁrst to systematically monitor 
safety (Lansbergen et al., 2011). 
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At the time our study was designed and begun, EEG-neurofeedback was thought to be a 
promising treatment for ADHD. So, we expected signiﬁcant improvement of ADHD symptoms 
after EEG-neurofeedback compared to placebo-neurofeedback. 
This current study is a valuable addition to the existing literature because of a larger study 
sample, the use of qualiﬁed neurofeedback therapists, the double-blind design and the 
inclusion of only participants with a deviant pre-treatment EEG. The latter made it possible 
to apply personalized EEG-neurofeedback.  
In sum, the present, double-blind, randomized, placebo-controlled trial was designed to 
critically evaluate the efﬁcacy in reducing ADHD symptoms and the safety of EEG-neuro-
feedback in children with ADHD. The study was registered on ClinicalTrials.gov (identiﬁer: 
NCT00723684). 
Methods
Trial design
This study started as a triple-blind, placebo-controlled treatment trial, with stratiﬁed 
randomization for age (younger vs. older than 12 years), electrophysiological state of arousal 
(hyper-arousal vs. hypo-arousal), and use of medication (with vs. without medication). 
After our pilot study (Lansbergen et al., 2011), we made 2 changes: (1) Automatically adjusted 
reward thresholds in the EEG-neurofeedback condition were changed into manually 
adjusted reward thresholds, with the consequence that the neurofeedback therapist was no 
longer blinded to treatment assignment; note that the children, their parents and teachers, 
and the raters were still blinded to treatment assignment. (2) Active learning strategies were 
introduced, so that children could integrate the learned strategies into daily life. 
Children with ADHD were stratiﬁed and then randomly assigned in a double-blind manner 
(1:1 assignment using random block sizes of two) to either EEG-neurofeedback or place-
bo-neurofeedback (treatments to be given twice per week for a total of 30 sessions). The 
assignment was done by the principal investigator, who was not involved in data collection.
All people involved in the study were blinded to treatment assignment, with the exception 
of the neurofeedback therapist and the principal investigator, who were not involved in data 
collection, data entry, and data analysis. Since both participants and raters were still blinded 
to treatment assignment, this study was labeled as double-blind.
Participants
Children (aged 8-15 years) were included if 1) they had been clinically diagnosed with ADHD 
according to the Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.; 
DSM-IV-TR, American Psychiatric Association, 2000), 2) they had an (estimated) full-scale 
intelligence quotient (IQ) of at least 80, 3) their qEEG, a technique to produce a visual map 
of different frequencies and locations of a signal measured from the brain using EEG, 
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deviated at least 1.5 standard deviations (SDs) from normative data, 4) they did not use 
psychoactive drugs, or they used a stable dose of psychostimulants or atomoxetine, and 5) 
there was room for improvement, deﬁned as a minimum score of 2 on a 4-point Likert scale 
for at least 6 items of the ADHD Rating Scale IV (ADHD-RS; Zhang, Faries, Vowles & 
Michelson, 2005). Children were excluded if they 1) were involved in individual or group 
psychotherapy, 2) used medication other than psychostimulants or atomoxetine, 3) had a 
comorbid disorder other than oppositional deﬁant disorder or any anxiety disorder, 4) had 
a neurological disorder and/or a cardiovascular disease, 5) participated in another clinical 
trial at the same time, 6) had received EEG-neurofeedback in the past, or 7) used alcohol or 
drugs. 
Psychostimulants or atomoxetine were permitted because the majority of severely affected 
children with ADHD in The Netherlands uses medication. The discontinuation of medication 
would have been ethically questionable due to the consequence of withholding an 
evidence-based treatment; moreover, the exclusion of children on medication would have 
limited the generalizability of ﬁndings.
A psychologist or doctor screened potential participants for eligibility by asking their 
parents a number of questions over the telephone. Current ADHD symptoms and other 
psychiatric symptoms were checked. The Dutch version of the Autism Screening 
Questionnaire (ASQ; Berument, Rutter, Lord, Pickles & Bailey, 1999) was used to screen for 
autism spectrum disorders. Children who screened positive for ADHD symptoms underwent 
an extensive diagnostic procedure, including the ADHD-RS and a developmental and 
psychiatric interview with a child and adolescent psychiatrist, who conﬁrmed the diagnosis 
on the basis of the ﬁndings. The presence of comorbid disorders was assessed with the 
Diagnostic Interview Schedule for Children (Shaffer, Fisher, Lucas, Dulcan & Schwab-Stone, 
2000; Steenhuis, Serra, Minderaa & Hartman, 2009). General functioning was measured 
using the Children’s Global Assessment Scale (CGAS; Shaffer et al., 1983), and the severity 
of ADHD was assessed with the Clinical Global Impressions-Severity Scale (Guy, 1976). If 
intelligence had not been assessed in the past 1.5 years, two subtests of the Wechsler 
Intelligence Scale for Children 3rd Edition (WISC-III) were administered (i.e., Vocabulary and 
Block Design) to estimate intelligence (Wechsler, 1949, 1989, 1991). Finally, a 20-minutes 
(min) EEG was recorded to assess whether the child’s qEEG deviated from the NeuroGuide 
normative database (Thatcher, 1998).
As predetermined, recruitment started in August 2008 and ended in May 2012. Children 
were recruited from among referrals to Karakter Child and Adolescent Psychiatry University 
Centre in Nijmegen, The Netherlands, and from responders to advertisements in the 
magazine Balans (the Dutch association of parents with children with learning or behavioral 
disorders). The study was approved by the Dutch Central Medical Ethics Committee (www.
ccmo.nl) and conducted in accordance with the Declaration of Helsinki. All parents and all 
children older than 12 years gave their written informed consent before participation; 
children younger than 12 year gave oral assent. Travel expenses were partially reimbursed. 
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All children received a gift certiﬁcate worth 10 euro and a small present during evaluation.
Sample size was calculated for the primary outcome, on the basis of the following 
considerations. Double-blind, placebo-controlled trials have shown an ES of 0.6 or more for 
the ﬁrst-line treatment of ADHD with medication (Michelson et al., 2002; Faraone & 
Buitelaar, 2010). Pilot open-label studies with EEG-neurofeedback also report an ES of 
about 0.6 (Fuchs, Birbaumer, Lutzenberger, Gruzelier & Kaiser, 2003). With an alpha error of 
.05, we calculated that a sample of 60 children in the EEG-neurofeedback arm and 60 in the 
placebo-neurofeedback arm would enable us to detect treatment effects with an ES of 0.5 
and a power of 80.0%.  
Interventions
The Neurofeedback Instituut Nederland provided the EEG-neurofeedback and placebo- 
neurofeedback training. Individualized EEG-neurofeedback protocols based on visual inspection 
of the raw EEG and qEEG were used for EEG-neurofeedback training. 
To determine whether EEG data deviated from the NeuroGuide database, a minimum of 10 
minutes of de-artifacted raw EEG per condition (i.e., eyes-open and eyes-closed) was 
acquired. The aim of the EEG-neurofeedback training was to normalize power within 
individually determined frequency bands and electrode sites by receiving feedback on their 
real-time EEG signal. During the 45-min sessions, after preparation, the children watched a 
ﬁlm for 20 min while sitting quietly on a chair in an ‘active focusing state’ with eyes open. 
They were instructed to try to self-regulate their brain activity by receiving positive feedback. 
Positive feedback was provided by brightening the computer screen and by presenting 
auditory tones. Most children in the EEG-neurofeedback group were trained to increase the 
presence of SMR or low-beta activity while simultaneously suppressing the presence of 
theta activity, meaning that when the production of SMR remained above threshold and/or 
the theta/beta remained below threshold positive feedback was given. Reward threshold 
levels were manually adjusted so that the child was rewarded about 80% of the time (i.e., 
received positive feedback). Consequently, the amount of reward remained at about the 
same level across sessions and across groups. An identical procedure was provided in the 
placebo-neurofeedback group, except that children in the placebo-neurofeedback group 
received feedback on a simulated EEG signal, consisting of a random signal similar to real 
EEG. BrainMaster Atlantis hardware and software were used to provide both training 
modalities (BrainMaster Technologies; Bedford, Ohio). Feedback on real EEG and simulated 
EEG signals seemed similar, in experiences in an earlier study (Logemann, Lansbergen, van Os, 
Bocker & Kenemans, 2010) and in our pilot study (Lansbergen et al., 2011), such that 
participants did not know whether they had received real or placebo-neurofeedback. 
At each session the child was given a sticker, and 30 stickers were rewarded, with a small 
present given at the last appointment.
Recruitment and assessments were performed at Karakter Child and Adolescent Psychiatry 
University Centre in Nijmegen, The Netherlands.
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Outcomes
Efficacy measures
The primary endpoint was efﬁcacy, measured as the difference before and after training of 
the total severity of inattentive and hyperactive/impulsive symptoms of ADHD according to 
the ADHD-RS, scored by the investigator in an interview with the parents at baseline; after 
6, 10, and 20 sessions, and at study end, using a 4-point Likert scale (0 = never occurs, 1 = 
occurs sometimes, 2 = occurs often, 3 = occurs very often). Additional analyses were 
performed for teacher-reported symptoms conducted on the ADHD-RS at baseline, after 10 
and 20 sessions, and at study end. The Clinical Global Impressions-Improvement scale 
(CGI-I) (Guy, 1976), a widely used scale to evaluate clinical effects in intervention studies, 
was administered in a ﬁnal interview by the investigator and was used as an additional 
outcome measure. The CGI-I consists of a single item 7-point scale (1 = very much improved, 
2 = much improved, 3 = minimally improved, 4 = no change, 5 = minimally worse, 6 = much 
worse, 7 = very much worse). Responders were deﬁned as children who were rated as very 
much improved or much improved. Another outcome measurement was the global 
improvement in functioning, which was assessed as the difference between baseline and 
end-of-study scores on the CGAS (scale 0–100, with 0 = most affected global functioning 
and 100 = best global functioning). 
Safety measures
Potential adverse effects of the intervention were measured with the Pittsburgh Side 
Effects Rating Scale (PSERS), a scale often used in drug treatment studies (Pelham et al., 
1993; Sandler & Bodﬁsh, 2008), using the total score for all items (4-point scale: 0 = not 
present, 1 = mild, 2 = moderate, 3 = severe) at baseline, in between, and at study end 
(Pelham et al., 1993; Sandler & Bodﬁsh, 2008). For this study, three items were added to the 
original scale, i.e., epileptic seizures, nausea, and feeling agitated. Side effects on sleep 
quality were assessed by summing the scores of 14 insomnia items on the Dutch version of 
the Sleep Disorders Questionnaire (SDQ) (Sweere, 1998) (5-point scale: 0 = never, 1 = rarely, 
2 = sometimes, 3 = usually, 4 = always) at baseline and at study end. 
Feasibility outcome
Parents and children were asked about their experience with the training and whether they 
thought the child had received EEG-neurofeedback or placebo-neurofeedback training.
Statistical methods
Statistical analyses were performed with the IBM SPSS Statistics, version 20.0 (Armonk, 
New York; IBM Corp.). For each parameter, mean and SD were computed. The signiﬁcance 
level was set at p = .05 (two-tailed). Repeated-measures analyses of variance, with time 
as within-subjects factor and group (EEG-neurofeedback vs. placebo-neurofeedback) as 
 between-subjects factor were performed separately for the sum of inattentive symptoms, 
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the sum of hyperactive/impulsive symptoms, the sum of all symptoms on the ADHD-RS, the 
total sum of adverse events (PSERS), the total sum of sleep problems as rated by the SDQ, 
and the CGAS. For the analysis of the ADHD-RS scores, as rated by the investigator, the 
within-subjects factor time had ﬁve levels (i.e., baseline, after 6, 10, and 20 sessions, and at 
study end). For the analysis of the teacher-rated ADHD-RS, the PSERS, the SDQ, and the 
CGAS, the within-subjects factor time had two levels (i.e., baseline and study end). 
Differences between the groups on the CGI-I at study end were tested by a t-test. Post-hoc 
analysis of covariance was performed with the covariates gender, age, medication, and 
electrophysiological state of arousal.
In preliminary analyses, the efﬁcacy and safety of the EEG-neurofeedback treatment of the 
ﬁrst 8 patients (automatic thresholding, no implementation of active learning strategies) 
and of another 14 patients (manual thresholding and implementation of active learning 
strategies) were assessed. As there were no differences in efﬁcacy and safety between 
these two groups, the data of the two series of EEG-neurofeedback were summed, and 
results for the whole sample are reported.
Results
Demographic and clinical characteristics
In total, 63 children and their parents were eligible for the study and were examined clinically 
(Figure 1). Twenty-two subjects were excluded. One child withdrew during selection. Four 
children were included but not enrolled; just before training started, the parents and/or 
child decided to withdraw because it was difﬁcult ﬁtting the sessions into their daily 
schedule. Seventeen children either did not meet the inclusion criteria or did meet exclusion 
criteria and were excluded for the following reasons: no room for improvement (n = 6), no 
deviant EEG (n = 3), epileptic activity on EEG (n = 1), comorbid Gilles de la Tourette (n = 1), 
no ADHD (but dysthymic disorder) (n = 1), too great a burden to participate (n = 1), unstable 
use of ADHD-medication (n = 1) and a combination of criteria (n = 3) (above the cut-off 
score on the SCQ, unstable use of ADHD-medication and too great a burden to participate 
[n = 2], above cut-off score on the SCQ and no room for improvement [n = 1]).
Thus, 41 children participated in the study. The mean (SD) age of the sample was 10.62 
(2.25) and there were 34 boys; 22 children were allocated to the EEG-neurofeedback group 
(8 in the pilot study, 14 post-pilot study), and 19 were allocated to the placebo-neurofeed-
back group. As expected as a result of randomization, no signiﬁcant differences were found 
between the two groups on baseline characteristics (Table 1). All 41 children completed 
training. Two children unintentionally changed the dosage of their medication during the 
treatment phase (one increased the dosage of the psychostimulant, and the other 
incidentally introduced drug-free weekends and holidays). 
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Efficacy outcomes
Table 2 presents detailed statistical results for all study measures by treatment group.
ADHD-RS as rated by the investigator. ADHD symptoms decreased over time (F(1,39) = 26.56, 
p < .001) to a similar extent in both groups and there was no group x time interaction effect 
(F(1,39) = 0.36, p = .554) (Figure 2). Similar results were observed when the inattentive and 
hyperactive/impulsive scores were analyzed separately. 
ADHD-RS as rated by the teacher. As nine teacher questionnaires were missing for the 
end-of-study assessment, last observation carrier forward (LOCF) data were used, except 
for two end-of-study measurements for which a baseline measurement was the only data 
Figure 1 CONSORT ﬂow diagram of study participants.
Abbreviations: CONSORT, Consolidated Standards of Reporting Trials, n, number; EEG, electroencephalographic.
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Table 1   Descriptive baseline demographic and clinical characteristics by treatment 
group (n = 41)
characteristics EEG-
neurofeedback 
(n = 22)
placebo-
neurofeedback 
(n = 19)
analysis
T,r2
p-value
age, m (SD), y 10.5 (2.2) 10.7 (2.3) p = .734
gender, n (%)
male
female
19 (86.4)
3 (13.6)
15 (78.9)
4 (21.1)
p = 1.000
race, n (%)
Caucasian
Black
20 (91)
2 (9)
18 (95)
1 (5)
p = 1.000
full-scale IQ, m (SD) 108.8 (19.4) 102.1 (12.2) P = .205
medication for ADHD, n (%)
psychostimulants
atomoxetine
no medication
11 (50)
1 (4.5)
10 (45.5)
14 (73.7)
0 (0)
5 (26.3)
p = .726
EEG arousal, n (%)
hypo-aroused
hyper-aroused
19 (86.4)
3 (13.6)
14 (73.7)
5 (26.3)
p =.513
ADHD subtype, n (%)
combined
inattentive
hyperactive/impulsive
17 (77.3)
4 (18.2)
1 (4.5)
13 (68.4)
5 (26.3)
1 ( 5.3)
 p =.543
comorbidity, n (%)
oppositional deﬁant disorder 
anxiety disorders
dyslexia
5 (22.7)
3 (13.6)
2 (9)
1 (5.3)
2 (10.5)
3 (15.8)
p = .191
p = 1.000
p = .649
ADHD-RS-INV, m (SD)
total symptoms
inattentive symptoms
hyperactive/impulsive symptoms
30.6 (7.5)
17.0 (5.1)
13.6 (5.5)
32.0 (9.6)
18.2 (3.4)
13.8 (7.9)
p = .601
p = .369
p = .942
ADHD-RS-Teacher, m (SD)
total symptoms
inattentive symptoms
hyperactive/impulsive symptoms
23.6 (14.8)
13.1 (7.5)
10.6 (8.4)
25.7 (12.8)
13.9 (6.2)
11.8 (8.2)
p = .639
p = .712
p = .632
CGI-S, n (%)
3- mildly ill
4- moderately ill
5- markedly ill
3 (13.6)
12 (54.5)
7 (31.8)
0 (0)
11 (57.9)
8 (42.1)
p = .405
CGAS, m (SD) 51.3 (6.6) 51.6 (5.6) p = .703
Abbreviations: EEG, electroencephalographic; n, number; T, independent sample t-test; r2, chi-square test; 
p-value, probability value; m, mean; SD, standard deviation; y, years; IQ, Intelligence Quotient; ADHD, attention- 
deﬁcit/hyperactivity disorder; ADHD-RS, ADHD Rating Scale IV; INV, Investigator; CGI-S scale, Clinical Global- 
Impressions Severity scale; CGAS, Children’s Global Assessment Scale.
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present. Teacher-rated ADHD symptoms decreased signiﬁcantly over time (F(1,37) = 13.54, 
p = .001), without a difference between groups (F(1,37) = 0.45, p = .509). Similar results were 
obtained for the inattentive and hyperactive/impulsive scores.
CGI-I. On the CGI-I scale, 4 of 22 children (18%) in the EEG-neurofeedback group were rated 
as ‘much improved’, 9 of 22 (41%) in the EEG-neurofeedback group and 8 of 19 (42%) in the 
placebo-neurofeedback group were rated as ‘minimally improved’, and 9 of 22 (41%) in the 
EEG-neurofeedback group and 11 of 19 (58%) in the placebo-neurofeedback group were 
rated as unchanged at the end of the study. The differences between the groups were not 
signiﬁcant (p = .092). None of the children deteriorated.
CGAS. One end-of-study value was missing in the EEG-neurofeedback group. The CGAS 
score increased signiﬁcantly over time (F
(1,38) = 15.47, p < .001), but increased similarly in the 
two groups (F(1,38) = 1.96, p = .169).
Safety outcomes
Adapted SDQ. Two end-of-study scores were missing in the placebo-neurofeedback group. 
Total sleep problems decreased signiﬁcantly over time (F(1,37)  = 5.42, p = .025), but similarly 
in the two groups (F(1,37)  = 0.05, p = .818).
Adapted PSERS. Two values were missing in the EEG-neurofeedback group; the LOCF method 
was used for the missing data. The total number of adverse events decreased signiﬁcantly 
over time (F(1,39) = 6.30, p = .016) and decreased similarly in the two groups (F(1,39)  = 0.10, 
p = .754).
Post-hoc analyses
Post-hoc analyses with the covariates age, gender, medication use, and state of electro-
physiological arousal did not reveal any signiﬁcant treatment effect (i.e., group by time 
interaction) for any outcome. After correction, almost all signiﬁcant results became non- 
signiﬁcant, except for the effect of time on the CGAS, which changed to a marginally 
signiﬁcant level ( F(1,34) =3.48, p = .071). 
Feasibility examination
Among the children, 10 of 41 (24%) correctly guessed which treatment they had received, 
13 of 41 (32%) guessed incorrectly, and 10 of 41 (24%) did not know; data were missing for 
8 of 41 (20%) children. Among the parents, 14 of 41 (34%) guessed the treatment 
assignment correctly, 19 of 41 guessed incorrectly (46%), and 6 of 41 did not know (15%); 
data were missing for 2 of 41 (5%) parents. Fisher exact tests showed that the children and 
their parents did not guess treatment assignment signiﬁcantly better than chance level 
(p = .224 for children, p = .643 for parents). 
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Discussion
This study examined the safety and efﬁcacy of EEG-neurofeedback treatment for core 
symptoms in children with ADHD, using a double-blind, randomized, placebo-controlled 
design with blinded participants and raters. Treatment assignment was not guessed better 
than chance level. EEG-neurofeedback was not superior to placebo-neurofeedback in 
affecting ADHD symptoms or other secondary efﬁcacy outcomes. The intervention was 
safe as no adverse effects were reported. Post-hoc analyses with the covariates age, gender, 
medication, and electrophysiological state of arousal did not lead to any signiﬁcant results 
compared to the main analyses. These ﬁndings are in line with those of our previous 
feasibility pilot study (Lansbergen et al., 2011) and two recently published placebo-con-
trolled EEG-neurofeedback studies (Perreau-Linck et al., 2010; Arnold et al., 2012). Moreover, 
a recent systematic review and meta-analysis of randomized controlled trials of non-phar-
macological interventions in children with ADHD concluded that the signiﬁcant effect size 
of unblinded ratings could not have been replicated if blinded ratings were used 
(meta-analysis of seven open-label and one triple-blind EEG-neurofeedback studies) 
(Sonuga-Barke et al., 2013). Thus, it seems that methodologically sound studies do not 
conﬁrm the efﬁcacy of EEG-neurofeedback in children with ADHD. 
Figure 2 Mean total summed score and 95% conﬁdence intervals for the ADHD Rating 
Scale IV over time as rated by the investigator and shown by treatment group.
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Changing from automatic to manual thresholds did not result in larger effects for EEG- 
neurofeedback, nor did the addition of active learning strategies. Making passive learning 
active by adopting learning strategies is hypothesized to be an important aspect of the 
working mechanism of EEG-neurofeedback (Gevensleben et al., 2012). Our ﬁndings did not 
support this hypothesis. 
Unfortunately, we were unable to recruit a sufﬁcient number of participants to meet our 
planned sample size. Post-hoc, our sample had 80% power to detect a treatment effect of 
0.90. However, since there was virtually no difference between the effect of EEG-neuro-
feedback and placebo-neurofeedback in the smaller sample, it is unlikely that our negative 
results were due to limited statistical power.
The study was carefully designed to tackle the methodological shortcomings of previous 
studies, resulting in a randomized placebo-controlled trial with blinded participants and 
raters, an extended selection procedure, and several behavior and safety evaluations of 
both interventions. Conducting such study has drawbacks. First, the 50% chance of 
receiving placebo-neurofeedback treatment probably adversely inﬂuenced recruitment. 
During our entire clinical trial, patients with ADHD had access to EEG-neurofeedback in the 
general clinical practice without the risk of being assigned to placebo-neurofeedback and 
treatment costs were fully reimbursed by health insurance companies. Another potential 
limitation is the change from a triple-blind to a double-blind design (which means that the 
neurofeedback therapist was no longer blinded); however, participants and raters were still 
blinded to treatment assignment. The use of medication by most participants may have 
inﬂuenced the ability to detect a signiﬁcant effect of EEG-neurofeedback. At this time, 
follow-up data are not available yet; we plan to re-assess all participants after six months 
and will describe these ﬁndings in a separate report. Last, because most children were 
white, the generalizability of ﬁndings to other races cannot readily be assumed.
In conclusion, our results seriously question claims that EEG-neurofeedback is an effective 
treatment for children with ADHD. Further research with more participants is needed to 
determine whether this traditional form of neurofeedback is effective in particular patient 
subgroups. 
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Clinical Points
% The ﬁndings are in line with a recent meta-analysis that concluded that EEG-neurofeed-
back does not have proven efﬁcacy as a treatment for children with ADHD.
% Guidance regarding EEG-neurofeedback as a treatment for children with ADHD must be 
in line with these current ﬁndings.
% Further research on this topic is needed to determine whether EEG-neurofeedback is of 
clinical relevance in subgroups of children with ADHD.
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Abstract
The number of placebo-controlled randomized studies relating to EEG-neurofeedback and 
its effect on neurocognition in ADHD is limited. For this reason, a double-blind, randomized, 
placebo-controlled study was designed to assess the effects of EEG-neurofeedback on 
neurocognitive functioning in children with attention-deﬁcit/hyperactivity disorder 
(ADHD), and a systematic review on this topic was performed.
Forty-one children (8-15 years) with a DSM-IV-TR diagnosis of ADHD were randomly 
allocated to EEG-neurofeedback or placebo-neurofeedback treatment for 30 sessions, twice 
a week. Children were stratiﬁed by age, electrophysiological state of arousal, and medication 
use. Neurocognitive tests measuring executive functioning, attention, reward-related 
processes, and timing were administered before and after treatment. Researchers, teachers, 
children, and their parents, with the exception of the neurofeedback-therapist, were all 
blinded to treatment assignment. Outcome measures were the changes in neurocognitive 
performance before and after treatment. 
No signiﬁcant treatment effect on any of the neurocognitive variables was found. A 
systematic review of the current literature also did not ﬁnd any systematic beneﬁcial effect 
of EEG-neurofeedback on neurocognitive functioning.
Overall, the existing literature and this study fail to support any beneﬁt of neurofeedback 
on neurocognitive functioning in ADHD, possibly due to small sample sizes and other study 
limitations. 
Trial Registration: ClinicalTrials.gov identiﬁer: NCT00723684.
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Introduction
Attention-deﬁcit/hyperactivity disorder (ADHD) is the most common childhood mental 
disorder, affecting about 5% of all children worldwide (Polanczyk, de Lima, Horta, Biederman 
& Rohde, 2007) with an increasing prevalence over the last decade (Getahun et al., 2013). 
ADHD affects children’s personal development substantially and is associated with 
impairments in social and emotional development, and poor academic and vocational 
outcomes (Wehmeier, Schacht & Barkley, 2010). Consequently, the substantial burden on 
families and society in general is notable (Biederman, 2005; Biederman et al., 2012). Because 
of the severity and long-term nature of the impairments associated with ADHD, efforts 
have been made to understand the underlying deﬁcits and identify effective treatments for 
ADHD.
ADHD & neurocognitive dysfunctions 
Neurocognitive models of ADHD have attempted to explain the behavioral symptoms in 
underlying impairments in executive functions (EFs), attention regulation, reward-related 
processes, and timing. Associations between ADHD and EFs are found in domains of 
response inhibition, vigilance, working memory, and planning (Martinussen, Hayden, 
Hogg-Johnson & Tannock, 2005; Willcutt, Doyle, Nigg, Faraone & Pennington, 2005). 
ADHD-related attention problems are described as weak performances in selective and 
sustained attention, and attention shifting tasks (Weissman, Chu, Reddy & Mohlman, 2012). 
Studies on reward-related processes in ADHD indicate a preference for small immediate 
rewards over later larger rewards (for review see Sonuga-Barke, Sergeant, Nigg & Willcutt, 
2008). Finally, timing deﬁcits have consistently been found in subjects with ADHD in three 
major domains, i.e., motor timing, perceptual timing, and temporal foresight (for review see 
Noreika, Falter & Rubia, 2013).  Differentiation could be made between timing deﬁcits and 
delay deﬁcits (Sonuga-Barke, Bitsakou & Thompson, 2010; de Zeeuw, Weusten, van Dijk, 
van Belle & Durston, 2012).
ADHD & EEG-neurofeedback
Concerns about the safety and long term efﬁcacy of ﬁrst-line treatment medication in 
ADHD have led to interest in developing alternative non-pharmacological treatment 
approaches. Electroencephalographic neurofeedback (EEG-NF) is based on the rationale 
that voluntary modulation of speciﬁc brain activity patterns can be learned by operant 
learning strategies. In other words, by providing continuous real time feedback, i.e., positive 
reinforcement when changes are made in the desired direction, the self-regulation of 
ongoing neuronal oscillations in one or more frequency-bands can be enhanced 
(Gevensleben, Rothenberger, Moll & Heinrich, 2012). Resting-state electroencephalogram 
(EEG) in the majority of children with ADHD is characterized by increased slow-wave activity 
and decreased fast-wave activity, primarily theta and beta activity respectively, and higher 
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theta/beta and theta/alpha ratios compared to controls (for review see Barry, Clarke & 
Johnstone, 2003), often referred to as an hypo-aroused physiological state. Therefore most 
neurofeedback protocols focus on these frequency-bands (Monastra et al., 2005). A 
minority of children with ADHD has shown increased power of beta activity (Clarke, Barry, 
McCarthy, Selikowitz & Brown, 2002), creating a subgroup with a hyper-aroused 
physiological state.
The placebo-controlled randomized trials published to date, have not found superior effects 
of EEG-NF compared to placebo-neurofeedback (PL-NF) (Perreau-Linck, Lessard, Levesque 
& Beauregard, 2010; Lansbergen, van Dongen-Boomsma, Buitelaar & Slaats-Willemse, 
2011; Arnold et al., 2012; van Dongen-Boomsma, Vollebregt, Slaats-Willemse & Buitelaar, 
2013). In addition, a systematic review and meta-analysis of randomized controlled trials 
(RCTs) of non-pharmacological interventions in children with ADHD including EEG-NF 
studies, reported non-signiﬁcant results for the blinded rating of symptoms (p = .07) 
(Sonuga-Barke et al., 2013).
Most studies have focused on behavioral outcome measures. However, it is worthwhile to 
examine whether EEG-NF is able to improve neurocognitive functioning in ADHD because 
the persistence of neurocognitive deﬁcits is strongly associated with occupational problems 
and morbidity (Barkley & Murphy, 2010; Biederman et al., 2012).
The objectives of this paper were two-fold: (1) to systematically review the existing literature 
on the effects of two modalities of EEG-NF, namely frequency NF (F-NF) and Slow Cortical 
Potential (SCP)-NF on neurocognitive functioning and (2) to assess the effect of F-NF on 
neurocognitive functioning in a double-blind, placebo-controlled trial in children with 
ADHD. 
Review on neurocognitive outcome measures after EEG-NF in children with ADHD 
A literature research was carried out in PubMed for the period between 1994 and May 2012 
by combining the following MeSH terms; (‘Attention Deﬁcit Disorder with Hyperactivi-
ty’[MeSH]) AND (‘Biofeedback, Psychology’[MeSH] OR ‘Neurofeedback’[MeSH]). A ﬁnal 
search was conducted to check for the most recent published trials (February 2013). The 
database search outlined above was supplemented by manual searches. The inclusion 
criteria that were applied to the publications retrieved were a) study was peer reviewed, b) 
diagnosis of ADHD was classiﬁed by the Diagnostic and Statistical Manual of Mental 
Disorders (3rd ed.; DSM-III; American Psychiatric Association, 1980), DSM-III-R (American 
Psychiatric Association, 1987), DSM-IV (American Psychiatric Association, 1994), DSM-IV-TR 
(American Psychiatric Association, 2000), or the ICD-10 (World Health Organization, 1992), 
c) age was in the range from 0-18 years, d) the study was an RCT, e) F-NF and/or SCP-NF 
was used as treatment modality, f) neurocognitive data were reported in the publication. In 
total, 10 randomized controlled trials met these inclusion criteria (Linden, Habib & Radojevic, 
1996; Heinrich, Gevensleben, Freisleder, Moll & Rothenberger, 2004; Levesque, Beauregard 
& Mensour, 2006; Leins et al., 2007; Holtmann et al., 2009; Perreau-Linck et al., 2010; 
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Bakhshayesh, Hansch, Wyschkon, Rezai & Esser, 2011; Steiner, Sheldrick, Gotthelf & Perrin, 
2011; Wangler et al., 2011; Arnold et al., 2012). See Table 1 of the supplement.
The 10 selected EEG-NF studies were quite heterogeneous in their design and methodology. 
The studies included a range of different sample sizes and control conditions (e.g., passive 
control conditions vs. active control conditions). Investigators were blinded to treatment 
assignment in some studies while in others they were not. The NF-protocol as well as the 
duration, frequency, and number of sessions varied between studies. Signiﬁcant differences 
between the studies were also noted in terms of the participants’ characteristics (especially 
the use of medication), the statistical methods used, and the choice of neurocognitive 
tasks. The differences in neurocognitive tasks employed also render a meta-analysis 
impossible. However, areas in which the studies overlapped included the use of predominantly 
male participants in the same age range (mean round 10 years) as well as a common 
inclusion criterion that subjects must have a full-scale intelligence quotient (FSIQ) of more 
than 80 points. 
Three of the 10 studies reported signiﬁcant improvement on at least one neurocognitive 
variable for the NF condition superior to the control condition (Heinrich et al., 2004; 
Holtmann et al., 2009; Bakhshayesh et al., 2011). More speciﬁcally, treatment (i.e., time x 
group interaction) effects were seen for the variable representing impulsivity on the 
stop-signal task (Holtmann et al., 2009) and for all variables representing attention on the 
paper-and-pencil attention test (Bakhshayesh et al., 2011). However, in the paper-and-pen-
cil attention test, the number of errors also increased signiﬁcantly more in the F-NF 
condition than in the control condition, suggesting that improved speed came at the 
expense of accuracy. Note that speed-accuracy trade-off calculation was not reported. One 
study appeared to show a time x group effect on the composite variable of the Kaufman-BRIEF 
Intelligence Test, a German intelligence scale. However, this was not explicitly reported 
(Linden et al., 1996). The study investigating the efﬁcacy of SCP-NF showed a time x group 
effect for the variable representing impulsivity on a Continuous Performance Task (Heinrich 
et al., 2004).
Overall, these studies had many methodological limitations (including small sample sizes, 
increasing the chance for type II errors), and the majority failed to show positive 
neurocognitive effects of F-NF or SCP-NF. Taken together, these studies suggest that there 
is no systematic beneﬁcial effect of these two types of NF on neurocognitive functioning.
Methods
Trial design
This study was designed as a triple-blind, placebo-controlled treatment trial, with stratiﬁed 
randomization for age (younger vs. older than 12 years), electrophysiological state of 
arousal (hyper-arousal vs. hypo-arousal), and use of medication (with vs. without 
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medication). After a pilot study (Lansbergen et al., 2011), two adaptations were made: 1) In 
the F-NF condition, reward thresholds were changed from automatic into manual 
adjustment, resulting in the unblinding of the neurofeedback-therapist (NF-therapist). 
Participants and raters remained blinded, creating a double-blind study. 2) Active learning 
strategies were implemented, so that children could apply the learned strategies into daily life. 
Participants
Children (8-15 years) were included if 1) they had been clinically diagnosed with ADHD 
according to the criteria of the DSM-IV-TR (American Psychiatric Association, 2000), 2) 
they had an FSIQ of at least 80, 3) their quantitative EEG (qEEG) deviated at least 1.5 
standard deviations (SD) from normative data, 4) they did not use psychopharmaca or used 
a stable dose of ADHD medication, and 5) there was room for improvement, deﬁned as a 
minimum score of 2 on a 4-point Likert scale (0-3) for at least 6 items of the ADHD Rating 
Scale IV (ADHD-RS; Zhang, Faries, Vowles & Michelson, 2005). Children were excluded if 
they 1) were involved in psychotherapy, 2) used medication other than ADHD medication, 
3) had a comorbid disorder other than oppositional deﬁant disorder or any anxiety disorder, 
4) had a neurological disorder and/or a cardiovascular disease, 5) participated in another 
clinical trial simultaneously, 6) had received NF in the past, or 7) used alcohol or drugs. 
A doctor or psychologist screened potential children via a telephone interview with their 
parents in which ADHD symptoms and other psychiatric symptoms were checked. The 
Dutch version of the Social Communication Questionnaire (SCQ; Berument, Rutter, Lord, 
Pickles & Bailey, 1999) was used to screen for autism spectrum disorders. The presence of 
other comorbid disorders was assessed with the Diagnostic Interview Schedule for Children 
(Shaffer, Fisher, Lucas, Dulcan & Schwab-Stone, 2000; Steenhuis, Serra, Minderaa & 
Hartman, 2009). A positive screening-outcome was followed by a diagnostic procedure, 
including the ADHD-RS and a developmental and psychiatric interview with a child and 
adolescent psychiatrist. General functioning was measured by the Children’s Global 
Assessment Scale (CGAS; Shaffer  et al., 1983) and the severity of ADHD was assessed with 
the Clinical Global Impressions-Severity scale (CGI-S; Guy, 1976). If an intelligence test had 
not taken place over the past 1.5 years, two subtests of the Wechsler Intelligence Scale for 
Children (WISC-III) were administered (i.e., Vocabulary and Block Design) to estimate 
intelligence (Wechsler, 1991). Finally, 20 minutes (min) of de-artifacted raw EEG in an 
eyes-open and eyes-closed condition was acquired to determine deviation from the 
NeuroGuide database (Thatcher, Walker, Biver, North & Curtin, 2003).
Recruitment started in August 2008 and ended in May 2012. Children were recruited from 
referrals to Karakter Child and Adolescent Psychiatry University Centre in Nijmegen, and 
from responders to advertisements in the journal of the Dutch Parents Association for 
Children with Developmental Disorders. The study was approved by the Dutch Central 
Medical Ethics Committee (www.ccmo.nl) and conducted in accordance with the declaration 
of Helsinki. All parents and children older than 12 years gave their written informed consent 
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before participation; children younger than 12 year gave oral assent. Travel costs were 
partially reimbursed. All children received a 10-euro gift certiﬁcate and a small present after 
collecting 30 stickers, given after each session.
The study was registered in the Clinical trial register under ‘Project ADHD and EEG-Neuro-
feedback THERapy’; www.clinicaltrials.gov; NCT00723684.
Interventions
The Neurofeedback Instituut Nederland B.V. provided both the F-NF and the PL-NF training. 
Individualized F-NF protocols based on visual inspection of the raw EEG and qEEG were 
used for F-NF training. 
The F-NF training was intended to normalize power within individually determined frequen-
cy-bands and electrode sites by receiving feedback on their real-time EEG-signal. In this 
study, personalized protocols were used to address different EEG abnormalities, i.e., 
hypo-arousal vs. hyper-arousal, in children with ADHD, consisting of a protocol focusing on 
the EEG abnormality in that child.
Children watched a ﬁlm for 20 min in an ‘active focusing state’ with eyes open. They were 
instructed to attempt to self-regulate their brain activity. Positive feedback was provided by 
brightening the computer screen and presentation of auditory tones. Most children in the 
F-NF group were trained to increase the presence of the sensory motor rhythm (SMR) or 
low-beta activity while simultaneously suppressing the presence of theta activity, meaning 
that when the production of SMR remained above threshold, and/or the theta/beta 
remained below threshold, positive feedback was given. Reward threshold levels were 
manually adjusted to 80% for each training target (i.e., frequency- band and/or location). 
Therefore, the actual percentage reinforcement depended on the amount of co-occurrence 
of desirable activity towards training targets (e.g., theta power going downwards at P3 
while simultaneously going downwards at P4). Reinforcement was 80% when all training 
targets were achieved simultaneously only. When assuming no correlation in activity 
between the different training targets, the reinforcement was 0.8 to the power of the 
number of training targets (e.g., training theta power downwards and beta power upwards 
resulted in a rewarding percentage of 64%). In practice, the reinforcement lay between 0.8 
and 0.8 to the power of the number of training targets. Thresholds were manually adjusted 
according to the expertise of the NF-therapist. No speciﬁc guideline or protocol was 
followed. This method was in line with the objective of this study to investigate the efﬁcacy 
of NF as delivered in ‘care as usual’, in which decisions about adjustments of the threshold 
are determined by the involved clinical NF-therapist. All of the NF-therapists were BCIA 
certiﬁed (Biofeedback Certiﬁcation International Alliance, 10200 W 44th Ave, Suite 310, 
Wheat Ridge CO 80033-2840). An identical procedure was provided in the PL-NF group, 
except that children in the PL-NF group received feedback on a simulated EEG signal, 
consisting of a random signal similar to real EEG, in accordance with the procedure of an 
earlier study (Logemann, Lansbergen, van Os, Bocker & Kenemans, 2010). BrainMaster 
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Atlantis hardware and software provided both training modalities (BrainMaster Technologies; 
Bedford, Ohio). Feedback on real EEG and simulated EEG signals seemed similar in experience 
in an earlier study and in our pilot study (Logemann et al., 2010; Lansbergen et al., 2011). 
The behavioral effects of this study have been published elsewhere (van Dongen-Boomsma 
et al., 2013).
Neurocognitive outcomes
All children included in the study underwent a neurocognitive assessment of 90 min before 
and after treatment. Two versions of the neurocognitive battery controlled for a possible 
task-order effect. If available, different versions of the tasks were administered before and 
after the treatment to control for a potential learning effect. Complete task descriptions can 
be found in the supplement (subsection; ‘neurocognitive task descriptions’). Below, the 
neurocognitive tasks are brieﬂy described. 
Sustained Attention Dots task (SA-DOTS). The Continuous Performance Task from the 
computerized neurocognitive test-battery of the Amsterdamse Neuropsychologische Taken 
(ANT; de Sonneville, Schmidt, Michel & Batzler, 1990; de Sonneville, 1999) was used to 
measure sustained attention. Variables of interest were the number of correct responses, 
the mean reaction time (RT) in milliseconds (ms) on correct responses and its standard 
deviation, and the number of premature responses (RT < 150 ms). Note there was a trade-off 
to be made between RT and accuracy. Therefore, the expected (negative) relationship 
between RT and number of correct trials was addressed by performing similar analyses 
while controlling for each other.
Visuospatial Sequencing (VSS). To measure visuospatial memory, the VSS subtest from the 
ANT (de Sonneville, 1999) was used. The number of correct trials and the number of targets 
identiﬁed in the correct order were determined and used for analyses. 
Digit Span from the Wechsler Intelligence Scale for Children-III (DS-WISC-III). To measure 
verbal working memory, the DS (forward and backward) from the WISC-III (Wechsler, 1991; 
de Kort et al., 2002) was used. The total number of correctly recalled forward digit-sequenc-
es and backward digit-sequences compared to an age-norm was the variable of interest.
The Rey Auditory-Verbal Learning Test (RAVLT). Verbal working memory and long term verbal 
memory was assessed using the Dutch adaptation of the RAVLT. In the Dutch version Rey’s 
procedure (Rey, 1964) is applied without an interference trial (van den Burg & Kingma, 
1999). In this form, the AVLT was administered in the present study. The total number of 
immediately recalled words over all ﬁve presentations and the amount of words recalled 20 
min after the last presentation were chosen as the variables of interest.
Instrumental Learning task. Instrumental learning tasks are widely used instruments that 
have their origin in the instrumental/operant learning principle (Thorndike, 1898). A version 
of this task appropriate for children was created derived from two example instrumental 
learning paradigms (O’Doherty et al., 2004; Pessiglione, Seymour, Flandin, Dolan & Frith, 
2006). The variables of interest were the total number of choices of high versus low 
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probability actions in reward trials and the trial at which the learning criterion was reached. 
The learning criterion was deﬁned as 8 consecutive high probability actions. 
Time Production task. To measure precision of time perception, a time production task was 
constructed based on the task description of van Meel, Oosterlaan, Heslenfeld & Sergeant 
(2005). The mean absolute discrepancy and its standard deviation between stimulus length 
and response length were measured.
Time Reproduction task. To measure precision of time reproduction, a task was constructed 
based on the task description of Rommelse, Oosterlaan, Buitelaar, Faraone & Sergeant 
(2007). The mean absolute discrepancy and its standard deviation between stimulus length 
and response length were measured.
Sample size
Sample size was calculated for the primary outcome and was based on the following 
considerations. Double-blind, placebo-controlled trials have shown an effect size (ES) of 0.6 
or more for the ﬁrst-line treatment of ADHD with medication (Michelson et al., 2002; 
Faraone & Buitelaar, 2010). Pilot open-label studies with EEG-neurofeedback also report an 
ES around 0.6 (Fuchs, Birbaumer, Lutzenberger, Gruzelier & Kaiser, 2003). With an alpha 
error of .05, a sample of 60 children in the EEG- neurofeedback arm and 60 in the place-
bo-neurofeedback group and a power of 80.0% would enable treatment effects to be 
detected with an ES of 0.5.
Randomization
Participating children were stratiﬁed and subsequently randomly assigned (1:1 assignment 
using random block sizes of two), double-blindly, to either F-NF or PL-NF. The principal 
investigator who was not involved in data collection performed this. Randomization by 
means of minimization was applied, including EEG proﬁle, age, and medication use as 
factors (Han, Enas & McEntegart, 2009). The treatment group that most strongly would 
minimize the imbalance was chosen to allocate the participant.
Blinding
All people involved in the study were blinded to treatment assignment, except the 
NF-therapist and the principal investigator, who were not involved in data collection, data 
entry, and data analysis. 
Statistical methods
As ﬁrst step, we analyzed all neurocognitive variables at group level. Variables of the 
Instrumental Learning task, Time Reproduction task, and the Time Production task were 
created using MATLAB R2009a (The Math-Works, Inc., Natrick, MA). All statistical analyses 
were conducted employing the IBM SPSS Statistics, version 20.0 (Armonk, New York; IBM 
Corp.). The signiﬁcance level was set at p = .05.  Imputation of missing data was used to 
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obtain the most accurate data set (Donders, van der Heijden, Stijnen & Moons, 2006).
To optimize control for the variance at baseline, baseline was used as a covariate in analyses 
of the covariance (ANCOVA). For each neurocognitive parameter the endpoint measurement 
was the dependent variable while the baseline measurement was a covariate, and group 
(F-NF vs. PL-NF) was the ﬁxed factor.
To reduce within-group error variance and to eliminate confounding, additional ANCOVAs 
were performed (Field, 2009). For all main analyses, we also conducted ANCOVAs with age, 
gender, FSIQ, medication use, and electrophysiological arousal as covariates to control for 
their possible inﬂuence.
To conﬁrm the reliable use of ANCOVA, all required assumptions were tested per variable, 
except the assumption for independence of the sample, which was not expected to be 
present in this experimental design and the independence of the covariate and treatment 
effect, which was covered, by randomization and stratiﬁcation. B-weights, the unstandardized 
regression coefﬁcients, represent the relationship between the groups and the outcome 
variable included in the analysis. In this study, a positive value indicates an effect for the 
F-NF group, a negative value an effect for the PL-NF group. The signiﬁcance on the t-tests 
tells whether this relationship is signiﬁcant.
The next step was to examine whether participants might show signiﬁcant and reliable 
individual changes on neurocognitive variables that might be overlooked at group level. The 
Reliable Change Index (RCI) was used to address this issue. The RCI-method, described by 
Jacobson & Truax (1991) was subsequently applied to a placebo-controlled medication 
study in children with ADHD (Buitelaar, van der Gaag, Swaab-Barneveld & Kuiper, 1995). 
This method was also used by another NF study (Perreau-Linck et al., 2010). The RCI was 
calculated for each individual, i, using the following formula:
RCI =
 Di – Pi
SE
In which Di is the observed change between pre- and post- measurement, Pi the mean 
change score of the placebo group, and SE  the corresponding standard error. If a child 
exceeded the critical value of (-)1.96 (equaling our signiﬁcance value set at p = .05), it was 
said to reliably change on this measure.  
Results
The demographic and clinical characteristics are summarized in Table 1. In sum, 41 children 
(mean age 10.6 ± 2.3 83.0 % boys, and estimated FSIQ of 105.7 ± 16.7) were included. Of 
these, 22 children were assigned to the F-NF group (8 of the pilot-study, 14 post pilot-study) 
and 19 children to the PL-NF group (no differences made after pilot). Analyses with respect 
to the neurocognitive results performed on the sample without the pilot NF sample (n = 33) 
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and the total sample (n = 41), did not yield different results, and therefore data of the total 
sample will be presented. Further, we did test for blinding of the participants. This test 
revealed that guessing treatment assignment was not better than at chance level (p = .224 
for children, p = .643 for parents). For a complete overview of the clinically examination 
procedure and the administered NF, see Figure 1 and Table 2, both in the supplement. 
Neurocognitive characteristics
All variables were distributed normally within groups, unless speciﬁcally stated and dealt 
with accordingly (e.g., by removing outliers, deﬁned as 25% of the size of the largest leaf 
entry in the clustering feature tree, based on the default deﬁnition used by SPSS 20.0). All 
Table 1   Demographic characteristics
characteristics frequency 
neurofeedback 
(n = 22)
placebo-
neurofeedback 
(n = 19)
analysis
T, r2
p-value
age, m (SD), y 10.5 (2.2) 10.7 (2.3) p = .734
gender (%)
male
female
86.4
13.6
78.9
21.1
p = 1.000
race (%)
Caucasian
Black
91
9
95
5
p = 1.000
full scale IQ, m (SD) 108.8 (19.4) 102.1 (12.2) p = .205
medication for ADHD (%)
psychostimulants
atomoxetine
no medication
50
4.5
45.5
73.7
0
26.3
p = .726
EEG arousal (%)
hypo-aroused
hyper-aroused
86.4
13.6
73.7
26.3
p = .513
ADHD subtype (%)
combined
inattentive
hyperactive/impulsive
77.3
18.2
4.5
68.4
26.3
5.3
 p = .543
comorbidity (%)
oppositional deﬁant disorder 
anxiety disorders
dyslexia
22.7
13.6
9
5.3
10.5
15.8
p = .191
p = 1.000
p = .649
Abbreviations: n, number; T, independent sample t-test; r2, chi-square test; p, probability; m, mean; SD, standard 
deviation; y, years; IQ, Intelligent Quotient; ADHD, attention-deﬁcit/hyperactivity disorder; EEG, electro-
encephalographic.
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Table 2   Baseline and endpoint scores on all neurocognitive parameters. Also depicted 
are the change scores between baseline and endpoint and the mean individual 
interaction effect size
neurocognitive parameter 
(m and SD)
baselinea
F-NF  (n ) 22) PL-NF  (n ) 19)
Sustained Attention Dots 
correct trials
response time correct trials
SD response time correct trials
551.9 (31.5)
3417.2 (873.6)
1533.8 (736.8)
556.6 (29.6)
3434.9 (824.5)
1649.6 (674.5)
Visuospatial Sequencing
correct trials
identiﬁed in correct order
19.6 (2.5)
90.9 (9.7)
18.3 (2.9)
86.7 (10.8)
Digit Span-WISC-III
z-score forward and backward 10.6 (3.2) 10.0 (2.7)
RAVLT 
direct recall
delayed recall
46.6 (8.4)
9.7 (2.6)
44.2 (6.7)
9.6 (2.5)
Instrumental Learning task
high probability action 
reach learning criterion
44.8 (3.9)
17.3 (2.7)
44.9 (4.1)
16.8 (2.0)
Time Production task
MAD from 1 sec (ms)
SD from MAD (ms)
205.5 (80.4)
182.5 (76.2)
224.9 (74.0)
208.2 (84.4)
Time Reproduction task
MAD from trial (ms)
SD from MAD (ms)
2043.2 (1254.0)
2178.1 (1584.8)
2694.4 (1740.2)
2947.5 (1644.2)
* p < .01.
Note: Data were used without using imputed data or outliers.  a Independent sample t-tests between groups for 
which p > .20. b Time x group interactions of repeated measures ANOVAs for which p > .10.
Abbreviations: m, mean; SD, standard deviation; F-NF, frequency neurofeedback; n, number; PL-NF, placebo- 
neurofeedback; Cohen's d, the difference between groups (PL-NF subtracted from F-NF) for the change scores 
between endpoint and baseline divided by the pooled standard deviation of the change scores taking into 
account the sample size; ?, direction of the change score in opposite direction than direction hypothesized to 
be improvement; Digit Span-WISC-III, Digit Span from the Wechsler Intelligence Scale for Children-III; RAVLT, 
Rey Auditory Verbal Learning Test; MAD, mean absolute deviation.
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endpoint change score effect sizeb
Cohen’s dF-NF (n ) 22) PL-NF (n ) 19) F-NF (n ) 22) PL-NF (n ) 19)
549.2 (29.7)
3146.7 (1058.1)
1464.9 (891.8)
555.5 (32.2)
2981.5 (653.5)
1504.3 (777.2)
-0.9 (14.9) ?
-354.5 (571.9) 
-155.5 (551.9)
-0.8 (25.1) ?
-511.7 (342.4)
-212.5 (336.8)
-0.01
0.34
0.13
19.1 (3.8)
87.6 (16.0)
19.4 (3.3)
90.3 (12.0)
0.0 (3.7)
-1.5 (15.3) ?
1.1 (3.0) 
3.8 (11.2)
-0.34
-0.42
11.5 (3.4) 11.5 (2.4) 0.9 (2.8) 1.5 (2.2) -0.24
45.5 (9.0)
9.7 (2.5)
45.1 (7.0)
9.8 (2.5)
-1.1 (7.5) ?
0.0 (2.5)
0.9 (6.0)
0.2 (2.2)
-0.30
0.15
42.5 (7.3)
17.9 (4.6)
40.2 (7.2)
18.0 (4.5)
-2.3 (8.2) ?
0.6 (5.8) ?
4.8 (7.9)
1.2 (4.4) ?
-0.90
-0.12
228.2 (113.7)
338.1 (473.0)
230.4 (83.8)
209.7 (102.8)
22.7 (83.8) ?
155.5 (429.5) ?
5.5 (65.0) ?
1.5 (97.2) ?
0.23
0.50
2672.4 (1604.7)
3089.6 (1597.1)
2388.5 (1556.2)
2317.6 (1281.6)
473.9 (949.3) ?
734.1 (1453.1) ?
310.3 (1258.5) ?
619.6 (1412.3) ?
0.15
0.08*
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assumptions conﬁrmed permission for using ANCOVA as statistical test method. However, 
for some variables removing outliers was needed to meet these assumptions. A maximum 
of 4.9% was removed in favor of creating a normal distribution. Imputation of missing data 
was used for the SA-DOTS, the VSS, the Instrumental Learning task, and the Time 
Reproduction task with an average of 4.9% and a maximal imputation of 14.6%. Table 2, 
among others, gives an overview of baseline values and shows that there was no difference 
between groups at baseline.
Neurocognitive outcomes
All main outcomes are depicted in Table 2 and Figure 1.
SA-DOTS. Two outliers were detected in the F-NF group and three in the PL-NF group. No 
treatment effect was found on any of the variables (correct: t(33) = -0.090, p = .928; RT: 
t(33) = 0.868, p = .385; SD of RT: t(33) = 0.109, p = .913). When additionally controlling for the 
number of correct trials, RT still did not reveal a treatment effect (t(32) = 0.864, p = .387). 
Likewise, the number of correct trials did not reveal a treatment effect after additionally controlling 
for RT (t(32) = -0.075, p = .940). Making more than eight premature responses was deﬁned as 
an outlier. After treatment no difference in premature responses between groups was found 
(Fisher’s Exact Test: p = 1.000). 
VSS. Two outliers were detected in the F-NF group and excluded from the dataset. The 
number of correct trials after controlling for baseline score did not show a treatment effect 
(t(36) = -0.672, p = .502), neither did the number of targets identiﬁed in correct order (t(36) 
= -0.810, p = .418). 
DS-WISC-III. No signiﬁcant treatment effect was found on the norm-score of forward and 
backward DS after controlling for the baseline-score (t(38) = 0.586, p = .561).
RAVLT. No signiﬁcant treatment effect was found on direct- and delayed recall after controlling 
for the baseline-score (direct: t(38) = 0.591, p = .558; delayed: t(38) = -0.290, p = .773). 
Instrumental Learning task. Two outliers were detected in the PL-NF group when exploring 
the data and were excluded from the dataset. No treatment effect was observed on the 
number of high probability actions (t(36) = 1.003, p = .316) or on the moment at which the 
learning criterion of 8 consecutive high probability actions was reached (t(36) = -0.028, 
p = .978).
Time Production task. Two outliers were detected in the F-NF group and excluded from the 
dataset. No signiﬁcant treatment effect was found on the mean absolute deviation (MAD; 
in ms) from 1 second after controlling for baseline-score (t(36) = 0.599, p = .553). A trend 
towards more variance in response length (standard deviation of MAD) in the F-NF than 
PL-NF group was observed (t(36) = 1.833, p = .075). 
Time Reproduction task. No signiﬁcant treatment effect was found on the MAD from the 
trial (t(38) = 1.771, p = .077). A signiﬁcant treatment effect, the F-NF ﬂuctuating more in 
response length than the PL-NF, was observed on the SD of MAD (t(38)= 2.674, p = .008).
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Covariates analyses
To control for the inﬂuence of age, gender, FSIQ, medication, and electrophysiological 
arousal, these variables were added as covariates to the main ANCOVA with the 
neurocognitive parameter as dependent variable, and group as ﬁxed variable. These analyses 
Figure 1 95% conﬁdence intervals for each neurocognitive parameter
Based on B-weights, this ﬁgure shows that despite a relatively small sample size and thus 
limited statistical power, there is no reason to reject the null-hypothesis. A positive value 
indicates an effect for the EEG-neurofeedback group; a negative value indicates an effect 
for the placebo-neurofeedback group. 
Note: Values of which lowering is hypothesized to be an improvement are indicated with a preceding arrow ( ) and 
scales are inverted. 
Abbreviations: PL-NF, placebo-neurofeedback group; F-NF, frequency neurofeedback group; p-value, probability- 
value; n, number; ms, milliseconds; SD, standard deviation; Digit Span-WISC-III,  Digit Span from the Wechsler 
Intelligence Scale for Children-III; FW, forward; BW, backward; MAD, mean absolute deviation; s, seconds.
Sustained Attention - dots
n/10 of correct responses (-1.416 - 1.292)          .928
response time 100*ms (1.82 - 4.72)            .385
SD response time 100*ms (-3.07 - 3.43)          .913
Visual Spatial Sequencing
n of correct trials (-2.88 - 1.41)            .502
n/10 of correct order identified (-1.217 - 0.506)          .418
Rey Auditory-Verbal Learning Test
direct recall (-5.33 - 2.92)            .558
delayed recall (-1.48 - 1.11)            .773
 
Digit Span WISC-III 
total z-value (FW & BW) (-1.91 – 1.05)          .561
Instrumental Learning task
n of high probability actions (-2.28 - 7.05)          .568
reach learning criterion (-1.53 - 1.45)           .978
Time Production task
MAD from 1s 100*ms (-3.5 - 6.4)           .553
SD of MAD 100*ms (1.9 - 38.4)           .075
Time Reproduction task
 
MAD from trial 100*ms (-0.7 - 13.8)           .077
SD of MAD 100*ms (2.8 - 18.5)           .008
PL-NF better F-NF better  
   p-value-7   -6   -5   -4   -3    -2    -1    0     1    2     3    4     5    6   7 
-7   -6   -5   -4   -3    -2    -1    0     1    2     3    4     5    6   7 
PL-NF better F-NF better 
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Figure 2 Proportion of children that shows improvement or deterioration on the Reliable 
Change Index per group for each variable. 
Note: The preceding arrow ( ) indicates an inverted scale; values of which lowering is hypothesized to be an 
improvement.
Abbreviations: SA-DOTS, Sustained Attention Dots; VSS, Visuospatial Sequencing; Digit Span-WISC-III, Digit Span 
from the Wechsler Intelligence Scale for Children-III; F-NF, frequency neurofeedback; PL-NF, placebo-neurofeed-
back; n, number; SD, standard deviation; RT, reaction time; RAVLT, Rey Auditory Verbal Learning Test; MAD, mean 
absolute deviation.
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did not reveal any signiﬁcant treatment effects and also abolished the previous ANCOVA- 
results that suggested a potential treatment effect. 
Reliable Change Index
Similar to results of Perreau-Linck and colleagues (2010), each participant improved on at 
least one measure, however, each participant also deteriorated on at least one measure. 
Figure 2 displays the percentage children that showed improvement and deterioration per 
group for each variable. These results did not yield a different conclusion than group 
analyses did; i.e., F-NF was not superior to PL-NF in improvement on the neurocognitive 
measures. When focusing on the few children that showed a signiﬁcant behavioral 
improvement (i.e., a clinical response), see van Dongen-Boomsma and colleagues (2013), 
each of these children showed improvement on some neurocognitive measures but 
deterioration on others.
Post-hoc analyses of the F-NF training
EEG-data during the sessions were available for 10 children (14 children were part of the 
pilot group in which EEG recordings were not saved and for 4 additional children, data were 
missing). Mean power was calculated per trained frequency-band and electrode for the 
ﬁrst, 10th, 20th, and last session. Seven children showed a change in power towards one of 
the training targets. However, the variability between sessions was great and no children 
showed such a desired change in more than one frequency-band. Moreover, all children 
additionally showed a change in power away from a training target. Clinical responders 
showed an EEG change in the desired as well as non-desired direction also.
Discussion
This study evaluated whether or not F-NF had beneﬁcial effects on neurocognitive functioning 
in children with ADHD, based on the results of our placebo-controlled double-blind design, 
and on a review of the existing literature.
No signiﬁcant improvement of neurocognitive functioning after F-NF compared to PL-NF 
was found, which is in line with previous analyses of behavioral effects on the same dataset 
(van Dongen-Boomsma et al., 2013). Participants who showed positive behavioral responses 
to F-NF did not show any sign of neurocognitive improvement. In addition, RCIs assessing 
individual changes in neurocognitive measures for each participant yielded essentially the 
same results. Furthermore, the only signiﬁcant interaction effect found was in favor of the 
PL-NF.
The systematic review suggests that neurocognitive improvements occur over time, but 
when compared with the control conditions, only two out of the nine RCTs reported a 
treatment effect of F-NF on some neurocognitive variables (i.e., impulsivity and attention). 
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The ﬁndings of these two RCTs are likely based on chance since the family-wise error rate is 
large when conducting such a high number of statistical tests. Also, the few papers that 
report neurocognitive improvements had signiﬁcant methodological limitations. 
 The most likely explanation why we did not ﬁnd improvement of neurocognitive 
functioning after F-NF is that F-NF is not an effective treatment in ADHD. This conclusion 
is in line with three recently published placebo-controlled F-NF studies reporting no 
superior effect on the core behavior symptoms of ADHD (Perreau-Linck et al., 2010; 
Lansbergen et al., 2011; Arnold et al., 2012; van Dongen-Boomsma et al., 2013). Yet another 
explanation is that neurocognitive improvement takes longer to manifest and may only be 
detectable at later time periods after end of the study. Furthermore, the results are based 
on a selected battery of neurocognitive tests, reﬂecting neurocognitive functions 
hypothesized to be impaired in ADHD (Nigg, 2005). The battery focussed more on attentional 
processes, since these have been shown to be most sensitive to EEG-NF on behavioral level 
(Arns, de Ridder, Strehl, Breteler & Coenen, 2009). However, not all hypothesized impaired 
neurocognitive functions were (fully) represented by the chosen test-battery, as is the case 
for conﬂict resolution and inhibition. The current study was conducted with care, especially 
with respect to study design and implementation of a comprehensive neurocognitive 
test-battery. Due to the requirement of a deviant pre-treatment EEG, this study enabled the 
child to train speciﬁc EEG deviations, in line with the hypothesis that EEG-NF improves or 
even normalizes deviant pre-treatment brain activity. This requirement did not lead to gen-
eralizability problems, because 95% of the participating children did have a deviant 
pre-treatment EEG. 
Nevertheless, this study has some limitations. First, children with all subtypes of ADHD and 
with an FSIQ of at least 80 points were included in this study. Thus, clear ﬁndings of 
improvements in subgroups of ADHD or children with a signiﬁcant lower IQ cannot be made. 
Second, the current cohort is smaller in size than planned, due to recruitment difﬁculties. 
Especially the F-NF pilot group, which could have shown improvement driven by implemented 
learning strategies, was small (n = 14). However, all 95%-CIs of the B-weights, the 
unstandardized regression coefﬁcients (Figure 1) are centered around zero, which suggests 
that the signiﬁcant and marginal effects that were found for three parameters were possibly 
based on chance. Type II errors due to a lack of power are therefore less likely than if the 
95%-CIs had not been centered around zero. The RCI analyses also suggest that power was 
not the most likely explanation of the failure to ﬁnd an effect. Third, the NF-therapist was 
not blinded, allowing for the possibility of a different attitude or bias towards the child, 
depending on group assignment. Fourth, to arrive at a normal distribution, up to 4.9% of 
the data was removed and to deal with missing data, imputation was used for an average 
of 4.9%, up to 14.6% of the data. Although these procedures were necessary to perform 
analyses in the most valid way, these procedures are still regarded as limitations of the 
study. It should also be noted that the current ﬁndings are based on a Caucasian sample and 
thus should not be presumed to be applicable to other races. Finally, this study aimed to 
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investigate neurofeedback training delivered in ‘care as usual’. Applying 80% positive 
feedback per condition leaded to a relatively low amount of reward in the more complex 
protocols. This decision was made in congruency with ‘care as usual’, but adds a limitation 
to this study-design. Furthermore, EEG-data from children in the F-NF group (after the two 
protocol adaptations) recorded during the sessions, showed that not all desired training 
directions were met. Signiﬁcant improvement on group level can only solidly be interpreted 
if all training conditions hypothesized to improve ADHD (on either behavioral or 
neurocognitive level) are actually improved in the desired direction. In ‘care as usual’, 
decisions about adjustments of the threshold were determined by the involved clinical 
NF-therapist. Future research should focus on different ways to deliver neurofeedback. In 
addition, the inﬂuence of F-NF on neurocognitive domains not covered by the current study 
therapy should be investigated. 
This study was unable to establish positive treatment effects on neurocognitive functioning 
after F-NF compared to PL-NF. This ﬁnding is in line with a systematic review of the current 
literature, but maybe inﬂuenced by the existing study limitations.
Key Points
% This double-blind, randomized, placebo-controlled study could not demonstrate superior 
effects of F-NF on neurocognitive functioning.
% A systematic review of the existing literature on this topic was also unable to ﬁnd a ﬁrm 
indication of superior neurocognitive improvement after EEG-NF compared to control 
conditions.
% The systematic review as well as this small study does not support signiﬁcant beneﬁts of 
EEG-NF in its current form on neurocognitive functioning of children with ADHD, however 
this ﬁnding is probably inﬂuenced by methodological limitations.
Acknowledgements
This study was supported by BrainGain, a Dutch research consortium, funded by Smartmix, 
an initiative of the Netherlands Organization for Scientiﬁc Research (NWO) to support 
applied research.
The authors would like to thank the participating children and their parents and teachers, 
and appreciate the invaluable support of Mrs. Nadine Schalk, research management 
assistant (Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, the 
Netherlands) and dr. M. Lansbergen (former senior researcher at the Radboud University 
Nijmegen Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department 
of Psychiatry, Nijmegen, the Netherlands). 
116
Ch
ap
te
r 
V
117Neurocognition after EEG-neurofeedback in children with ADHD
Supplement
Figure 1 CONSORT ﬂow diagram of study participants.
Abbreviations: CONSORT, Consolidated Standards of Reporting Trials; n, number; EEG,  electroencephalographic.
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Table 1   Overview studies
Study age (years)1
(m, SD)
n (total)
n (F-NF)
n (controls)
duration
frequency
n sessions
blinding
P
R
NFT
Linden et al., 1996 5-15 18
9 (F-NF)
9 (WL)
45 minutes
2/week
40 sessions
P: no
R: yes
NFT: NAP
Heinrich et al., 2004 10.8 (1.8) 22
13 (SCP-NF)
9 (WL)
50 minutes
5/week
25 sessions
P: no
R: no
NFT: no
Lévesque et al., 2006 10.2 (0.9) 20
15 (F-NF)
5 (no F-NF)
60 minutes
3/week
40 sessions
No blinding
Leins et al., 2007 9.2 (1.5) 38
19 (F-NF)
19 (SCP-NF)
60 minutes
5/week3
3x10 sessions
P: yes
R: NA
NFT: no
Holtmann et al., 2009 10.3 (1.2) 34
20 (F-NF)
14 (CAST)
30 minutes
2/week
20 sessions
P: no
R: NA
NFT: no
Perreau-Linck et al., 2010 10.4 (1.7) 9
5 (F-NF)
4 (PL)
60 minutes
2/day5
40 sessions
P: yes
R: no
NFT: yes
Wangler et al., 2011 9.6 (1.2) 94
59 (F-NF/SCP-NF)
35 (AST)
50 minutes
2/day6
36 sessions
P: no
R: yes
NFT: no
Bakhshayesh et al., 2011 9.3 (1.9) 35
18 (F-NF)
17 (EMG-F)
30 minutes
2-3/week
30 sessions
P: no
R: NA
NFT: no
Steiner et al., 2011 12.4 (0.9) 36
10 (F-NF)
11 (SCF-AT)
15 (WL)
30 minutes
2/week
32 sessions
No blinding
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NC- tests results2 results2
Cohen’s d 
K-BIT K-BIT* 1.26
CPT CPT Impulsivity errors* -0.39
IVA-CPT
Digit Span
c- Stroop
IVA-CPT ***
Digit Span*
c- Stroop*
0.34
0.17
0.94-1.18
TAP-7
HAWIK-II
TAP-7 for theta/beta*4
HAWIK-II for theta/beta****
TAP-7 for SCP***-****
HAWIK-II for SCP***
0.66, -4
0.82
0.92-1.09, 0.77
0.54
Stop signal-t Stop signal-t impulsivity**** -1.03
CPT
Digit Span
Spatial span
VF/CWI-t
Key search
Zoo map
Six part test
Beels/Mesula’s-ct
Child CAT
TEA-ch
D2
All participants showed signiﬁcant change in  
the desired direction on at least one measure with 
equivalent change occurring in both groups.
-
ANT
CPT7
ANT** - **** -0.345-0.171
p-p attention-t
CPT
p-p attention-t *-**** 8
CPT**
0.68-0.99
-0.70
IVA-CPT No signiﬁcant effects at all -
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Table 1   Overview studies
Study age (years)1
(m, SD)
n (total)
n (F-NF)
n (controls)
duration
frequency
n sessions
blinding
P
R
NFT
Arnold et al., 2012 8.9 (1.7) 39
26 (F-NF)
13 (PL)
45 minutes
2-3/week
Max. 40 sessions
P: yes
R: NA
NFT: NAP
Note: 1 If mean and standard deviation were not available, the inclusion criterion was given. 2 Results are 
represented by Cohen’s d interaction when there were signiﬁcant time effects. Time effects are depicted in 
standard black and time x group effects in italic and bold in favor of the frequency neurofeedback group. If 
there are no time effects and/or time x group effects in favor of the frequency neurofeedback group, these are 
not mentioned. 3 3 phases of 10 sessions in two weeks, breaks of 4-6 weeks in between, transfer trials between 
phases. 4 Since this study contained active treatment groups only, time effect rather than treatment effects are 
given. Time effects consisted of either baseline-endpoint or baseline-follow-up measurements. Analyses were 
performed for ‘below and above average achievers’ and are reported as such respectively, separated by a 
comma. 5 spread over 7-9 weeks. 6  2-3 times a week with a break of 2-3 weeks between the two blocks. 7 Due 
to adaptation of the CPT during the study, the authors decided not to publish the results (personal 
communication with one of the authors). 8 On the paper-and-pencil attention test, there are time-effects for 
the variables speed and total concentration score, but also for the variable error. So the effects on variable 
error are in the opposite direction. Time x group effects are seen for these variables too, and also for the 
variable reaction time. For the CPT there was a time effect for commissions only.
* p < .05, ** p <.01, *** p < .005, **** p ) .001. When different p-values are within one test, the minimum and 
maximum p-values are presented. When there is also a time x group interaction, only this p-value is reported.
Abbreviations: m, mean; SD, standard deviation; n, number; F-NF, frequency neurofeedback; P, participants; 
R, rater; NFT, neurofeedback-therapist; NC-tests, neurocognitive tests; Cohen’s d, effect size of interaction; 
et al., et alii, meaning ‘and others’; WL, waiting list; NAP, not applicable; K-BIT, Kaufman-BRIEF Intelligence Test; 
SCP-NF, Slow Cortical Potential-neurofeedback; CPT, continuous performance task; IVA-CPT, Integrated Visual 
and Auditory Continuous Performance Task; c-Stroop, counting Stroop; NA, not available; TAP-7, Testbatterie 
zur Aufmerksamkeits-prufung; HAWIK-II, Hamburger-Wechsler-Intelligentenztest fur Kinder; CAST, 
Computerized Attention Skills Training; -t, test; PL, placebo; VF/CWI-t, Verbal Fluency Color Word Interference 
test; Beels/Mesula’s-ct, Beels and Mesula’s cancellation task; Child CAT, Children’s Apperception Test; TEA-ch, 
Test of Everyd; d2, d2 Test of Attention; AST, Attention Skills Training; ANT, Attentional Network Test; EMG-F, 
electro myograph-feedback; p-p attention-t, paper-and-pencil attention test; SCF-AT, Standard Computer 
Format-Attention Training; tx, tests; W-abbr.-IQ, Wechsler Abbreviated Scale of Intelligence; BRC-tx, 7 Brain 
Resource Center computer-based normed neuropsychological tests.
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NC- tests results2 results2
Cohen’s d 
Achievement-tx 
Timed math-t 
W-abbr-IQ  
BRC-tx
“No apparent advantage of active treatment over 
placebo” (no quantitative data reported)
-
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Neurocognitive task descriptions
Sustained Attention Dots task. Dot patterns of random asymmetric 10 x 10 centimeter 
conﬁgurations were randomly presented. Children covered the buttons of a mouse with 
both hands using their index ﬁngers and had to response ‘yes‘ with their dominant hand if 
a four-dots pattern was presented, and ‘no’ with their non-dominant hand if a three- or 
ﬁve-dots pattern was presented. In case of an opposite response an audible error-signal 
was presented. The interval between a response and the next stimulus was ﬁxed at 250 
Table 2   Characteristics of the administered EEG-neurofeedback for the EEG-neuro-
feedback group
participant electrode 
position
low frequencies (Hz)
train downwards
beta, low range (Hz)
train upwards
beta, high range (Hz)
train downwards
1 F3, F4 4-7 12-15 20-30
2 F3, F4 4-7 12-15 20-30
3 C3, C4 4-7 12-15
4 P3, C4 4-6 12-15
5 P3, P4 4-7 12-15
6 Fz 4-7 12-15
7 C3, C4 4-7 12-15
8 C3, C4 12-15 15-20 + 20-25
9 P3, P4 4-5 12-15 24-27
10 F3, F4 4-7 12-14 20-30
11 F3, F4 11-13 18-23 +24-28
12 CZ 4-7 15-20
13 CZ 4-7 12-16
14 P3, P4 11-13 +12-15 20-25
15 Fz 3-5 12-15 15-18
16 F3, F4 3-5 12-15
17 C3, C4 5-7 12-15
18 CZ 3-4 15-18
19 F3, F4 15-18 +18-20
20 P3, P4 3-6 12-15
21 CZ 3-7 12-15
22 CZ 4-7 15-18
Note: Electrode positions are according to the international 10-20 system. The trained frequencies deviated 1.5 
SD or more from the normative NeuroGuide database and were trained in the opposite direction.
Abbreviations: SD, standard deviation; EEG-neurofeedback, electroencephalographic neurofeedback; Hz, Hertz.
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milliseconds (ms). Reaction times were allowed to vary between 150 and 1000 ms. 
Responses outside these bounds were labeled as non-valid trials and therefore automatically 
replaced by a new trial. After 12 practice trials, a total of 600 valid trials were presented in 
20-30 minutes (min).
Visuospatial Sequencing. In a 3 x 3 matrix of nine circles, several circles were pointed at with 
a computer-driven hand. Children had to point at the same circles in correct order with a 
self-driven hand without having any time constraints. Difﬁculty level increased after every 
correct trial by an increase in number of circles or by an increase in complication of the 
spatial pattern, hence the distance between circles pointed at. One practice trial and a ﬁxed 
amount of 24 experimental trials were presented in 5-10 min.
Digit Span from the Wechsler Intelligence Scale for Children-III. In the ﬁrst block, sequences 
of digits were verbally presented, which the child had to repeat in forward order in the ﬁrst 
block and in backward order in the second block. The maximum sequence-length depended 
on the number of correctly repeated sequences. For each block, 2 trials of each se-
quence-length (two-eight digits) were presented until two repeatedly incorrect sequences 
of the same length occurred, at the most 14 presented trials.
The Rey Auditory-Verbal Learning Test. Fifteen unrelated concrete nouns were read aloud in 
ﬁve learning trials with an interval of 2 seconds (sec) between words. This series of words 
was presented ﬁve times. After each presentation immediate recall was tested. Twenty min 
after the ﬁfth presentation, the number of words correctly recalled indexed long-term 
memory.
Instrumental Learning Task. In this modiﬁed version, each trial involves the simultaneous 
presentation of a pair of cartoon-pictures. Children were required to choose between one 
of two stimuli: one associated with a high probability of obtaining feedback (70%) and the 
other with a low probability of obtaining feedback (30%). The task consists of two different 
pairs of pictures, each alone signiﬁes the onset of one of 2 distinct trial types: reward or 
neutral. In the reward trials, positive feedback involved the presentation of a smiley and a 
point, whereas neutral feedback involved the presentation of a smiley alone. After 14 
practice trials, two blocks, each containing 40 trials and two different sets of cartoon-pairs, 
were performed in a total duration of about 12 min. Children were encouraged to ‘break the 
record’ which was ﬁctively set at 25 points (62.5% rewarded responses).
Time Reproduction task. In this task, two light bulbs were presented on the lateral sides of a 
computer screen. A trial started with the word ‘kijk’ (‘look’ in Dutch) displayed above the left 
light bulb for 3000 ms. Then the left light bulb turned yellow for different durations (4, 8, 
12, 16, or 20 sec) in random order. As soon as the light bulb turned back to white, ‘jouw 
beurt’ (‘your turn’ in Dutch) were displayed above the right light bulb. This indicated that the 
duration of the stimulus had to be reproduced as accurately as possible by pressing a button 
for the same amount of time as the stimulus presentation, turning the right light bulb 
yellow. After release of the button, both light bulbs remained white for 1500 ms. After three 
practice trials, 20 experimental stimuli were presented in around 20 min. Children were not 
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informed about the length of the intervals and did not receive feedback concerning their 
performance.
Time Production task. In this task, one-sec intervals had to be produced. After presentation 
of a ﬁxation cross for 200 ms, an auditory tone of 800 Hz was presented for 50 ms. The end 
of the tone announced the start of the interval. Children were instructed to produce as 
accurately as possible the one-sec interval by pressing a button at the end of the one-sec 
interval. 1500 ms after the subject’s response, visual feedback (1000 ms) was given, 
indicating whether the response was correct, too short, or too long. A response was correct, 
if it fell between the lower and upper boundary set by a dynamic tracking algorithm. 
Boundaries were set at 500 to 1500 ms at the beginning of the task. If the response fell 
within or outside these boundaries, the boundaries of the subsequent trial were respectively 
narrowed or widened by 100 ms. The task consisted of 10 practice trials and 80 experimental 
trials are administered. Before the task started a picture of a cartoon-cow was presented for 
one sec 10 times. Children were instructed to develop a strategy to ‘get a feeling’ of how 
long a sec is. These variables were created using MATLAB 7.5.0.
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Abstract
Until now, working memory training (WMT) has not reached sufﬁcient evidence as effective 
treatment for attention-deﬁcit/hyperactivity disorder (ADHD) core behavioral symptoms in 
children with ADHD; for young children with ADHD, no studies are available. To this end, a 
triple-blind, randomized, placebo-controlled study was designed to assess the efﬁcacy of 
Cogmed WMT (CWMT) in young children with ADHD.
Fifty-one children (5-7 years) with a DSM-IV-TR diagnosis of ADHD (without current 
psychotropic medication) were randomly assigned to the active (adaptive) or placebo 
(non-adaptive) training condition for 25 sessions during ﬁve weeks. The compliance 
criterion (* 20 sessions) was met for 47 children. The primary outcome measure concerned 
the core behavioral symptoms of ADHD, measured with the ADHD Rating Scale IV 
(ADHD-RS). Secondary outcome measures were neurocognitive functioning, daily executive 
functioning, and global clinical functioning. The inﬂuence of the increase in difﬁculty level 
(index-improvement) for the treatment group was also analyzed. 
A signiﬁcant improvement in favor of the active condition was found on a verbal working 
memory task (p = .041; adapted Digit Span of the Wechsler Intelligence Scale for Children-III, 
backward condition). However, it did not survive correction for multiple testing. No signiﬁcant 
treatment effect on any of the primary or other secondary outcome measurements was 
found. The index-improvement signiﬁcantly contributed to ADHD-RS and the Behavior 
Rating Inventory of Executive Function, both rated by the teacher, but revealed no signiﬁcant 
group difference.
This study failed to ﬁnd robust evidence for beneﬁts of CWMT over the placebo training on 
behavioral symptoms, neurocognitive, daily executive, and global clinical functioning in 
young children with ADHD.
Trial Registration: ClinicalTrials.gov identiﬁer: NCT00819611.  
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Introduction
Persistence of neurocognitive deﬁcits in attention-deﬁcit/hyperactivity disorder (ADHD) is 
strongly associated with occupational problems and morbidity (Barkley & Murphy, 2010; 
Biederman et al., 2012). Medication is currently the most effective treatment for ADHD 
(Faraone & Buitelaar, 2010). However, insufﬁcient knowledge about long-term safety 
(Berger, Dor, Nevo & Goldzweig, 2008) and efﬁcacy (van de Loo-Neus, Rommelse & 
Buitelaar, 2011), as well as the continuous need for treatment (Jensen et al., 2007; Murray 
et al., 2008) call for non-pharmacological alternatives. Treatment alternatives have been 
developed, focusing on improvement of behavioral symptoms by training of ADHD-related 
neurocognitive functions. One of these cognitive training possibilities is Cogmed working 
memory training (CWMT). CWMT is based on the rationale that working memory (WM) (i.e., 
the ability to temporarily hold information while simultaneously manipulating the 
information [Baddeley, 1986]) is regarded as a fundamental higher-order function, underlying 
other executive functions (EFs) (Klingberg et al., 2005), and essential for goal-directed 
behavior (Molfese & Molfese, 2002). Training of WM might improve WM capacity, other 
neurocognitive functions, and core behavioral symptoms of ADHD.
So far, six studies examined the efﬁcacy of the original version of CWMT in children with 
ADHD (Klingberg, Forssberg & Westerberg, 2002; Klingberg et al., 2005; Holmes, Gathercole 
& Dunning, 2009; Beck, Hanson, Puffenberger, Benninger & Benninger, 2010; Gray et al., 
2012; Green et al., 2012); all but one (Holmes et al., 2009) used a randomized controlled trial 
design. Three out of four studies that investigated the efﬁcacy on the core behavioral 
symptoms of ADHD showed signiﬁcant treatment effects (Klingberg et al., 2005; Beck et al., 
2010; Green et al., 2012). Five studies reported on neurocognitive data and found 
improvement on at least one trained WM task (Klingberg et al., 2002; Klingberg et al., 2005; 
Holmes et al., 2009; Gray et al., 2012; Green et al., 2012). Four of these studies reported 
non-trained neurocognitive outcome measures, with two showing signiﬁcant improvement 
(i.e., on WM, response inhibition, and attention) (Klingberg et al., 2002; Klingberg et al., 
2005).
Recently, two meta-analyses on non-pharmacological treatment studies in children with 
ADHD were unable to derive an overall signiﬁcant ES for the core symptoms of ADHD for 
cognitive training (Hodgson, Hutchinson & Denson, 2012; Sonuga-Barke et al., 2013) as well 
as for several neurocognitive functions (Hodgson et al., 2012). In two meta-analytic reviews 
(Melby-Lervag & Hulme, 2013; Rapport, Orban, Koﬂer & Friedman, 2013) and two reviews 
(Shipstead, Redick & Engle, 2012; Chacko et al., 2013) further concerns were expressed 
about the efﬁcacy of WM training (WMT). Inconsistent ﬁndings within and between studies, 
yielded doubt about the generalization of the trained task effect in this training (Chacko et 
al., 2013).
In sum, WMT is not yet a well-established treatment in school-aged children with ADHD. 
Data on the efﬁcacy of WMT in a younger target group are not available yet. A relationship 
136
Ch
ap
te
r 
VI
between ADHD symptoms and WM deﬁcits has already been observed at preschool age 
(Kalff et al., 2002; Thorell & Wåhlstedt, 2006; Skogan et al., 2013). Whereas medication has 
been found to be less effective in younger children with ADHD (Riddle et al., 2013), WM 
shows a rapid development throughout preschool and early school-age (Carlson, 2005). 
Training children at this young age, before larger demands from school exist, could be 
beneﬁcial by increasing WM capacity and thereby preventing development of cognitive 
and/or behavioral problems (Rueda, Posner & Rothbart, 2005; Thorell, Lindqvist, Bergman 
Nutley, Bohlin & Klingberg, 2009). Therefore, investigating the efﬁcacy of WMT in younger 
children in ADHD is worthwhile.
The present study investigates the efﬁcacy of CWMT in young children (age 5-7 years) with 
ADHD on behavioral, neurocognitive, and global clinical functioning. To this end, a triple- 
blind, randomized, placebo-controlled design was used, including an extensive diagnostic 
procedure and neurocognitive battery assessing different EFs and attention in ADHD.
Methods
Trial design
The Cogmed JM training program designed for the age 4-7 years (developed by Cogmed 
Cognitive Medical Systems AB, Stockholm, Sweden) was used for the active condition and 
its (non-adaptive) placebo version. Children with ADHD were randomly and triple-blindly 
assigned to the active condition (the working memory group [WMG]) or the placebo 
condition (placebo group, [PLG]) with stratiﬁcation for age and gender. A research team 
member, not involved in data collection, assigned the children (in predetermined random 
order and 1:1 allocation). The study was triple-blind since the participants (the children, 
their parents, and teachers), the training coaches, and the investigators were blinded to 
treatment assignment. Endpoint of the study was deﬁned as the date of the assessment 
after the training, within two weeks after the last training session. 
Participants
To be included in the study, children had to meet the following criteria 1) age between 
5.5-7.3 years, 2) a diagnosis of ADHD classiﬁed according to the criteria of the Diagnostic 
and Statistical Manual of Mental Disorders (4th ed., text rev.; DSM-IV-TR; American 
Psychiatric Association, 2000), 3) a full scale intelligence quotient (FSIQ) of at least 80, 4) 
without current psychotropic medication, and 5) access to a computer with Windows Vista/
XP/7 and speakers, and access to internet. Children were excluded in case of 1) current 
intensive (i.e., weekly) psychotherapy, 2) another comorbid psychiatric diagnosis except for 
pervasive developmental disorder not otherwise speciﬁed or oppositional deﬁant disorder, 
3) any neurological and/or cardiovascular disease, currently or in the past, 4) a serious 
motor or perceptual handicap, and 5) participation in another clinical trial.
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A trained psychologist screened potential participants in a telephone interview with the 
parents. For children with a positive screening for ADHD symptoms, eligibility was assessed 
and a diagnostic procedure scheduled that included a developmental and psychiatric 
assessment with a board certiﬁed child and adolescent psychiatrist or a certiﬁed child mental 
health psychologist. This assessment also included the ADHD Rating Scale IV (ADHD-RS; 
Zhang, Faries, Vowles & Michelson, 2005). Autism spectrum disorders were screened with the 
Social Communication Questionnaire (Berument, Rutter, Lord, Pickles & Bailey, 1999) and the 
presence of other psychiatric disorders was screened with the Diagnostic Schedule for Children 
(Shaffer, Fisher, Lucas, Dulcan & Schwab-Stone, 2000; Steenhuis, Serra, Minderaa & Hartman, 
2009). All were subsequently examined in a clinical assessment. If intelligence had not been 
assessed in the past 1.5 years, the subtests picture completion, vocabulary, block design, and 
similarities from the Wechsler Preschool and Primary Scale of Intelligence Revised (Wechsler, 
1989), translated in Dutch (WPPSI-R NL; van der Steene, 1997) were administered.
Recruitment (May 2009-March 2013, predetermined) and assessments were performed at 
Karakter Child and Adolescent Psychiatry University Centre in Nijmegen, The Netherlands. 
Children were recruited among referrals to the centre and from responders to advertisements 
on the website and magazine of the Dutch Parents Association of Children with ADHD, and 
advertisements in two Dutch local newspapers. The training took place at home, except for 
one child who trained at school due to the lack of computer-facilities at home. 
The study was approved by the local Dutch Medical Ethics Committee and conducted in 
accordance with the declaration of Helsinki. All parents gave their written informed consent 
before participation; their children gave their oral assent. Travel expenses were partially 
reimbursed. All children received a gift certiﬁcate of 10 euro.
At the start of the study, the only published randomized controlled trial on CWMT reported 
an effect size (ES) of 0.6 for their primary outcome (Klingberg et al., 2005). Given an alpha 
error of .05 and an estimated dropout of 10%, a sample of 50 children per group gives a 
power of 81.2% to detect treatment effects of 0.6 ES. 
Interventions
Both conditions were translated in Dutch by Cogmed qualiﬁed practice BeterBrein 
(Groningen, The Netherlands). The training consisted of 25 sessions of 15 minutes, ﬁve days 
a week. Both conditions included seven visuospatial WM tasks. For all tasks, a number of 
visual stimuli were presented sequentially on the computer screen and the child had to 
remember both their location and order to subsequently respond by mouse clicking the 
targets in correct order. In the active condition, the software adjusted task difﬁculty based 
on the child’s performance. The placebo condition was identical to the active condition, 
except that the items to be remembered did not exceed the starting level of two items. 
Training data were uploaded to a server after each training session. The parents were 
instructed to encourage the child during the training course, and gave small rewards every 
ﬁve sessions and after training completion. A certiﬁed Cogmed coach contacted the parents 
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every week to evaluate the performance and motivation of the child with a standardized 
questionnaire. A complier was deﬁned by fulﬁlment of at least 20 sessions as deﬁned in the 
study by Klingberg (2005). 
Behavioral outcomes
The primary outcome measure was the difference between baseline and endpoint on the 
total symptom-score of the ADHD-RS rated by the investigator (ADHD-RS-INV), using a 
4-point Likert scale (0 = never occurs, 1 = occurs sometimes, 2 = occurs often, 3 = occurs 
very often). The teacher also rated the ADHD-RS at baseline and endpoint (ADHD-RS-T). 
Another outcome measurement was the change between baseline and endpoint on the 
Dutch version of the Behavior Rating Inventory of Executive Function (BRIEF), ﬁlled out by 
parents (BRIEF-P) and teacher (BRIEF-T) (see appendix for detailed information) (Gioia, 
Isquith, Guy & Kenworthy, 2000; Smidts & Huizinga, 2009). The BRIEF-P was additionally 
used to determine WM deviance at baseline by using the test-scores of the WM subscale. 
The amount of children that scored above clinical threshold (t * 6.5) was determined.
Neurocognitive outcomes
A neurocognitive assessment of approximately 60 minutes included the adapted Digit Span 
from the Wechsler Intelligence Scale for Children-III (DS-WISC-III) to measure verbal WM 
(Wechsler, 1949; Smidts, 2003; Raaijmakers et al., 2008), the Knox Cubes Leidse Diagnostische 
test (LDT) to measure short term memory for spatial sequences (Schroots & van Alphen de 
Veer, 1976), the Sentences of the WPPSI-R NL (Sentences) to assess memory for sentences 
(Wechsler, 1991), the Shortened Raven Coloured Progressive Matrices (RAVEN) for 
non-verbal reasoning ability (Raven, 1998), the Day-Night Stroop Task (DNST) to measure 
motor inhibition (Gerstadt, Hong & Diamond, 1994), the Sustained Attention Dots task, 
version 02K (SA-DOTS-02K) to measure visual sustained attention (de Sonneville, Schmidt, 
Michel & Batzler, 1990; de Sonneville, 1999) and the Shape School to assess inhibition and 
switching processes (Espy, 1997; Smidts & Groot, 2005). The appendix contains the 
neurocognitive task descriptions.
Global clinical functioning outcomes
Global clinical functioning served as a secondary outcome measure. The Clinical Global 
Impressions-Improvement scale (CGI-I) was administered after the training to measure 
training effect. The CGI-I consists of a single item 7-point scale (1 = very much improved, 2 
= much improved, 3 = minimally improved, 4 = no change, 5 = minimally worse, 6 = much 
worse, 7 = very much worse) (Guy, 1976). Responders were deﬁned as children that were 
rated ‘much improved’ or ‘very much improved’. 
Global improvement was assessed as the difference between baseline and endpoint on the 
Children’s Global Assessment Scale (CGAS) (scale 0–100, with 0 = most affected global 
functioning and 100 = best global functioning) (Shaffer et al., 1983). 
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Index-improvement
Trained task effects were assessed through a task improvement index (index-improvement) 
provided by Cogmed, calculated by subtracting the ‘start index’ (average performance on 
day 2 and 3 from four of the tasks in the program) from the ‘max index’ (average of the best 
two trials over the course of the training).
Statistical methods
Statistical analyses were performed with IBM SPSS Statistics, version 20.0 (Armonk, New 
York; IBM Corp.). For each parameter, mean (M) and standard deviation (SD) were computed. 
The signiﬁcance level was set at p = .05 (two-tailed). To evaluate the impact of multiple 
comparisons, a Bonferroni correction was performed, in which the amount of dependent 
variables corrected for was deﬁned per level (the initial p-value of the matching level was 
divided by 6 behavioral, 18 neurocognitive, and 2 global clinical variables, resulting in a 
signiﬁcance level of p = .008, p = .002, and p = .025 respectively). Missing data were 
imputed, using multiple imputation with 20 iterations (Donders, van der Heijden, Stijnen & 
Moons, 2006). Outliers (deﬁned as 25% of the size of the largest leaf entry in the clustering 
feature tree, based on the default deﬁnition used by SPSS 20.0) were removed. When all 
assumptions were valid, analysis of the covariance (ANCOVA) was applied to optimize 
control for the variance at baseline. For each parameter the endpoint measurement was the 
dependent variable, the baseline measurement a covariate, and group the independent 
variable. For the tasks containing a RT-accuracy trade-off (DNST, SA-DOTS-02K, and the 
Shape School), accuracy was an additional covariate. To inspect the overall pattern of the 
results, the 95% conﬁdence intervals (95%-CIs) of the b-values were calculated. When the 
parametric assumptions were not valid, non-parametric testing on the change score 
(baseline subtracted from endpoint score) was performed on non-imputed data, or the 
Reliable Change Index (RCI) (Jacobson & Truax, 1991) was measured in case of a very small 
remaining sample. Difference between the groups on the CGI-I was tested by a chi-square 
test. ESs (Cohen’s d; the difference between the change scores [endpoint-baseline] of each 
group divided by the pooled standard deviations of both groups at baseline) were calculated 
on the non-imputed data. 
Post-hoc, the difference between the start index and max index in the WMG was analyzed 
using a paired samples t-test. The difference between groups regarding the start index was 
calculated using a Mann-Whitney-Wilcoxon test, since it was a priory known that per 
deﬁnition the variance of distributions would be different between groups. The inﬂuence of 
the index-improvement in the WMG was evaluated for the DS-WISC-III, the total scores on 
the BRIEF-P, BRIEF-T, ADHD-RS-INV, and ADHD-RS-T, and the CGI-I. These scales were 
thought to reﬂect near to far transfer, respectively. If ANCOVAs were performed in the main 
analyses, they were repeated post-hoc with the index-improvement as additional covariate. 
If non-parametric tests were performed in the main analyses, a Pearson correlation between 
the change scores and index-improvement was determined. The CGI-I was tested using an 
140
Ch
ap
te
r 
VI
analysis of the variance (ANOVA) with the CGI-I as ﬁxed factor and the index-improvement 
as dependent variable. We calculated the correlation between the WM deviance measured 
with the BRIEF-P at baseline and the index-improvement to determine the importance of 
baseline deﬁcits to the ability to improve on the training. Finally, in addition to the analysis 
of all compliers describe above, an intention-to-treat (ITT) analysis was performed on all 
randomized children (independent of treatment completion) using the ADHD-RS-INV.
Results
All variables were distributed normally within groups and variances were homogeneous 
among groups, unless explicitly stated and dealt with accordingly. See Table 2 for all 
statistical results. See the appendix for detailed results and an overview of the 95%-CIs of 
the group difference b-values. Note that time differences, i.e., improvement independent of 
the groups, were often present.
Demographic and clinical characteristics
In total, 53 children were eligible for the study and were clinically examined (Figure 1). Two 
children were excluded; one due to technical problems and one due to a FSIQ<80. 
Twenty-seven children were allocated to the WMG and 24 to the PLG. Four children ﬁnished 
less than 20 sessions and were deﬁned as decliners. Forty-three children completed all 
training-sessions; two children completed 21 and two 22 training-sessions. Complier 
analyses thus were conducted for 47 children. Expected as a result of randomization, no 
differences were found on baseline characteristics (see Table 1). All children were 
psychotropic medication-naïve, except for one child that quit medication (pipamperon and 
methylphenidate) more than two months before the start of the study. 
WM deficits at baseline
For six children, the WM subscale of the BRIEF-P was missing. A clinical threshold (t * 6.5) 
was reached by 29.3% of the children (12/41). Another 31.7% (13/41) scored subthreshold 
(under clinical threshold but t * 6).
Behavioral functioning outcomes
There were no treatment effects of the primary outcome measurement, i.e., any of the 
ADHD-RS-INV subscales (total: t(41) = -0.237, p = .813; inattentive: p = .380; hyperactive/
impulsive: t(41) = -0.655, p = .512). Neither were treatment effects observed on the 
ADHD-RS-T or the BRIEF-P and BRIEF-T composite scores.
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Neurocognitive functioning outcomes
A signiﬁcant difference in favor of the WMG was found on the backward (BW) condition 
of the DS-WISC-III (p = .041), which did not survive the Bonferroni corrected signiﬁcance 
level of p = .002. No treatment effect was found on the forward condition (p = .980), or any 
of the other neurocognitive functioning outcomes. 
Global clinical functioning outcomes
There were no signiﬁcant differences on the global clinical functioning outcomes (CGI-I: 
r2-test, p = .124; CGAS: t(44) = -0.658, p = .514). 
Figure 1 CONSORT ﬂow diagram of study participants.
Abbreviations: CONSORT, Consolidated Standards of Reporting Trials, n, number; ITT, intention-to-treat.
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The relation between index-improvement and outcome measures
There was a signiﬁcant difference between groups (p < .001) on the start index. Nevertheless, 
the WMG signiﬁcantly improved on the task, as illustrated by a signiﬁcant difference 
between the start index and the max index (t(25) = 15.59, p < .001). The mean index- 
improvement of all Cogmed JM users in 2012 (18.44 ± 6.17; S. Söderqvist, Cogmed employee, 
personal communication, October, 17, 2013) did not signiﬁcantly differ from the mean 
 index-improvement of the WMG in the current sample (16.60 ± 5.170; t(26) = -1.818, 
p = .081). A correlation analysis (chosen because of violation of normality) showed no 
relationship between index-improvement and the DS-WISC-III-BW (r = 0.129, p = .568). 
Also, the BRIEF-P and the ADHD-RS-INV were not inﬂuenced by the index-improvement as 
covariate. The outcome of the BRIEF-T and ADHD-RS-T however, were signiﬁcantly 
inﬂuenced by the index-improvement, even though no group difference was revealed 
Table 1   Descriptive characteristics
characteristics WMG  
(n = 26)
PLG  
(n = 21)
analysis  
(T, r2)
age, m (SD), y 6.5 ± 0.6 6.6 ± 0.7 p = .536
gender, n (%)
male 18 (69.2) 16 (76.2) p = .596
race, n (%)
Caucasian 26 (100) 21 (100) p = 1.00
full-scale IQ, m (SD) 99.9 ± 10.2 96.8 ± 10.7 p = .325
BRIEF WM t-score (m ± SD)x 60.3 ± 7.4 61.1 ± 7.2 p = .749
ADHD subtype, n (%)
combined
inattentive
hyperactive/impulsive
21 (80.8)
2 (7.7)
3 (11.5)
12 (57.1)
2 (9.5)
7 (33.3)
p = .168
comorbidity, n (%)
pervasive developmental disorder NOS
oppositional deﬁant disorder 
developmental coordination disorder
disruptive behavior NOS
nocturnal enuresis 
parent-child relational problem
no comorbidity
0 (0)
1 (3.8)
0 (0)
0 (0)
1 (3.8)
0 (0)
24 (92.3)
1 (4.8)
2 (9.5)
2 (9.5)
1 (4.8)
0 (0)
1 (4.8)
14 (66.7)
p = 1.00
x WMG n = 22, PLG n = 19.
Abbreviations: WMG, working memory group; n, number; PLG, placebo group; T, independent sample t-test; r2, 
chi-square test; m, mean; SD, standard deviation; y, years; p, probability; IQ, Intelligence Quotient; BRIEF, 
Behavior Rating Inventory of Executive Function; WM, working memory; ADHD, attention-deﬁcit/hyperactivity 
disorder; NOS, not otherwise speciﬁed.
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(Global Executive Composition BRIEF-T: index-improvement: t(42) = 2.401, p = .016; 
 treatment-effect: t(42) = 1.623, p = .105; ADHD-RS-T: index-improvement: t(42) = 2.073, 
p = .038; treatment-effect: t(42) = 1.267, p = .205). Lastly, an ANOVA between the 
improvement CGI-I categories as ﬁxed factor and the index-improvement from the WMG 
as dependent variable, did not show an effect (F(20) = 0.145, p = .866). We were also 
unable to establish a signiﬁcant correlation between the baseline WM t-score on the 
BRIEF-P and the index-improvement (r = -.268, p = .228).
Compliance to the training
Data on the ADHD-RS-INV were available for two non-compliers that ﬁnished 16 and 17 
sessions, but not for those that ﬁnished 6 and 13 sessions. In addition, data were available 
for four children (three for the primary outcome) that were deﬁned as compliers, but did 
not ﬁnish all 25 sessions. Since an ITT-analysis would only expand the data with two 
children, children who completed all sessions were compared to children who completed 
fewer sessions instead. Of eight children that did not complete all sessions of training, only 
one was from the WMG. Assumptions to perform ANCOVA were valid after removal of 
outliers. An ANCOVA controlling for baseline showed signiﬁcant group differences between 
children that did and did not complete the entire training, independent of treatment 
assignment (total: t(40) = -3.172, p = .003; inattentive: t(40) = -2.858, p = .007; hyperactive/
impulsive: t(4) = -2.901, p = .006). Note however, that group sizes were very unequal 
(completers n = 38, non-completers n = 5).
 
Discussion
This study was designed to investigate the efﬁcacy of CWMT in young children with ADHD. 
A triple-blind, randomized, placebo-controlled design was used with outcome measures 
concerning behavioral, neurocognitive, and global clinical functioning. 
The results showed a signiﬁcant improvement in favor of the active condition on a verbal 
WM task, but this effect did not survive correction for multiple testing. Further, both the 
active and the placebo condition improved on many outcome measures over time. However, 
no additional effect in favor of the active condition was found on any of the primary or 
other secondary outcome measurements. The task improvement index inﬂuenced the BRIEF 
and ADHD-RS outcome, both evaluated by teacher, but correction for this variable did not 
yield signiﬁcant group differences. 
The hypothesis underlying WMT is that WM performance principally reﬂects the effects of 
a general-purpose attentional system and that effective WM training should 1) lead to a 
growth in a domain-general attentional capacity, and 2) show transfer effects to untrained 
tasks (Barnett & Ceci, 2002; Shipstead et al., 2012). Near-transfer effects are effects on 
tasks closely related to trained tasks, whereas far-transfer effects are effects on tasks not 
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Table 1   Results on behavioral, neurocognitive, and global clinical functioning
WMG-baseline WMG-endpoint PLG-baseline
ADHD-RS–INV, m (SD)
total Sx
inattentive Sx
hyperact./imp. Sx
35.9 ± 6.1
16.8 ± 3.8
19.0 ± 4.1
32.4 ± 5.7 
15.0 ± 4.7
17.4 ± 3.2
32.3 ± 4.1
15.4 ± 2.4
16.9 ± 3.6
ADHD-RS-T, m (SD)
total Sx
inattentive Sx
hyperact./imp. Sx
31.2 ± 7.2
13.5 ± 5.7
17.7 ± 4.7
27.5 ± 10.1
12.6 ± 6.5
15.0 ± 5.3
29.3 ± 6.7
14.9 ± 4.9
14.3 ± 5.3
BRIEF-P, m (SD)
BRI
MI
GEC 
BRIEF-T, m (SD)
BRI
MI
GEC 
60.4 ± 12.8
91.4 ± 11.8
151.8 ± 20.7
50.3 ± 14.6
88.8 ± 21.4
149.2 ± 31.7 
58.4 ± 11.4
94.4 ± 10.2
152.8 ± 13.9
57.4 ± 12.9
93.1 ± 20.2
150.4 ± 28.2
56.8 ± 10.0
92.6 ± 11.2
149.4 ± 17.1
54.7 ± 13.4
92.7 ± 14.5
147.4 ± 22.5
DS-WISC-III, m (SD)
FW
BW
5.7 ± 0.9
2.6 ± 0.7
5.9 ± 1.3
2.9 ± 0.9
5.4 ± 1.0
2.8 ± 0.8
LDT, m (SD)
FW
BW
7.4 ± 2.9
4.0 ± 1.6
8.7 ± 2.1
4.9 ± 2.2
5.8 ± 2.4
3.4 ± 1.6
Sentences, m (SD) 21.0 ± 5.9 21.4 ± 6.0 20.1 ± 4.5
RAVEN, m (SD) 22.0 ± 5.9 24.7 ± 4.8 20.5 ± 5.7
DNST, m (SD)
control time
switch time
difference 
35.0 ± 11.0
35.6 ± 7.5
0.6 ± 11.3
28.4 ± 4.2
33.9 ± 7.1
5.5 ± 5.7
35.7 ± 11.4
39.4 ± 8.7 
4.9 ± 9.7 
SA-DOTS-02K, m (SD)
RT
SD-RT
1315.0 ± 247.2
231.8 ± 79.2
1255.5 ± 249.6
278.0 ± 97.4
1370.6 ± 317.5
289.2 ± 83.0
Shape School, m (SD)
Control 
   red RT
   red SD-RT
   yellow RT
   yellow SD-RT 
Switch
   red RT
   red SD-RT
   yellow RT
   yellow SD-RT
1780.1 ± 449.8
587.2 ± 454.1
1635.7 ± 426.0
511.9 ± 536.7
1992.1 ± 481.2
502.2 ± 351.1
2133.4 ± 554.5
516.4 ± 333.2
1630.9 ± 632.7
455.0 ± 434.5
1603.7 ± 478.6
503.7 ± 354.1
1945.4 ± 712.7
302.9 ± 345.0
2079.8 ± 949.9
552.9 ± 1035.4
1778.4 ± 790.8
560.1 ± 326.5
1626.8 ± 422.7
302.3 ± 251.0
2102.2 ± 552.8
353.1 ± 278.0
2221.0 ± 791.0
545.8 ± 348.4
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PLG-endpoint n time effect group effect test Cohen’s d
30.3 ± 7.4 
14.9 ± 4.1 
15.4 ± 5.0
22-19
t(41) = 2.719** 
NAP
t(41) = 3.789*** 
t(41) = -0.237
-
t(41) = -0.655
ANCOVA
MWW
ANCOVA
0.28
0.40
0.03
25.5 ± 7.7
14.0 ± 4.7
11.5 ± 4.9
18-14 
t(42) = 2.103*
t(42) = 2.732** 
t(42) = 2.320*
t(42) = -0.398
t(42) = 0.318
t(42) = -1.175
ANCOVA
-0.01
0.00
-0.02
57.2 ± 10.0
92.7 ± 13.3
149.9 ± 20.7
53.1 ± 10.8
96.3 ± 15.5
149.4 ± 22.6
15-16 
14-14 
t(43) = 6.740*** 
t(43) = 2.654**
t(43) = 4.110***
t(43) = 4.017***
NAP
t(43) = 2.593**
t(43) = 0.553
t(43) = -0.617
t(43) = -0.307
t(43) = -0.095
-
t(43) = -0.109
ANCOVA
ANCOVA
MWW
ANCOVA
0.21
-0.25
-0.03
-0.62
-0.04
0.03
5.4 ± 0.9
2.4 ± 1.0
22-21 NAP
-
*
MWW
0.21
0.93
7.0 ± 2.7
4.1 ± 2.3
26-19 NAP
-
-
MWW
0.04
0.13
21.2 ± 5.1 25-21 t(44) = 8.973*** t(44) = 0.800 ANCOVA -0.13
23.7 ± 5.0 26-21 t(44) = 6.174*** t(44) = -0.106 ANCOVA -0.09
34.6 ± 10.0
37.9 ± 6.9
3.2 ± 8.2
20-20 
NA
NA
t(39) = 1.782
NA
NA
t(39) = 1.399
NA
NA
ANCOVA+
NA
NA
0.63
1231.0 ± 410.7
311.6 ± 93.0
23-20
t(40) = 2.104*
t(40) = 2.863** 
t(40) = -0.288
t(40) = 0.136
ANCOVA+
0.28
0.29
1474.7 ± 714.9
387.0 ± 416.5
1566.3 ± 669.1
255.2 ± 275.6
1743.3 ± 590.6
325.3 ± 301.2 
1728.3 ± 718.0
185.6 ± 168.0
24-15
23-12
24-13
18-10
22-11
17-8
21-13
18-10
t(35) = 1.428
t(31) = -0.113
t(33) = 0.966
t(24) = 0.395
t(29) = 2.924**
t(21) = 0.346
t(30) = 1.032
t(24) = 1.995
t(35) = 0.018
t(31) = -0.976
t(33) = 0.203
t(24) = -0.738
t(29) = -0.679
t(21) = 1.581
t(30) = -1.179
t(24) = -1.803
ANCOVA+
-0.26
-0.10
-0.07
-0.08
-0.62
0.52
-0.67
-1.17
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closely related to trained tasks (Melby-Lervag & Hulme, 2013). This study suggested 
improvement on the trained visuospatial WM represented by a signiﬁcant improvement on 
the training in the active condition. A near-transfer effect was not maintained after 
correcting for multiple testing. Far-transfer effects were absent. These results were in line 
with recent meta-analyses and reviews (Shipstead et al., 2012; Chacko et al., 2013; 
Melby-Lervag & Hulme, 2013; Rapport et al., 2013), which questioned if WMT could enable 
transfer effects. Rapport and colleagues explicitly targeted near vs. far transfer effects in 
their meta-analysis and concluded that CWMT was associated with moderate near transfer 
effects only (d = 0.63). Cognitive and behavioral far transfer effects were lacking. Moreover, 
higher ESs were found for unblinded raters than for blinded raters (Rapport et al., 2013; 
Table 1   Continued
WMG-baseline WMG-endpoint PLG-baseline
CGI-S, n (%)
3-mildly ill
4-moderately ill
5-markedly ill
1 (4.2)
17 (70.8)
6 (25)
NAP
1 (5)
17 (85)
2 (10)
CGI-I, n (%)
2-much improved
3-minimally improved
4-no change
5-minimally worse
NAP
1 (4)
11 (44)
12 (48)
1 (4)
NAP
CGAS, m (SD) 51.2 ± 6.8 53.8 ± 6.7 52.3 ± 7.0
* p < .05, ** p < .01, *** p < .001. 
Note: ‘-‘ indicates a non-signiﬁcant (p <.05) result after non-parametric testing.
Abbreviations: WMG, working memory group; PLG, placebo group; n, number of children for which both a 
baseline and endpoint measurement were available; Cohen’s d of interaction, the difference in change scores 
(endpoint-baseline) between groups (WMG-PLG) divided by the pooled baseline standard deviation based on 
the standard deviation while taking into account the overlapping non-imputed n per group; ADHD-RS-IV, at-
tention-deﬁcit/hyperactivity disorder Rating Scale IV; -INV, rated by the investigator; SD, standard deviation; 
Sx, symptoms; hyperact./imp., hyperactive/impulsive; NAP, not applicable; ANCOVA, analysis of covariance with 
the measurement at baseline as covariate; MWW, Mann–Whitney–Wilcoxon; -T, rated by the teacher; m, mean; 
BRIEF, Behavior Rating Inventory of Executive Function; -P, rated by parent; BRI, Behavioral Regulation Index; 
MI, Metacognition Index; GEC, Global Executive Composition; DS-WISC-III, adapted Digit Span of the Wechsler 
Intelligence Scale for Children-III; FW, forward condition; BW condition, backward; LDT, Knox Cubes Leidse 
Diagnostische Test; Sentences, Sentences of the Wechsler Preschool and Primary Scale of Intelligence revised, 
translated in Dutch;  RAVEN, Shortened Raven Coloured Progressive Matrices; DNST, Day-Night Stroop Task; 
NA, not analysed; +, additionally controlling for correct responses; SA-DOTS-02K, Sustained Attention Dots 
task, version 02K; RT, response time; SD-RT, standard deviation response time; CGI-S, Clinical Global-Impressions 
Severity scale; CGI-I; Clinical Global Impressions-Improvement scale;r2; chi-square test; CGAS, Children’s Global 
Assessment Scale.
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Sonuga-Barke et al., 2013). Our study showed an ES of 0.28 for the total score on the 
ADHD-RS-investigator, which is in accordance with the mean ES of 0.24 for cognitive 
training as reported by probably blinded raters in a meta-analysis on non-pharmacological 
treatment studies in children with ADHD (Sonuga-Barke et al., 2013). 
Despite the robust trial design, this study had some limitations. First, the CWMT placebo 
condition has been criticized in that it does not match with the intensity of parents’ support 
of the active condition. Although the placebo condition is designed to be as long and 
intense as the active condition, due to a stable difﬁculty level along with improvement in 
training skills, training is less challenging and training time per session is shorter in the 
placebo condition than in the active condition. This possibly inﬂuenced the quality of 
PLG-endpoint n time effect group effect test Cohen’s d
NAP 24-20 NAP NAP NAP NAP
2 (9.5)
3(14.3)
15 (71.4)
1 (4.8)
25 -21 NAP - r2 test NAP 
53.2 ± 9.3 26-21 t(44) = 4.593*** t(44) = -0.658 ANCOVA 0.38
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interaction with the parent and involvement of the coach during training negatively (Chacko 
et al., 2013). In line with the concern by Chacko and colleagues, compliance in the current 
study was found to be different between groups, since 87.5% of the children who did not 
complete the training were in the PLG. Comparison between children who did and did not 
complete the training showed a group difference in favor of the completers’ group. The 
impact of these ﬁndings would be more relevant if treatment effects had been found in this 
study. Second, although the coach was able to encourage parents and child, motivation and 
support of parents and child in this study - in contrast to CWMT in clinical practice – could 
not be based on individual training results because the coach was blinded to group 
assignment (due to the triple-blind design). Furthermore, treatment outcome studies in 
youth with ADHD have shown that support and motivation may improve parent reports of 
ADHD symptoms (Sonuga-Barke, Daley, Thompson, Laver-Bradbury & Weeks, 2001), 
suggesting a need to work in partnership with the family. Third, since our study showed 
time effects independent of group assignment, inclusion of a passive control condition (i.e., 
a waiting list group) might have differentiated between non-speciﬁc training effects and 
learning effects. Fourth, the sample was smaller in size than planned, due to recruitment 
difﬁculties, leading to an elevated chance for making a type-II error. The fact that the 
95%-CIs of the b-values were centred around zero (see Figure 1, appendix), supported an 
actual lack of difference between groups rather than a type-II error. Furthermore, imputation 
was necessary to deal with missing data. Due to the sample characteristics, current ﬁndings 
should not be presumed to be applicable to races other than Caucasian, other age-ranges 
than 5-7 years, or children with IQs lower than 80. 
There are several possible explanations for the lack of transfer effects of CWMT to ADHD 
symptoms and global functioning. First, weekly call-contact between therapist and parents 
in CWMT may be insufﬁcient to keep parents active and involved. Second, coaching based 
on training results -equal to coaching in clinical practice- might already enlarge the possible 
efﬁcacy. Third, CWMT training can be seen as an intensive but rather short intervention. A 
much longer training period may be more effective. This may however have other trade-off 
effects, such as lower feasibility, less compliance, and larger drop-out percentage, and may 
induce side-effects as well, such as fatigue. Fourth, an active transfer component might be 
further created if WM and EF exercises are implemented in daily life.  Practising in real life 
situations during meal times, leisure activities, etc. might be a decisive factor regarding 
efﬁcacy. Another explanation is that an intervention that improves a single EF component 
such as WM may be too limited to lead to meaningful reductions of behavioral symptoms. 
In this way, CWMT is possibly too much a stand-alone intervention. Probably a broader set 
of EFs, such as inhibition, set shifting, and WM, should be addressed. Yet another possibility 
is that WM deﬁcits are not part of the causal pathway to ADHD symptoms. Rather, WM 
deﬁcits may be associated with ADHD as a form of ‘cognitive comorbidity’. Moreover, it has 
been suggested that CWMT would be more accurately classiﬁed as a short-term memory 
training (Gibson et al., 2011; Shipstead et al., 2012; Rapport et al., 2013) than a WMT. The 
149Working memory training in children with ADHD
claim of CMWT is that improving the targeted memory functioning would lead to 
improvement regarding the academic, behavioral, and cognitive beneﬁts. However, the 
speciﬁc targeted memory is not clear-cut the most impaired executive function in ADHD 
(Rapport et al., 2013). 
This study provides clinical implications by casting doubts on claims that CWMT is an 
effective treatment in young children with ADHD. We were able to provide support for the 
hypothesis that changes can be brought in aspects of WM in children as young as 5-7 year 
old, but unable to support the hypothesis that changes in trained measures can affect 
untrained measures. Future studies might consider a more speciﬁc (i.e., coaching based on 
training results) and active role for the coach (e.g. weekly face-to-face contacts), with the 
consequence that the coach should be unblinded and should focus on better understanding 
of affected components and the neural bases of WM to optimize the possible effects of this 
training. This recommendation is based on the general concerns about enabling transfer 
effects in cognitive training programs (Shipstead et al., 2012; Chacko et al., 2013; 
Melby-Lervag & Hulme, 2013), and although some studies showed neural indices for WMT 
(Olesen, Westerberg & Klingberg, 2004; McNab et al., 2009; Takeuchi et al., 2011), a speciﬁc 
neural mechanism underlying WMT and transfer effects has not yet been indicated 
(Buschkuehl, Jaeggi & Jonides, 2012).
Key Points
% So far, reviews and meta-analyses did not prove WMT to be a well-established treatment 
for children with ADHD. 
% The present study failed to support robust beneﬁt of CWMT on behavioral, neurocognitive, 
and global clinical functioning in young children with ADHD, i.e., no transfer effect was 
found. 
% Guidance regarding CWMT as a treatment for children with ADHD must be in line with 
these ﬁndings.
% Future research might focus on discovering a speciﬁc neural mechanism underlying WMT 
and transfer effects. 
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Appendix
Methods
Behavior Rating Inventory of Executive Function (BRIEF)
The Dutch BRIEF consists of 75 items. Each item pertains to speciﬁc everyday behavior, 
relevant to executive functioning of which 72 comprise the eight clinical scales. The 
remaining items comprise (among others) two validity scales ‘Negativity’ (the extent to 
which the respondent answers selected BRIEF items in an unusually negative manner 
relative to clinical samples) and ‘Inconsistency’ (the extent to which the respondent answers 
similar BRIEF items in an inconsistent manner relative to the clinical samples, a measure of 
validity). The items of the BRIEF are categorized into eight clinical scales: ‘Inhibit’, ‘Shift’, 
‘Emotional Control’, ‘Initiate’, ‘Working Memory’, ‘Plan/Organize’, ‘Organization of Materials’, 
and ‘Monitor’. Two composite scores can be obtained based on these eight scales: Behavior 
Regulation Index (BRI) based on the ﬁrst three and the Metacognition Index (MI) based on 
the latter four scales. BRI and MI form the summary score Global Executive Composite 
(GEC). In case the inconsistency score was acceptable, the BRI, MI, and GEC scales were the 
variables of interest.
Adapted Digit Span from the Wechsler Intelligence Scale for Children-III 
(DS-WISC-III)
This task required the child to repeat strings of words, i.e., concrete unrelated nouns, which 
were read aloud. In the forward condition (FW), this repetition should be in similar order, in 
the backward condition (BW) in reversed order. The maximum presented sequence-length 
depended on the number of correctly repeated sequences. For each block, 2 trials of each 
sequence-length (two-six words) were presented until two repeatedly incorrect sequences 
of the same length occurred, with a maximum of 10 presented trials per condition. The total 
number of correctly recalled words the child repeated in FW and BW order were the variables 
of interest.
Knox Cubes Leidse Diagnostische Test (LDT)
In this task the child had to repeat a series of ticking blocks in FW and BW order. First, after 
having watched the instructor ticking series of blocks, series should be repeated in FW 
order. The second part of the task required BW repeating. Preceding the task, two 2-series 
practice trials were offered on which the child was not scored. The actual task started with 
one 2-series trial, followed by four 3-series, four 4-series, and three 5-series. The task 
ﬁnished when the child repeated three sequences erroneously or after the last presented 
trial. The total number of correctly FW and BW repeated taps were the variables of interest.
151Working memory training in children with ADHD
Sentences from the WPPSI-R NL (Sentences)
Sentences with variable length of 2-19 words were read aloud by the instructor and had to 
be repeated by the child. Maximum possible score varied with length from one to ﬁve points 
per sentence. Individual score was acquired by subtracting the number of errors (i.e., 
omission of a word, interchange of words, substitution by a new word, addition of a new 
word) from the maximum score. The sum score of all sentences was the variable of interest.
Shortened Raven Coloured Progressive Matrices (RAVEN)
Thirty-six items of the RAVEN were presented in three sets (A, Ab, B); 12 items per set. Each 
of the set of items started with a problem and ascended in order of the difﬁculty by building 
on the argument of what was done before. This ascending order of the difﬁculty approach 
provided the respondent with ﬁve opportunities to become familiar with the frame and 
method of thought required to solve the problems. The variable of interest was the total 
number of problems solved.
Day-Night Stroop task (DNST)
This task was programmed and presented using Presentation software (Neurobehavioral 
Systems, Inc).  DNST was administered in two blocks of trials; a control and conﬂict block. 
Each block contained 16 randomly ordered and even pictures of a sun and a moon. In the 
ﬁrst block, congruent responses were required; hence the child had to say day when a sun 
was depicted and night when a moon was depicted. In the second block, incongruent 
responses were required, saying night to the sun-picture and day to the moon-picture. 
Instructions were given while the appropriate pictures were presented on the screen. 
Understanding of the instructions was monitored by asking the child to correctly respond 
to the two possible pictures. It was explicitly mentioned that the word should be pronounced 
correctly to avoid a mixture of the answers. If such a mixture did occur, it was counted 
incorrect. If an immediate self-correction was made after an error, the picture response was 
counted correct, but also as a self-correction. The variable of interest was completion time 
of the congruent condition minus that of the incongruent condition, while controlling for 
the amount of correct responses on the incongruent condition.
Sustained Attention Dots task (SA-DOTS, version 02K)
This task consists of a series of 240 valid trials. On the computer screen a house with three 
windows was continuously presented. On each trial a yellow bee, blue bird, or purple 
butterﬂy was presented in one of windows in a random order. The child had to respond yes 
if a bee picture was presented, and no if a bird or butterﬂy picture was presented. Because 
of balanced presentations of the animal presentations, a ‘no’-response (bird or butterﬂy 
picture) was required twice as often as a ‘yes’-response (bee picture). The child was told to 
press the ‘yes’-button when a bee was displayed in one of the windows and the ‘no’-button 
when he or she saw another animal. In case of an error, the computer generated a beep 
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signal. Because of the variable response latencies, the task was self-paced. The variables of 
interest were the mean and ﬂuctuation of reaction time (RT and SD-RT, respectively) on hits 
while controlling for the amount of hits.
 
Shape School
The Shape School was modiﬁed into a computerized version. This task was programmed and 
presented using Presentation software (Neurobehavioral Systems, Inc). It consists of four 
blocks; the ﬁrst block is a control condition in which the child had to push the button (a red 
right button or yellow left button) of the color of the ﬁgure (red or yellow) that appeared 
on the screen. Second, in the inhibition condition; the child had to respond by pushing the 
button of the correct color only when the ﬁgure looked happy, and had to suppress this 
response when the ﬁgure looked sad. Third, in the switch condition; the child had to respond 
to the color of the ﬁgure, but when the ﬁgure wears a hat, the child had to push the button 
of the contrasting color. In the last condition, both inhibiting and switching had to be 
applied. Only this ‘both’ condition was used for analyses. Variables were derived from the 
output log-ﬁles by using Matlab 2012a (The MathWorks, Inc., Natrick, MA). The variables of 
interest were the mean RT and SD-RT on correct trials while controlling for the number of 
correct responses, the total number of correct inhibitions, and the total amount of omissions 
in both the control and switch condition. 
Results
Behavioral functioning outcomes
Despite randomization, the WMG was signiﬁcantly more affected on two variables of 
interest at baseline (i.e., ADHD-RS-INV total score [p = .037] and ADHD-RS-T subscale 
hyperactive/impulsive [p = .049]). 
ADHD-RS-INV. Three outliers were removed to reach a normal distribution. Homogeneity of 
variance was violated in the inattention subscale (p = .026). Therefore, this subscale was 
tested non-parametrically. For the other subscales, ANCOVAs were performed. 4.6% of the 
data were imputed at baseline and at endpoint. There were no treatment effects (i.e., 
differences between groups) for any of the ADHD-RS-INV subscales (total: t(41) = -0.237, 
p = .813; inattentive: p = .380; hyperactive/impulsive: t(41) = -0.655, p = .512)
ADHD-RS-T. Two outliers were removed to reach normality. ANCOVAs were performed on all 
subscales after imputation of 15.6% of the data at baseline and 20.0% at endpoint. No 
treatment effects on any of the ADHD-RS-T subscales were found (total: t(45) = -0.398, 
p = .691; inattentive: t(42) = 0.318, p = .750; hyperactive/impulsive: t(42) = -1.175, p = .240).
BRIEF-P. No outliers were removed. Data from one child were removed due to an 
unacceptable inconsistency scale. Data from four children at baseline and ﬁve at endpoint 
contained high negativity scores. At endpoint, ANCOVAs were performed on all subscales 
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after imputation of 13.0% of the data at baseline and 26.1% at endpoint. No differences 
between groups for any of the BRIEF-P composite scores or total score were found (BRI: 
t(43) = 0.553, p = .581; MI: t(43) = -0.617, p = .537; GEC:  t(43) = -0.307,  p = .759).
BRIEF-T. No outliers were removed. Data from 3 children were removed due to an 
unacceptable inconsistency scale. Data from 1 child at baseline contained high negativity 
scores. At endpoint, ANCOVAs were performed on all subscales after imputation of 17.4% 
of the data at baseline and 32.6% at endpoint. No treatment effects on any of the BRIEF-T 
composite scores or total score were found (BRI: t(43) = -0.095, p = .924; MI: p = .613; GEC: 
t(43) = 0.256,  p = .798).
Neurocognitive functioning outcomes
Despite randomization, two signiﬁcant differences between groups were found on the 
variables of interest at baseline (i.e., LDT-FW (p = .027), SA-DOTS-O2K SD-RT (p = .024). 
DS-WISC-III. After removal of four outliers, data remained skewed. No data were missing. 
Differences between groups were analyzed non-parametrically. A signiﬁcant difference in 
favor of the WMG was found on the BW condition (p = .041), which did not remain 
signiﬁcant after multiple comparisons correction. No signiﬁcant differences were found 
between the groups on the FW condition (p = .980). 
LDT. Normality was still violated after removal of two outliers. Therefore, non-parametric 
tests were performed, without the two outliers. There were no data missing.  For both 
conditions, no differences between groups were detected in the amount of correctly 
repeated tapping of the blocks (FW: p = .898; BW: p = 1.00).
Sentences. There were no outliers and 2.1% of the data were imputed at baseline. ANCOVAs 
were performed. The groups did not differ from each other on the correctly repeated 
sentences score (t(44) = 0.800,  p = .424)
RAVEN. No outliers were removed and no data were missing. An ANCOVA showed no 
difference between the two groups on the total score (t(44) = -0.106, p = .916)
DNST. Four outliers were removed to reach normality. 4.7% of the data at baseline and 2.3% 
at endpoint were imputed. Afterwards, an ANCOVA was performed. The difference in RT 
between the switch and control condition while controlling for the amount of correct 
answers did not differ between groups (t(39) = 1.399, p = .162)
SA-DOTS-O2K. Three outliers were removed. Data were imputed for 2.3% at endpoint. 
ANCOVAs were performed while controlling for hits and showed no differences between 
groups (RT: t(40) = -0.288, p = .773; SD-RT: t(40) = 0.136, p = .892)
Shape School. One outlier was removed to reach normality. Data from four children at 
baseline and ﬁve children at endpoint were missing. Imputation was not possible due to 
non-random missing values of children with no correct responses (RT’s and SD-RT’s 
missing) or one correct response (SD-RT’s missing) to all 3 stimuli of a certain trial-type (24 
stimuli, 8 trial-types). ANCOVAs were performed despite the small variable sample size. 
There were no differences between groups (Control condition –red– RT: t(35) = 0.018, 
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p = .986; SD-RT: t(31)= -0.976, p = .337; –yellow– RT: t(33) = 0.203, p = .840; SD-RT: t(24) 
= -0.738, p = .468. Switch condition –red– RT: t(29) = -0.679, p = .502; –yellow– RT: t(21) 
= 1.581, p = .129) barring two marginal signiﬁcant differences in the switch condition; one 
in favor of WMG (red SD-RT: t(30) = -1.179, p = .248) and one in favor of PLG (yellow SD-RT: 
t(24) = -1.803, p = .084).
Due to a leftward skewed distribution and the small remaining sample, the Reliable Change 
Index was calculated (including the outliers) for the number of omissions and correct 
inhibitions. The change in amount of control and switch stimuli that was omitted and 
correctly inhibited before and after training was not clearly different between groups. See, 
table 1 of this appendix for statistical details.
Global clinical functioning outcomes
As expected due to randomization, no signiﬁcant differences between groups were found 
on the variables of interest at baseline.
CGI-I. Four percent from the WMG and 9.5% from the PLG were rated as ‘much improved’; 
44.0% in the WMG and 14.3% in the PLG were rated as ‘minimally improved’, and 48.0% in 
the WMG and 71.4% in the PLG were rated as ‘unchanged’ at endpoint. 4.0% from the WMG 
and 4.8% from the PLG was rated as ‘minimally worse’. The difference between the groups 
was not signiﬁcant (r2-test, p = .124). None of the children showed clear deterioration.
CGAS. No outliers were removed and no data were missing. An ANCOVA was performed. 
The score on the CGAS did not signiﬁcantly differ between the two groups (t(44) = -0.658, 
p = .514).
Table 1   Amount and percentage reliable improvement and deterioration per group on 
the Shape School task, according to the Reliable Change Index
improvement, n (%) deterioration, n (%)
WMG PLG WMG PLG
inhibition
control red
control yellow
switch red
switch yellow
3/23 (13.0) 1/17 (5.9) 4/23 (17.4) 0/17 (0)
5/23 (21.7) 3/17 (17.6) 3/23 (13.0) 3/17 (17.6)
1/24 (4.2) 2/17 (11.8) 5/24 (20.8) 2/17 (11.8)
1/24 (4.2) 3/17 (17.6) 4/24 (16.7) 4/17 (23.5)
omission
control red
control yellow
switch red
switch yellow
1/24 (4.2) 2/17 (11.8) 0 (0) 2/17 (11.8)
3/24 (12.5) 3/17 (17.6) 0 (0) 1/17 (5.9)
6/24 (25) 4/17 (23.5) 1/24 (4.2) 2/17 (11.8)
2/24 (8.3) 3/17 (17.6) 1/24 (4.2) 1/17 (5.9)
Abbreviations: n, number; WMG, working memory group; PLG, placebo group.
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Figure 1 95% conﬁdence intervals of the b-values for each parameter for which an 
ANCOVA could be performed; i.e., parametric assumptions were valid. A positive value 
indicates an effect for the working memory group, a negative value an effect for the 
placebo group. Note that values of which lowering is hypothesized to be an improvement 
are indicated with an arrow ( ).
* additionally controlling for correct responses.
Abbreviations: ANCOVA, analysis of the covariance; PLG, placebo group; WMG, working memory group; ADHD-RS, 
attention-deﬁcit/hyperactivity disorder Rating Scale IV; -INV, rated by the investigator; -T, rated by the teacher; 
Sx, symptoms; hyperact./imp., hyperactive/impulsive; CGAS, Children’s Global Assessment Scale; BRIEF, Behavior 
Rating Inventory of Executive Function; -P, rated by parents; BRI, Behavioral Regulation Index; MI, Metacognition 
Index; GEC, Global Executive Composition; Sentences, Sentences of the Wechsler Preschool and Primary Scale of 
Intelligence revised, translated in Dutch; RAVEN, Shortened Raven Coloured Progressive Matrices; DNST, 
Day-Night Stroop Task, SA-DOTS-02K, Sustained Attention Dots task, version 02K; RT, response time; SD-RT, 
standard deviation response time.
-8    -7    -6    -5    -4    -3     -2    -1     0       1     2      3     4       5     6     7     8 
ADHD-RS-INV
    total Sx (-4.205-3.298)          .813
    hyperact./imp. Sx (-2.925-1.459)           .512
ADHD-RS-T
    total Sx (-5.720-3.789)          .691
    inattentive Sx (-2.643-3.665)         .750
    hyperact./imp. Sx (-4.497-1.126)            .240
CGAS (-5.217-2.650)             .514
BRIEF-P
    BRI (-3.168-5.646)          .581
    MI (-7.524-3.922)           .537
    GEC (-8.966-6.537)              .759
BRIEF-T
    BRI (-5.710-5.183)              .924
    GEC (-10.514-13.667)              .798
Sentences (-1.124-2.675)              .424 
RAVEN (-2.267-2.040)              .916 
DNST (-1.156-6.925)              .162  
SA-DOTS-O2K*
    RT (-223.268-168.522)              .784
    SD-RT (-52.819-60.961)              .888 
Shape School*
  control 
    red RT (-390.819-397.643)             .98
    red SD-RT (-395.736-139.579)             .337
    yellow RT (-358.843-438.352)             .840
    yellow SD-RT (-448.346-212.203)            .468 
  switch
    red RT (-619.625-310.691)             .502
    red SD-RT (-51.422-377.647)             .129
    yellow RT (-828.443-222.004)             .248 
    yellow SD-RT (-141.042-95.081)              .084
  
PLG better WMG better  
p-value
PLG better WMG better 
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163Summary
Attention-deﬁcit/hyperactivity disorder (ADHD) affects about 5% of the children worldwide 
(Polanczyk, de Lima, Horta, Biederman & Rohde, 2007) and is associated with a high risk for 
adverse psychiatric outcomes in adult life (Biederman et al., 2006), poorer educational and 
vocational outcomes (Kuriyan et al., 2013), parental strain (Hinojosa, Hinojosa, Fernandez-
Baca, Knapp & Thompson, 2012), and elevated ﬁnancial costs by burden on health, social 
care, and justice systems in society (Pelham, Foster & Robb, 2007).
The essential feature of children with ADHD, deﬁned by the Diagnostic and Statistical 
Manual of Mental Disorders (ﬁfth ed.; DSM5; American Psychiatric Association, 2013) is a 
persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with 
adaptive functioning or development. Children presenting with these symptoms have been 
described since almost three centuries, but the nomenclature of the clustered symptoms 
has been changed over time, due to variable opinions and increased knowledge.
Despite a remarkable effort to investigate the clinical concept and to discover etiological 
factors, the underlying pathophysiology, and potential effective treatment modalities, there 
are still gaps in our knowledge about ADHD. 
To contribute to the knowledge about ADHD, this thesis addressed two important topics, 
i.e., resting-state oscillations and non-pharmacological interventions. The ﬁrst part 
of this thesis (Chapter II and III) explored resting-state oscillations in ADHD and the 
relationship between resting-state oscillations on one side and neurocognitive and 
behavioral functioning on the other side in adults and children with ADHD. The second part of 
this thesis (Chapter IV, V, and VI) comprised two RCTs in children with ADHD, investigating 
the efﬁcacy of frequency neurofeedback (F-NF) and Cogmed working memory training 
(CWMT). 
NF is a form of biofeedback targeting brain oscillations, including conventional F-NF and 
slow cortical potential-NF, and is deﬁned as a process, in which sensors are placed on the 
scalp and devices are used to monitor and provide moment-to-moment information about 
the physiological brain activity, that is fed back to the individual to improve brain functioning 
(Hammond et al., 2011). NF is hypothesized to work via operant learning, in which 
simultaneous and contingent feedback is given by positive reinforcement through visual 
and/or acoustic signals when changes in the brain oscillations are made in the desired 
direction, leading to voluntary modulation of these oscillations and controlling their 
underlying processes, thereby enhancing the self-regulation (Gevensleben, Rothenberger, 
Moll & Heinrich, 2012). 
CWMT is based on the idea that intensive training of working memory (WM) may improve 
WM, other neurocognitive functions, and ultimately diminish the core behavioral symptoms 
of ADHD. WM is the ability to temporarily hold information while simultaneously 
manipulating the information (Baddeley, 1986) and is often regarded as a fundamental 
neurocognitive function underlying other executive functions (Klingberg et al., 2005).
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Resting-state oscillations in ADHD
Chapter II
The case-control study described in this chapter was conducted 1) to investigate 
resting-state oscillations in adults with ADHD compared to healthy controls in an 
eyes-closed and eyes-open condition, and 2) to investigate the correlations between 
resting-state oscillations and performance on a neurocognitive task (a stop-signal task, 
measuring response inhibition) in both groups and the correlations between resting-state 
oscillations and the core behavioral symptoms in ADHD. The latter goal was of particularly 
interest because it was the ﬁrst study investigating neurocognitive correlations in adults. To 
address both goals, for 24 adults with the combined subtype of ADHD and 24 healthy adults 
the resting-state electroencephalogram (EEG) in both eyes-open and eyes-closed condition 
was analyzed. Subsequently, the correlation analyses were performed. Adults with ADHD 
showed a greater reduction in alpha power from eyes-closed to eyes-open (i.e., alpha 
attenuation) compared to healthy controls. Regarding the correlation with neurocognitive 
functioning, theta/beta power ratio was negatively correlated to the speed of responding to 
choice stimuli; for the ADHD group this was probably at the expense of accuracy. No 
signiﬁcant relation was found between resting-state oscillations and the core behavioral 
symptoms in adults with ADHD.
Chapter III
The study in this chapter focused on exploring whether the relationship b etween the theta/
beta power ratio and/or relative theta power on one hand and neurocognitive functioning 
and behavioral symptoms on the other hand is confounded by a low alpha peak frequency 
(APF). This focus was based on earlier work in which a lower APF was actually responsible 
for the ﬁnding of an elevated theta/beta power ratio in a subgroup of children with ADHD. 
This led to the suggestion that the most robust ﬁnding of elevated theta power in ADHD 
(incorporated in the elevated ratio) is sometimes misinterpreted because of alpha peaking 
at a lower frequency thereby leaking into the theta-band power estimation. To investigate 
the inﬂuence of the APF on correlations between theta/beta power ratio and relative theta 
power on one hand and neurocognitive and behavioral functioning on the other hand, 
resting-state EEG, neurocognitive data, and ADHD symptom scores were analyzed. For 38 
children (age between 8-15 years), resting-state oscillations data and ADHD symptom 
scores were available. Additional neurocognitive data were available for 32 children. The 
individual APF was measured by using both the eyes-open and eyes-closed resting-state 
recordings. The frequency-bands were analyzed using the eyes-open condition. A signiﬁcant 
positive relationship was found between the theta/beta power ratio and the overall ADHD 
symptom score and the hyperactive/impulsive symptom sub-score. Further, a signiﬁcant 
positive relationship between relative theta power and the hyperactive/impulsive symptom 
sub-score was found. Both relationships became stronger when controlling for the 
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individual APF. Eight out of 38 (21%) children showed a low APF (i.e., an APF of 9 Hz or 
lower), creating a supposed overlap between their individually determined alpha-band and 
the theta-band. Neurocognitive functioning did not show any relationship with the theta/
beta power ratio or relative theta power. The results of this study conﬁrmed that the theta/
beta power ratio and relative theta power indeed correlated with behavioral symptoms in 
children with ADHD and stressed the important role for individual APF in studies concerning 
electrophysiological underpinnings in ADHD.  
Non-pharmacological interventions in children with ADHD
Frequency neurofeedback
Chapter IV described a study investigating the efﬁcacy and safety of daily practice F-NF in 
children with ADHD by a double-blind, semi-randomized, and placebo-controlled study. For 
this purpose, 41 children (8-15 years) with ADHD were semi-randomly allocated to F-NF or 
placebo-NF treatment for 30 sessions, twice a week. Children were stratiﬁed by age, elec-
trophysiological state of arousal, and medication use. Everyone involved in the study, except 
the NF-therapist, was blinded to treatment assignment. Although both groups improved 
over time, this study did not ﬁnd any beneﬁt of F-NF compared to placebo-NF on the core 
behavioral symptoms in ADHD. In addition, no superior effect of F-NF was found on global 
clinical functioning. In both groups no relevant side effects were observed. The feasibility of 
this study-design by implementing a placebo-NF, in which the feedback signal was based on 
a simulated EEG signal, was satisﬁed by the ﬁnding that guessing treatment assignment 
was not better than chance level. Chapter V contained a second study in the same 
population, with the aim to detect possible efﬁcacy of F-NF on neurocognitive functioning 
and included a systematic review on this topic. In this study, a wide range of neurocognitive 
tests was administered before and after treatment, chosen to reﬂect hypothesized impaired 
neurocognitive functioning in ADHD (i.e., attention, executive functioning, reward-related 
processes and timing). Nor signiﬁcant effects in favor of F-NF on any of the neurocognitive 
variables was found by analyzing differences on group level, neither by analyzing individual 
changes. The included systematic review of the current literature also did not indicate any 
systematic beneﬁcial effect of F-NF on neurocognitive functioning. In addition, based on 
analyzing neurophysiological measures (i.e., trained EEG targets), no support for improved 
core behavioral symptoms based on improved neural regulation was found.
In sum, F-NF was not found to be superior to placebo-NF in improving the core behavioral 
symptoms of ADHD, global clinical functioning, and neurocognitive functioning in children 
with ADHD. No support was found for the neurophysiological hypothesis.
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Cogmed working memory training
Chapter VI consisted of a study investigating the efﬁcacy of CWMT on the core behavioral 
symptoms, neurocognitive, daily executive, and global clinical functioning in children with 
ADHD. A triple-blind, semi-randomized, and placebo-controlled study was conducted. For 
this purpose, 51 children (5-7 years) with ADHD were semi-randomly assigned to the active 
or placebo condition of the Cogmed JM training program for 25 sessions, ﬁve times a week. 
Children were stratiﬁed by age and gender. Everyone involved in the study was blinded to 
treatment assignment. Although children improved over time (independent on groups 
assignment), this study did not ﬁnd any beneﬁt of CWMT compared to the placebo condition 
on the core behavioral symptoms of ADHD. In addition, no superior effect was found on 
neurocognitive functioning (based on a wide battery of neurocognitive tasks), daily 
executive, and global clinical functioning. Although children in the active condition 
improved on the trained WM task, no superior effects were found on the non-trained 
measures (the so-called transfer effects). In sum, this study failed to ﬁnd evidence for 
beneﬁts of CWMT training compared to the placebo condition on the core behavioral 
symptoms of ADHD, neurocognitive, daily executive and global clinical functioning in young 
children with ADHD. In other words, no evidence for transfer effects was found. 
In the discussion (Chapter VIII) the ﬁndings of the ﬁve studies are discussed and clinical 
implications are given. These three points are regarded as the most relevant lessons from 
this thesis;
1) Resting-state oscillations may offer a great value to the knowledge about ADHD. 
However, currently, unraveling their role has not yet been ﬁnished. Alpha power and 
alpha peak frequency do merit a more prominent role in detecting the electrophysio-
logical underpinnings of ADHD. Furthermore, correlations between resting-state 
oscillations on one hand and core behavioral symptoms of ADHD and neurocognitive 
functioning on the other hand have been found; however the inconsistency of these 
ﬁndings makes ﬁrm conclusions not yet possible.
2) The studies described in this thesis regarding F-NF and CWMT in children with ADHD 
could not prove superior beneﬁt compared to the placebo condition. It is possible that 
methodological and other limitations of these studies have prevented us from ﬁnding 
speciﬁc treatment effects with large ESs comparable to those of ADHD-medication. 
However, since speciﬁc treatment effects were consistently lacking at all levels rather 
than found to be inconsistent, it is less likely that the negative ﬁndings are only due to 
limitations of the studies. Of course, future research should address these limitations 
to justify more ﬁrm conclusions about the efﬁcacy of F-NF and CWMT.
3) Regarding F-NF and CWMT, guidance to parents and their children with ADHD must be 
in line with the actual ﬁndings of current research. 
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Further, directions for future research are given. Suggestions for improvement of the 
present studies are discussed. The most relevant recommendation for future research is to 
optimize earlier study designs to enlarge the chance to detect potential speciﬁc and unique 
effects of F-NF and CWMT to justify more deﬁnitive conclusions about the true impact of 
these interventions in the treatment of children with ADHD. 
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The aim of the present thesis was two-fold. The ﬁrst aim was to investigate resting-state 
oscillations and to examine the correlations between these oscillations on one hand, and 
neurocognitive functioning and the core behavioral symptoms in attention-deﬁcit/
hyperactivity disorder (ADHD) on the other hand. The second aim was to investigate the 
efﬁcacy of two non-pharmacological interventions in children with ADHD, i.e., frequency 
neurofeedback (F-NF) and Cogmed working memory training (CWMT). Here, the ﬁndings of 
the studies will be discussed, followed by the clinical implications and directions for future 
research.
Resting-state oscillations in ADHD
Despite the bulk of research on resting-state oscillations in ADHD, the inconsistency of the 
ﬁndings complicates their interpretation. This inconsistency of resting-state ﬁndings may 
have different causes; differences between studies regarding methodological aspects, such 
as different sample characteristics (e.g., age, gender, and subtypes of ADHD) and technical 
aspects of the EEG recordings (e.g., differences in EEG registration and analysis and 
measurement, like relative and absolute power, and difference in the use of an eyes-closed 
and/or eyes-open condition). Furthermore, in studies on the correlation of resting-state 
oscillations on one hand and neurocognitive functioning and core behavioral symptoms in 
ADHD on the other hand, also the different ways of dealing with multiple testing can explain 
inconsistency. In addition, differences in neurocognitive tasks and behavioral rating scales 
may contribute to the inconsistency of the ﬁndings. Furthermore, inconsistency can also be 
based on the heterogeneity of ADHD itself. Besides, measurement over a short time interval, 
like recording resting-state oscillations, has been supposed to be more vulnerable to 
transient state effects, compared to behavioral measurements, which are based on a 
signiﬁcantly longer time period (Kendler & Neale, 2010). Another possible explanation is 
based on the idea that these oscillations may reﬂect too complicated, too basic and/or too 
far away processes, to give a clear-cut electrophysiological ﬁngerprint of the clinical and 
neurocognitive aspects of ADHD. Finally, of course a combination of these hypothesized 
causes may play a role in clarifying the inconsistency.
The ﬁrst study in this thesis (Chapter II) was designed 1) to investigate resting-state 
oscillations in adults with ADHD, compared to healthy controls, and 2) to investigate 
correlations between resting-state oscillations on one hand and performance on a 
stop-signal task (measuring response inhibition) in both groups and core behavioral 
symptoms in the ADHD group on the other hand. Given the idea that the inconsistency of 
the resting-state oscillations ﬁndings may be partially based on the different use regarding 
the eyes-open and/or an eyes-closed condition, this study analyzed the results under both 
conditions. To address the possibly inﬂuence on ﬁndings based on difference in dealing with 
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multiple testing, the alpha level of signiﬁcance was set at p = .01, two-tailed. Analyses of 
the mean absolute theta, alpha, beta power, the theta/beta power, and theta/alpha power 
ratios did not yield any signiﬁcant difference between adults with ADHD and healthy 
controls for both conditions. So, in contrast to previous ﬁndings, this study did not replicate 
the most consistent ﬁnding of elevated theta power. The ﬁnding of a large variability in the 
theta power across participants may have prevented to ﬁnd a signiﬁcant result. Further 
analyses showed a greater reduction in alpha power from eyes-closed to eyes-open (i.e., 
alpha attenuation) in ADHD compared to the healthy controls. This ﬁnding is in line with a 
recent study in children with ADHD (Fonseca, Tedrus, Bianchini & Silva, 2013) and may 
reﬂect a hypo-arousal state (in the eyes-closed condition), based on the hypothesis that 
alpha activity is associated with arousal (Barry, Clarke, Johnstone, Magee & Rushby, 2007). 
Further exploration revealed no signiﬁcant correlations between resting-state oscillations 
and the core behavioral symptoms of ADHD. However, positive signiﬁcant correlations were 
found between the theta/beta power and theta/alpha ratios on one hand and the speed of 
responding on the stop-signal task on the other hand for both groups. These correlations 
were attributed to increased impulsivity, because not only the speed, but also the error rate 
was increased in the ADHD group; a so-called speed-accuracy trade-off effect was 
hypothesized in this group. However, for the control group, a speed-accuracy trade-off was 
probably not the case (no higher error rate was found), and so for this group these ﬁndings 
could not reﬂect impulsivity. Neglecting the latter remark, the ﬁndings for the ADHD group 
together were seen as supportive to the biophysical model presented by Rowe and 
colleagues (2005), in which hypo-arousal of the cortex is caused by a tonic overdrive of the 
locus coeruleus. This leads to an increase in inhibitory activity of the thalamic reticular 
nucleus, which in turn results in increased EEG slow waves. 
Altogether, although the intention to diminish noise by analyzing both conditions and to 
deal with multiple testing, these results still indicate inconsistency of resting-state 
oscillations ﬁndings in ADHD, especially regarding the resting-state theta activity. Of course 
these ﬁndings may have been inﬂuenced by study limitations, such as a small sample, only 
reporting the absolute power, and the use of only one neurocognitive task. Correlations, 
however, between resting-state oscillations on one hand and neurocognitive functioning 
and core behavioral symptoms in ADHD on the other hand can be regarded as weak. 
The design of the second study (Chapter III) was driven by the hypothesis that a low alpha 
peak frequency (APF) may inﬂuence the estimation of the most robust ﬁnding of an elevated 
theta power (incorporated in the theta/beta power ratio) in ADHD (Arns, Conners & Kraemer, 
2012), thereby inﬂuencing the relationship between this ﬁnding and neurocognitive 
functioning and the core behavioral symptoms. The hypothesis that a low APF can lead to 
misinterpretation of theta power was proposed in earlier work; the study by Lansbergen and 
colleagues (2011a) showed a difference in the theta/beta power ratio between children with 
ADHD and healthy controls when using ﬁxed frequency-bands, while this difference was 
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absent when the APF was used to determine individual frequency-bands, due to a lower 
individual APF in a subgroup of the sample. Our hypotheses were 1) theta and the theta/
beta power ratio are positively related to impaired neurocognitive functioning and the core 
behavioral symptoms of ADHD, and 2) a low APF inﬂuences these relationships by showing 
an overlap between alpha-band based on APF and the ﬁxed theta-band, thereby falsely 
overestimating theta. As expected, a positive relationship was found between the theta/
beta power ratio and the total symptom score and hyperactive/impulsive symptom 
sub-score. In addition, also expected, a positive relationship was found between relative 
theta and hyperactive/impulsive symptoms. Twenty-one percent of the children in our 
study showed an overlap between the alpha-band based on APF and the ﬁxed theta-band. 
All relationships between theta and the theta/beta power ratio, and core symptoms of 
ADHD became stronger when controlling for APF. In addition, the relationship between 
theta and total symptom score after controlling for APF changed from non-signiﬁcant to a 
strong signiﬁcant correlation. Based on the study by Lansbergen and colleagues (2011a), 
the direction of the inﬂuence of the individual APF in this study was not expected. 
Lansbergen and colleagues (2011a) found that a dichotomous difference between ADHD 
and controls was absent regarding the theta/beta power ratio when taking into account the 
individual APF. To come to this conclusion, the theta frequency-band in that study was 
determined using APF as anchor point. A shift of individual APF, however, does not 
necessarily imply a proportional shift of the other frequency-bands, among them the 
theta-band. Application of this method may have resulted in an underestimation of theta 
power since not the entire theta-band would be covered by this new determined band. 
Although those results illustrated that the individual APFs differ enough from 10 Hertz (Hz) 
to shift the bands away from the dichotomous difference, the results did not necessarily 
imply an actual lack of the dichotomous difference from the ‘true’ theta- and beta-band. 
The current study aimed at unraveling the inﬂuence of the APF-based alpha-band on the 
ﬁxed theta-band of 4-8 Hz. By using a ﬁxed theta-band comparable to the majority of 
previous studies (Arns et al., 2012), and an alpha-band based on APF comparable to 
Lansbergen and colleagues (2011a), we were able to show that the relationship between the 
conventional theta and the theta/beta power ratio, and core symptoms of ADHD became 
stronger when controlling for APF rather than eliminated. In contrast to our hypothesis, 
neurocognitive performance did not show any relationship with theta and the theta/beta 
power ratio. The fact that this study could not conﬁrm the hypothesis for neurocognitive 
functioning may have different causes. One cause may be the neurocognitive heterogeneity 
found in ADHD (Nigg, 2005). Another is the vulnerability of both the neurocognitive as well 
as the EEG measurements for transient state effects due to the short duration of the 
measurements, compared to the behavioral measurement, which is based on a signiﬁcantly 
longer time period (Kendler & Neale, 2010). Finally, interpretation of the ﬁndings should 
take into account the study limitations. First, the sample size and so the statistical power 
was small, and also made analyses of neurocognitive subtypes as suggested in the literature 
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not feasible. Second, the majority of the children in our sample used medication also during 
the assessment; yet, all children displayed symptoms in the clinical range, meaning that 
medication-use did not diminish ADHD-symptoms sufﬁciently. Third, the a-priori and 
conscious choice (based on previous studies as well as on our pilot-analysis) to include a 
limited number of electrophysiological variables, restricted the analyses to one electrode, 
enlarging the potential inﬂuence of noise and not allowing for topographical localization of 
the measures. Despite these limitations, this study supported the hypothesized inﬂuence of 
APF in ADHD.
Non-pharmacological interventions in children with ADHD
Most child and adolescent mental health specialists agree that new evidence-based 
non-pharmacological treatment modalities are needed for children with ADHD. This 
agreement may be based on different arguments, related to limitations of the ﬁrst-line 
treatment medication, and/or to the need to provide an alternative treatment. For parents 
and the older child, the same arguments may be true. However, until now, not one non-phar-
macological treatment modality has proven to be sufﬁcient efﬁcacious to claim an 
important role in the treatment of ADHD. Even, the beneﬁt of behavioral therapy as an 
add-on modality above medication is only proven (MTA Cooperative Group, 1999b, 1999a) 
and advised in a minority of children with ADHD (Taylor et al., 2004; Landelijke Stuurgroep 
Multidisciplinaire Richtlijnontwikkeling in de GGZ, 2005; National Institute of Mental Health 
[NIMH], 2009). Nevertheless, the rise of non-pharmacological interventions is signiﬁcant 
and often so the claim for their efﬁcacy (distributed by social media, newspapers and 
magazines), causing parents, children, and often even health insurance companies to 
believe in these treatments, although they have not yet been proven to be effective and 
safe. Based on the grounded general agreement about the need for new evidence-based 
interventions and the potential harmfulness and unnecessary costs of widely administered 
non-evidence based treatments for children with ADHD, we felt encouraged to investigate 
the efﬁcacy and the safety of two non-pharmacological treatments options, i.e., F-NF and 
CWMT.
Frequency neurofeedback
By now, quite many randomized controlled trials, reviews, and two meta-analyses 
concerning the efﬁcacy of NF in children, have been published. However, the question about 
its efﬁcacy has still been unanswered; the three randomized placebo controlled trials did 
not ﬁnd a superior effect of F-NF over placebo-NF on the core behavioral symptoms of 
ADHD (Perreau-Linck, Lessard, Levesque & Beauregard, 2010; Lansbergen, van Dongen-
Boomsma, Buitelaar & Slaats-Willemse, 2011b; Arnold et al., 2012). This conclusion was in 
line with the most recent systematic review/meta-analysis on randomised controlled trials 
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of non-pharmacological interventions in children with ADHD. Analyses of probably 
unblinded ratings for NF in children with ADHD showed an effect size (ES) of 0.29 (p = .07) 
(Sonuga-Barke et al., 2013). Furthermore, neurophysiological evidence that NF improves 
neural regulation and subsequently signiﬁcantly affects behavioral outcome, has sparsely 
been investigated. The study in this thesis (described in Chapter IV and V) could not prove 
superior efﬁcacy compared to the placebo condition on core behavioral symptoms, 
neurocognitive, and global clinical functioning in children with ADHD by using a double-blind, 
semi-randomized, placebo-controlled treatment design investigating daily practice 
personalized F-NF. In addition, analyses on the trained EEG-targets for children in the NF 
group across the sessions, did not ﬁnd support for increased neural regulation after F-NF. 
Furthermore, analyzing these targets for the clinical responders only, no support for 
improved core behavioral symptoms due to improved neural regulation was found. No 
adverse side effects were found, indicating F-NF to be at least a safe intervention. A major 
limitation of this study was the small sample size. Furthermore, the implementation of 
mental learning strategies and the change from automatically into manually thresholds 
after the pilot period could only be of beneﬁt for an even smaller sample. Taking into 
account these study limitations, a ﬁrm conclusion that daily clinical practice F-NF as 
performed widely in The Netherlands does not bring any beneﬁt to children with ADHD is 
not appropriate. Nevertheless, this study adds serious doubts about the efﬁcacy of F-NF, 
strengthened by similar negative ﬁndings (meaning no speciﬁc treatment effects were 
found) of the three other published placebo-controlled studies and the most recent 
systematic review/meta-analysis (including F-NF as well as SCP-neurofeedback) 
(Perreau-Linck et al., 2010; Lansbergen et al., 2011b; Arnold et al., 2012; Sonuga-Barke et al., 
2013). Interestingly, although no superior effects of F-NF were found compared to the 
placebo condition, all placebo-controlled studies (including our studies) did ﬁnd 
improvement over time on the core behavioral symptoms of ADHD in the active as well as 
the placebo condition. 
There are two possible explanations for the negative ﬁndings on efﬁcacy of F-NF; 
1) There is in reality no effect, so the null-hypothesis is correctly conserved. This would 
implicate that the originally idea that regulating, whether it is improving, normalizing 
or rather controlling resting-state oscillations can lead to improvement on behavioral 
and/or neurocognitive level in children with ADHD has proven to be incorrectly. The 
time effects found are then purely based on non-speciﬁc treatment and/or placebo 
effects. 
2) Actually there is an effect, so the null-hypothesis is incorrectly conserved. In this case, 
methodological (e.g., too small sample) and/or other shortcomings create a type-II 
error. This suggests that characteristics of the performed studies have prevented to 
ﬁnd an effect that in reality did exist. 
In my opinion, to come to more deﬁnitive conclusions about whether or not F-NF is an 
efﬁcacious treatment modality in children with ADHD, future studies should address all the 
178
Ch
ap
te
r 
VI
II
following aspects. First, a larger sample is necessary to overcome the power-discussion. 
Second, the operant learning principles may be expanded by the development of a paradigm 
in which instructions are clearly goal-directed and in which the child is encouraged to actively 
attempt to reach a certain ‘brain-state’. Third, more and better attempts to facilitate potential 
transfer effects are necessary. Furthermore, future studies should answer the key question 
whether there is supporting evidence, i.e., neurophysiological background, for a speciﬁc effect 
of F-NF. This can be reached by a similar method used in our study on a larger sample (i.e., 
analyzing EEG-targets during the sessions and correlations between these neurophysiological 
measures and behavioral outcome measures). Knowledge derived by neurofeedback studies 
with a more experimental set-up, such as tomographic NF (tNF) (Liechti et al., 2012), 
 magnetoencephalographic NF (MEG-NF) (Foldes, Vinjamuri, Wang, Weber & Collinger, 2011), 
and real-time functional magnetic resonance imaging NF (fMRI-NF) (Weiskopf, 2012; Sulzer 
et al., 2013) may help to further unravel the neurophysiological background. 
If these improved future studies don’t bear speciﬁc treatment effects on a proven neuro-
physiological background, other effects must be ascribed to non-speciﬁc treatment and/or 
placebo effects. It would then be of valuable interest to know the background of these 
potential non-speciﬁc treatment effects. Implementing a third (next to an active and 
placebo condition), passive control condition would enable to further unravel the potential 
non-speciﬁc treatment effects like learning and expectancy effects. If a learning effect, like 
enhanced self-control clariﬁes (partially) the found time effects, it would offer great 
opportunities to develop new treatment modalities without the intermediate role of an EEG. 
Cogmed working memory training
In recent years the amount of studies investigating the efﬁcacy of cognitive training 
programs with among them WMT has been rising. In addition, a number of valuable reviews 
and meta-analyses have now been published. Focusing on cognitive training literature in 
ADHD children, including WMT, one systematic review/meta-analysis reported an ES of 0.24 
(p = .34) for studies using probably blinded assessments, leading to the conclusion that 
efﬁcacy of cognitive training cannot be stated until blinded studies will demonstrate 
efﬁcacy (Sonuga-Barke et al., 2013). In addition, another meta-analytic review on non-phar-
macological interventions concerning children with ADHD concluded that WMT did not 
result in greater improvement compared to the control condition (Hodgson, Hutchinson & 
Denson, 2012). Furthermore, a meta-analytic review and a review on WM programs 
seriously question the efﬁcacy of WMT mainly due to insufﬁcient evidence about 
generalization to non-trained skills, i.e., evidence for transfer effects (Shipstead, Redick & 
Engle, 2012; Melby-Lervag & Hulme, 2013). Transfer effects refer to improvements on 
trained WM-tasks leading to improvement on non-trained WM tasks (near-transfer effects), 
other neurocognitive functioning, and behavioral functioning (far transfer effects). 
Concerns about transfer effects were further expressed by a recent meta-analysis on 
 training-modalities targeting neurocognitive functioning in children with ADHD because 
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CWMT was associated with moderate near transfer effects only (d = 0.63), so no far transfer 
effects were found (Rapport, Orban, Koﬂer & Friedman, 2013). The review by Chacko and 
colleagues (2013) focused exclusively on CWMT in children with ADHD and children with an 
elevated ADHD symptom-score. In this review, reasonable critical concerns are outlined, like 
the inconsistent ﬁndings within and between studies, the weak evidence for the hypothesized 
underlying working mechanism, the questionable quality of the placebo condition and the 
differences between the sample characteristics. Future directions were mainly based on 
these concerns, and consisted of the recommendations to investigate CWMT in a more 
heterogeneous and so more clinical sample, with a smaller and lower age range with 
broadening outcome measures referring functional impairment.
The study in this thesis (Chapter VI) addressed all the directions, discussed by Chacko and 
colleagues (2013). This study found improvement on the trained visuospatial WM 
represented by a signiﬁcant improvement on the training in the active condition, however a 
near-transfer effect was not maintained after correcting for multiple testing and far-transfer 
effects were absent at all. No side effects were found (measured, but not reported). So, the 
hypothesis that changes in the adaptability of (some aspects of) WM may already be able in 
the pre-school developmental period (Carlson, 2005) was supported by improvement on 
the trained tasks, however, it was not supported by transfer to non-trained WM measures. 
Although addressing the earlier mentioned directions, this study also had some limitations. 
First of all, the sample size was smaller than planned. However, taking into account that the 
95%-CIs of the b-values were all centered around zero, an actual lack of efﬁcacy in favor 
of the active condition is more likely than a type-II error. The second limitation is the 
absence of feedback on the individual training performance of the child. In order to maintain 
triple-blindness, but in contrast to training applied in clinical setting, the therapist was 
blinded to the training progress of the child. Therefore, coaching based on personal training 
results was lacking. Personal feedback may be a prerequisite to challenge past performances 
and keep the child motivated to improve WM capacity. Therefore, this study might leave out 
an important aspect of the training efﬁcacy. 
Several factors may contribute to the lack of transfer effects in CWMT. First, CWMT training 
can be seen as an intensive but rather short intervention. A longer training period may be 
more effective. This may however have other undesirable effects, such as lower feasibility, 
less compliance, and a larger drop-out percentage and may induce side effects as well, such 
as fatigue (in case the frequency is kept the same) or loss of motivation. Second, the weekly 
call between therapist and parents may be insufﬁcient to keep parents and child motivated. 
Third, implementation of WM exercises in daily life might be crucial to facilitate potential 
transfer effects. Fourth, it might be insufﬁcient to train a single executive function (EF) 
component, i.e., WM, to diminish behavioral symptoms. Probably a broader set of executive 
functions EFs should be addressed. Yet another possibility is that WM deﬁcits are not part 
of the causal pathway to ADHD symptoms. Rather, WM deﬁcits may be associated with 
ADHD as a form of ‘cognitive comorbidity’.
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So, the conclusion, based on this study, is that the results suggest no beneﬁt of CWMT on 
behavioral, neurocognitive, and global clinical functioning in young children with ADHD. 
Furthermore, this study supports earlier concerns about the efﬁcacy of CWMT by not 
ﬁnding any transfer effects.
Future research needs a larger study sample. Another issue that needs to be addressed in 
future research is investigating the efﬁcacy of CWMT with a more prominent, guiding role 
for the therapist. In addition, like for EEG-NF, studies should optimize the facilities to create 
potential transfer effects. Furthermore, similar to my recommendations regarding F-NF, 
further unraveling non-speciﬁc effects is necessary. This can be investigated by expanding 
our study design by implementing a third (next to an active and placebo condition) passive 
control condition. In case of a signiﬁcant learning effect, aspects of the offered training do 
improve core behavioral symptoms, neurocognitive, daily executive, and/or global clinical 
functioning. This can guide future research to develop new treatment modalities.  
Another concern is the actual lack of a speciﬁc neural mechanism underlying WMT and 
transfer effects that would ﬁt within one single framework (Buschkuehl, Jaeggi & Jonides, 
2012). Further research should focus on the potential neural correlates of WMT. 
Conclusions
1) Resting-state oscillations may offer a great value to the knowledge about ADHD. 
However, currently, unraveling their role in ADHD has not yet been ﬁnished. Alpha 
power and alpha peak frequency do merit a more prominent role in detecting the 
 electrophysiological underpinnings of ADHD. Correlations between resting-state oscillations 
on one hand and core behavioral symptoms of ADHD and neurocognitive functioning 
on the other hand have been found, however the inconsistency of the ﬁndings makes 
ﬁrm conclusions prematurely.
2) The studies described in this thesis regarding F-NF and CWMT in children with ADHD 
could not prove superior beneﬁt compared to the placebo condition. It is possible that 
methodological and other limitations of these studies have prevented us from ﬁnding 
speciﬁc treatment effects with large ESs comparable to those of ADHD-medication. 
However, since speciﬁc treatment effects were consistently lacking at all levels rather 
than found to be inconsistent, it is less likely that the negative ﬁndings are only due to 
limitations of the studies. Of course, future research should address these limitations 
to justify more ﬁrm conclusions about the efﬁcacy of F-NF and CWMT.
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Clinical Implications
Guidance to parents and their children with ADHD regarding F-NF and CWMT must be in 
line with the actual ﬁndings; there is not yet a proven beneﬁt of any of both treatment 
options. Further, in my opinion, the currently insufﬁciently scientiﬁc backing for the efﬁcacy 
of both treatment options in children with ADHD, questions the (partially) reimbursement 
of these interventions by health insurance companies. 
Directions for Future Research
Resting-state oscillations in ADHD
1) To further diminish inconsistent ﬁndings based on noise regarding resting-state oscillations, 
future studies investigating resting-state oscillations and their neurocognitive and 
behavioral correlates should use as far as possible similar methodological (e.g., same 
sample characteristics and the same way of dealing with multiple testing) and technical 
aspects of the EEG recordings (e.g., EEG registration and analysis, reporting relative 
rather than absolute power, and measurement of the same condition; eyes-closed and/
or eyes-open).
2) To better understand the electrophysiological underpinnings of ADHD, more research 
focusing on correlation between resting-state oscillations and the core behavioral 
symptoms of ADHD and neurocognitive functioning is needed. Especially, the role of 
alpha activity must be further investigated in ADHD. Recent literature further 
suggesting an inhibitory role for alpha activity in ADHD. This suggestion should be 
used as a launching pad for future research (Mazaheri et al., 2010; ter Huurne et al., 
2013).
3) Technical innovations of EEG, such as independent component analysis may be valuable 
in strengthen the role of the EEG in ADHD (Loo & Makeig, 2012). 
4) Furthermore, other electrophysiological approaches should be applied more in ADHD 
research, like coherence analyses (Clarke et al., 2007) and event-related potentials 
(Johnstone, Barry & Clarke, 2013). 
Non-pharmacological interventions in children with ADHD
Frequency neurofeedback
1) Future studies should include a larger sample to overcome the power-discussion.
2) In future research projects, the operant learning paradigm may be expanded with a 
paradigm in which instructions are clearly goal-directed and in which the child is 
encouraged to actively attempt to reach a certain ‘brain-state’.  
3) Studies should optimize the facilities to create potential transfer effects. 
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4) Future research should focus on the question whether there is a neurophysiological 
background for F-NF that makes F-NF a valuable treatment for children with ADHD. 
This can be reached by analyzing EEG targets across the sessions and correlations 
between these neurophysiological measures and behavioral outcome measures. 
Knowledge from studies with a more experimental set-up may help to further unravel 
the neurophysiological background, like tNF (Congedo, Lubar & Joffe, 2004; Liechti et 
al., 2012), MEG-NF (Foldes et al., 2011), and fMRI-NF (Weiskopf, 2012; Sulzer et al., 
2013). 
5) Non-speciﬁc treatment effects must be further investigated. Implementing a third 
(next to an active and placebo condition), passive control condition would enable to 
further disentangle the non-speciﬁc treatment effects like learning and expectancy 
effects. If enhanced self-control clariﬁes (partially) time effects, it would offer great 
opportunities to develop new treatment modalities without the intermediate role of an 
EEG. 
6) At the same time, research on more innovative methods of NF in children with ADHD 
can be of great value in developing new treatment modalities and/or enlarging the 
knowledge about ADHD. 
Cogmed working memory training
1) Future studies should include a larger sample to overcome the power-discussion.
2) Future studies should address the potential contributing role of the therapist. A study 
should be conducted with a comparable design to our study, but than with a more 
active role for the therapist, providing a context in which it is possible to optimally 
motivate parents and children throughout the whole training. Unblinding of the 
therapist should be considered, enabling the therapist to reinforce the child depending 
on individual training results.
3) Studies should optimize the facilities to create potential transfer effects. 
4) As for F-NF and in a similar way, non-speciﬁc treatment effects should be further 
investigated. This can guide future research to develop new treatment modalities.  
5) Future research should focus on potential neural correlates of WMT in ADHD by 
performing methodological sound studies with a wide variety of neurocognitive, 
behavioral measures, as well as neuroimaging measures.
6) The concern that currently available cognitive training modalities, with among them 
WMT, may not be able to create sufﬁcient (transfer) effects, may encourage future 
research to further develop alternative cognitive based training programs for children 
with ADHD, for example expanding the training focus with other EFs rather than WM 
alone, or focusing on self-control. This latter is hypothesized to balance between 
reward-driven and cognitive control systems proposed by Rutledge, van den Bos, 
McClure & Schweitzer (2012). 
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For all above mentioned directions, a prerequisite to justify more deﬁnitive conclusions is 
the use of a sufﬁcient large sample. In my opinion, to fulﬁll this need, at least all academic 
Mental Health Institutions should have the priority to put effort in including every referred 
patient in a research project, unless the patient doesn’t ﬁt or doesn’t want to participate. 
Lastly, I want to encourage future research to develop efﬁcacious and safe non-pharma - 
cological treatment options, taking into account the expected costs and the cost-effectiveness 
of such treatments and also the accessibility and availability for the affected child and his/
her parents. Especially in this relatively economical hard time, affordable but effective 
treatments are urgently needed.
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Samenvatting
Aandachtstekortstoornis met hyperactiviteit (ADHD) komt wereldwijd bij ongeveer 5% van 
de kinderen voor en is daarmee één van de meest voorkomende neuropsychiatrische 
aandoeningen die in de kindertijd ontstaat (Polanczyk, de Lima, Horta, Biederman & Rohde, 
2007). ADHD is geassocieerd met een verhoogd risico op andere psychiatrische stoornissen 
op volwassen leeftijd (Biederman et al., 2006), lagere prestaties ten aanzien van onderwijs 
en opleiding (Kuriyan et al., 2013), een grote belasting voor ouders/verzorgers (Hinojosa, 
Hinojosa, Fernandez-Baca, Knapp & Thompson, 2012) en hoge ﬁnanciële kosten op sociaal-
maatschappelijk niveau (Pelham, Foster & Robb, 2007).
ADHD kenmerkt zich door een persisterend patroon van inattentie en/of hyperactiviteit/
impulsiviteit, dat interfereert met leeftijdsadequaat functioneren, gedeﬁnieerd door de 
“Diagnostic and Statistical Manual of Mental Disorders” (ﬁfth ed.; DSM5; American 
Psychiatric Association, 2013). Kinderen met deze symptomen worden al drie eeuwen 
beschreven, maar de naamgeving van deze symptomen samen is door de eeuwen heen 
gewijzigd door veranderde visies en toegenomen kennis.
Ondanks een opmerkelijke hoeveelheid wetenschappelijk onderzoek, zijn er nog steeds 
relevante hiaten in de kennis over ADHD. Om bij te dragen aan de kennis over ADHD, 
behandelde dit proefschrift twee belangrijke onderwerpen, namelijk hersengolven in rust 
en niet-farmacologische interventies. Het eerste deel van dit proefschrift (Hoofdstuk II 
en III) onderzocht hersengolven in rust bij ADHD en de relatie tussen hersengolven in rust 
aan de ene kant en neurocognitief en gedragsmatig functioneren aan de andere kant bij 
volwassenen en kinderen met ADHD. Het tweede deel van dit proefschrift (Hoofdstuk IV, V 
en VI) beschreef twee gerandomiseerde klinische onderzoeken bij kinderen met ADHD met 
als doel de effectiviteit van frequentie neurofeedback (F-NF) en Cogmed werkgeheugen 
training (CWMT) te onderzoeken.
NF is een vorm van biofeedback gericht op het elektro-encefalogram (EEG) en bestaat uit 
zowel conventionele F-NF als ‘slow cortical potential’-NF. NF is een methode waarbij met 
behulp van electroden op de hoofdhuid registratie plaatsvindt van de hersenactiviteit, die 
vervolgens wordt teruggekoppeld aan degene die de NF ondergaat (Hammond et al., 2011). 
De hypothese is dat NF werkt via het operante leerprincipe, waarbij terugkoppeling 
plaatsvindt door positieve bekrachtiging via visuele en/of akoestische signalen, op het 
moment dat verandering in de hersenactiviteit plaatsvindt in de gewenste richting. 
Zodoende kan vrijwillige modulatie van deze hersenactiviteit optreden, gepaard gaande met 
modulatie van onderliggende processen met als uiteindelijk doel het vergroten van de 
zelfregulatie (Gevensleben, Rothenberger, Moll & Heinrich, 2012). 
CWMT is gebaseerd op het idee dat intensieve training van het werkgeheugen mogelijk 
andere neurocognitieve functies verbetert en zo - in het geval van ADHD - de ADHD-kern-
symptomen vermindert. Het werkgeheugen is een onderdeel van het executief functioneren. 
Het omvat het vermogen informatie tijdelijk vast te houden en tegelijkertijd te bewerken 
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(Baddeley, 1986) en wordt gezien als een fundamentele neurocognitieve functie, onderliggend 
aan andere executieve functies (Klingberg et al., 2005). 
Hersengolven in rust bij ADHD
Hoofdstuk II
De ‘case-control’ studie in Hoofdstuk II richtte zich 1) op het onderzoeken van de 
hersengolven in rust bij volwassenen met ADHD vergeleken met gezonde volwassenen in 
een ogen-dicht en ogen-open conditie, en 2) op het onderzoeken van correlaties tussen 
hersengolven in rust en het presteren op een neurocognitieve taak (een ‘stop-signal task’, 
die respons inhibitie meet) in volwassenen met ADHD en gezonde volwassenen en correlaties 
tussen deze hersengolven in rust en de ADHD-kernsymptomen in volwassenen met ADHD. 
Dit tweede punt was vooral interessant omdat dit de eerste studie was die dergelijke neuro-
cognitieve correlaties bij volwassenen met ADHD onderzocht. Om deze studie uit te voeren, 
werd het EEG in rust voor 24 volwassenen met ADHD (gecombineerde subtype) en 24 
gezonde volwassenen in zowel de ogen-dicht als de ogen-open conditie geanalyseerd. 
Volwassenen met ADHD lieten een grotere afname zien van de alpha ‘power’ van de 
ogen-dicht naar de ogen-open conditie. Er werd geen signiﬁcante relatie gevonden tussen 
de hersengolven in rust en de ADHD-kernsymptomen bij volwassenen met ADHD. Voor de 
correlatie met de neurocognitieve taak bleek de theta/beta ‘power’ ratio negatief 
gecorreleerd met de responssnelheid; voor de volwassenen met ADHD ging dit waarschijnlijk 
ten koste van de nauwkeurigheid. 
Hoofdstuk III
De studie in Hoofdstuk III richtte zich op het onderzoeken van de invloed van een lage 
alpha piek frequentie (APF) op de relatie tussen de theta/beta power ratio en de relatieve 
theta power in rust enerzijds en neurocognitief en gedragsmatig functioneren anderzijds. 
Deze onderzoeks-focus ontstond naar aanleiding van eerder onderzoek waaruit bleek dat 
een lagere APF verantwoordelijk was voor de verhoogde theta/beta power ratio in een 
subgroep bij kinderen met ADHD. Dit leidde tot de suggestie dat verhoogde theta power (als 
onderdeel van de verhoogde theta/beta power ratio) als meest robuuste bevinding bij ADHD 
- als het gaat over hersengolven in rust - soms verkeerd wordt geïnterpreteerd. Dit wordt 
dan veroorzaakt door het pieken van alpha op een lagere frequentie, waardoor deze mee 
wordt genomen in de schatting van theta power. Om de invloed van de APF te onderzoeken 
op de correlaties tussen de theta/beta power ratio en de relatieve theta power enerzijds en 
neurocognitief en gedragsmatig functioneren anderzijds, werden data betreffende 
hersengolven in rust, neurocognitief functioneren en ADHD-kernsymptomen geanalyseerd. 
Voor 38 kinderen (8-15 jaar) waren data van hersengolven in rust en scores van ADHD-
kernsymptomen beschikbaar. Voor 32 kinderen waren ook neurocognitieve data voorhanden. 
191Samenvatting
De individuele APF werd gemeten door het gebruik van zowel de ogen-open als de 
ogen-dicht conditie. De frequentiebanden werden geanalyseerd op basis van de ogen-open 
conditie. Een signiﬁcant positieve relatie werd gevonden tussen de theta/beta power ratio 
en de totale score op de ADHD-kernsymptomen en de score op de sub-schaal hyperactivi-
teit. Tevens werd een signiﬁcante relatie gevonden tussen relatieve theta power en de 
sub-schaal hyperactiviteit/impulsiviteit. Beide relaties werden sterker wanneer gecontroleerd 
werd voor de individuele APF. Acht van de 38 kinderen (21%) lieten een verlaagde APF zien 
(een APF van 9 Hz of lager), waardoor een overlap ontstond tussen hun individuele 
alpha-band en de theta-band. Een relatie tussen de theta/beta power ratio en/of relatieve 
theta power in rust en het neurocognitief functioneren werd niet gevonden. De resultaten 
van deze studie bevestigden dat de theta/beta power ratio en relatieve theta power 
inderdaad correleren met de ADHD-kernsymptomen. De bevindingen suggereren verder een 
belangrijke rol voor de individuele APF in de onderliggende elektrofysiologie bij ADHD. 
Niet-farmacologische interventies bij kinderen met ADHD
Frequentie neurofeedback 
Hoofdstuk IV beschreef een studie bij kinderen met ADHD naar de effectiviteit van F-NF op 
de ADHD-kernsymptomen en het globaal klinisch functioneren en de veiligheid, zoals deze 
gegeven wordt in de dagelijkse klinische praktijk. Dit onderzoek betrof een dubbel-blinde, 
semi-gerandomiseerde, placebo-gecontroleerde studie. Eenenveertig kinderen (8-15 jaar) 
met ADHD werden semi-willekeurig toegewezen aan F-NF of placebo-NF voor 30 sessies 
met een frequentie van tweemaal per week. Stratiﬁcatie werd toegepast voor leeftijd, elek-
trofysiologische staat van ‘arousal’ en medicatiegebruik. Alle betrokkenen in deze studie, 
behalve de NF-therapeut, waren blind ten aanzien van groepstoewijzing. Hoewel beide 
groepen op het niveau van ADHD-kernsymptomen verbetering lieten zien, kon de studie 
geen superieur effect aantonen voor F-NF groep ten opzichte van de placebo-NF groep. 
Bovendien werd er ook geen superieur effect gevonden op globaal klinisch functioneren. Er 
werden geen relevante bijwerkingen gevonden. Haalbaarheid van deze studie-opzet ten 
aanzien van de geïmplementeerde placebo-NF, waarbij het feedback signaal gebaseerd was 
op een gesimuleerd EEG signaal, bleek uit de bevinding dat het raden van de groepstoewij-
zing niet beter was dan op basis van kans. Hoofdstuk V omvatte verdere analyses van 
dezelfde studie met als doel de effectiviteit van F-NF op neurocognitief functioneren te 
onderzoeken en bevatte tevens een systematische ‘review‘ over dit onderwerp. Daarnaast 
werd het EEG gedurende de sessies geanalyseerd met als doel te onderzoeken of er toename 
van neurale regulatie plaatsvond gedurende de F-NF. Een breed palet aan neurocognitieve 
taken werden voor en na de behandeling afgenomen. Deze neurocognitieve taken waren 
uitgekozen op grond van de veronderstelde neurocognitieve disfuncties bij kinderen met 
ADHD (aandacht, executief functioneren, belonings-gerelateerde processen en ‘timing’). 
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Zowel op groepsniveau als op individueel niveau werden geen signiﬁcante effecten 
gevonden op neurocognitief functioneren ten gunste van F-NF. De systematische review 
over dit onderwerp liet tevens geen superieur effect zien van F-NF op neurocognitief 
functioneren. Bovendien werd geen steun gevonden voor toegenomen neurale regulatie na 
F-NF. 
Samenvattend toonden deze studies geen superieur effect aan van F-NF ten opzichte van 
placebo-NF op de ADHD-kernsymptomen, globaal klinisch en neurocognitief functioneren. 
Er werd bovendien geen steun gevonden voor de neurofysiologische hypothese van F-NF. 
Cogmed werkgeheugen training
Hoofdstuk VI betrof een studie bij jonge kinderen met ADHD naar de effectiviteit van 
CWMT op de ADHD-kernsymptomen, het neurocognitief, dagelijks executief en globaal 
klinisch functioneren. Dit onderzoek betrof een triple-blinde, semi-gerandomiseerde, place-
bo-gecontroleerde studie. Eenenvijftig kinderen (5-7 jaar) met ADHD werden semi-willekeu-
rig toegewezen aan de actieve of placebo conditie van het Cogmed JM training programma 
voor 25 sessies met een frequentie van vijf keer per week. Stratiﬁcatie werd toegepast voor 
leeftijd en geslacht. Alle betrokkenen in deze studie waren blind ten aanzien van groepstoe-
wijzing. Hoewel kinderen vooruitgang lieten zien op diverse maten, toonde deze studie geen 
superieur effect aan van CWMT ten opzichte van de placebo conditie op de ADHD-kern-
symptomen, neurocognitief, dagelijks executief en globaal klinisch functioneren. Kinderen 
in de actieve conditie lieten wel verbetering zien op de getrainde werkgeheugentaak, maar 
geen superieure verbetering op de niet-getrainde taken. Samenvattend kon deze studie 
geen bewijs vinden voor de effectiviteit van CWMT bij jonge kinderen met ADHD. Met 
andere woorden, deze studie liet geen transfer-effecten zien. 
In de discussie (Hoofdstuk VIII) werden de bevindingen van de vijf studies besproken en 
werd ingegaan op de betekenis van de bevindingen voor de klinische praktijk. De drie 
belangrijkste lessen van dit proefschrift waren:
1) Hersengolven in rust kunnen mogelijk een belangrijke bijdrage leveren aan onze kennis 
over ADHD. Echter, de puzzel over de betekenis van deze hersengolven in ADHD is nog 
helemaal niet opgelost. Alpha power en APF verdienen in elk geval een meer prominente 
rol in de zoektocht naar de elektrofysiologische achtergrond van ADHD. Correlaties 
tussen hersengolven in rust enerzijds en ADHD-kernsymptomen en neurocognitief 
functioneren anderzijds zijn aangetoond; echter inconsistentie van deze bevindingen 
maken duidelijke conclusies nu (nog) niet mogelijk. 
2) De studies naar de effectiviteit van F-NF en CWMT bij kinderen met ADHD in dit 
proefschrift toonden geen superieur effect aan van de behandelconditie ten opzichte 
van de placebo conditie. Het is mogelijk dat methodologische en andere tekortkomingen 
van deze studies oorzaak zijn van het niet vinden van grote speciﬁeke behandeleffec-
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ten zoals die gevonden worden bij ADHD-medicatie; hoewel de resultaten niet 
inconsistent waren, maar signiﬁcant afwezig waren op alle niveaus. Echter, de 
beperkingen van beide onderzoeken mogen niet genegeerd worden en moeten worden 
aangepakt in toekomstig wetenschappelijk onderzoek. 
3) Voorlichting aan ouders en hun kinderen met ADHD over F-NF en CWMT dient in lijn te 
zijn met de actuele onderzoeksresultaten. 
Aanbevelingen voor toekomstig wetenschappelijk onderzoek werden vervolgens besproken. 
Er werd stilgestaan bij de beperkingen van de huidige studies. Het belangrijkste advies voor 
toekomstig wetenschappelijk onderzoek was het optimaliseren van eerdere studies om de 
mogelijk speciﬁeke en unieke effecten van F-NF en CWMT verder te onderzoeken, met als 
doel een meer deﬁnitieve uitspraak te kunnen doen over de werkelijke betekenis van beide 
potentiele behandelmethoden bij kinderen met ADHD.
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